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ABSTRACT 
Brenna McJury Richardson: Multidimensional Separation of Intact Proteins for Differential 
Proteomics Employing Top-Down and Bottom-up Proteomic Strategies 
(Under the direction of James W. Jorgenson) 
 
 Differential proteomics, sometimes referred to as differential expression proteomics, 
is a subset of proteomics that attempts to identify and quantify changes in protein expression 
between multiple samples.  One of the major challenges associated with any proteomics 
experiment is sample complexity.  The traditional method of analysis involves a gel-based 
separation of intact protein for a quantitative comparison followed by analysis by mass 
spectrometry to identify differentially expressed proteins.  While this method does have the 
resolving power to accommodate the sample complexity encountered in proteomics, there 
has been a shift towards liquid chromatography-based separations to improve automation, 
reduce sample bias, and more easily couple the separation to mass spectrometry. 
 In Chapter 2, an on-line liquid chromatographic separation strategy was developed 
similar in nature to the traditional gel-based approach and was applied to the analysis of 
differential yeast samples.  It involved the on-line 2D separation of intact protein followed by 
MS analysis and fraction collection.  A digestion of select fractions was performed to 
identify differentially expressed protein in a bottom-up manner.  The experiment is top-down 
as it uses the intact protein MS signal for quantification and determination of  the intact 
protein molecular weight, but is bottom-up in that proteins are identified following enzymatic 
digestion.  This methodology is applied in Chapter 6 to study the differential expression of 
 iv 
proteins in both wild-type and β-arrestin 1,2 double knockout mouse embryonic fibroblast 
cells. 
 Chapters 3, 4 and 5 focus on examining the correlation between experiments 
performed in either a top-down or bottom-up manner.  A digestion of the complete sample 
set was performed in Chapter 3 in a conventional, bottom-up only experiment.  The analysis 
discussed in Chapter 4 directly compares the differential expression of protein determined by 
a top-down experiment to the expression from a bottom-up experiment.  To facilitate this 
comparison, intact proteins were initially fractionated and then split such that each fraction 
was analyzed by both proteomic methods.  In Chapter 5, intact proteins were fractionated 
prior to digestions in an attempt to improve both identification and quantification of proteins.  
The differential expressions from all forms of analysis of the same sample set were analyzed 
and compared. 
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 Introduction and Background for Multidimensional Separations and CHAPTER 1:
Differential Proteomics 
 
1.1 Multidimensional separations for differential proteomics 
 Background and theory 1.1.1
One of the main issues facing the field of chemical separations is the seemingly 
endless complexity of samples to be analyzed.  An area currently being heavily researched 
that involves the analysis of highly complex samples includes the ‘-omics’ analyses.  Some 
examples include the comprehensive analysis of genes, as is the case in genomics, 
metabolites (metabolomics), and proteins (proteomics), to name a few.  In proteomics, much 
of the research now involves analysis by mass spectrometry (MS) due to the high mass 
accuracy and structural information that can be gained.  Although some mass spectrometers 
have mass resolution upwards of 100,000, as is the case with a Fourier-transform ion 
cyclotron resonance (FT-ICR) instrument, due to the complexity of the samples in this area, a 
separation is still usually needed prior to analysis by MS.   
One way in which separation performance can be assessed is through the 
determination of peak capacity.  Peak capacity is defined as the number of peaks that can fit 
in a separation space with a resolution of 1.0 between neighboring peaks.
1
  This represents 
the maximum number of components that could be theoretically separated on a given column 
or gel within a specified gradient time or separation space, respectively.  Conventional high 
pressure liquid chromatography (HPLC) methods with operating pressures below 6,000 psi 
 2 
and columns packed with 5 µm particles have peak capacities around 200.
2
  With the use of 
smaller particles, less than 2 µm in diameter, and pumps capable of supplying the necessary 
pressure to run these columns, the peak capacity can increase to roughly 600. 
3, 4
  In spite of 
these improvements, there still remains a substantial disparity between the complexity of a 
complete proteome and the resolving power of a single dimension separation.  To address 
this shortcoming, advances have been made in the way of multidimensional separations.   
The peak capacity of a two-dimensional (2D) separation is the linear combination of 
the peak capacities in both of the single dimensions.  For example, with a peak capacity of 50 
in the first dimension and 100 in the second dimension, the theoretically obtainable peak 
capacity for the multidimensional separation would be 5,000.  However, this is only true 
under ideal conditions.  To obtain the full advantage that a multidimensional separation can 
offer, two criteria must be fulfilled.  First, the separation modes must be orthogonal, or 
dissimilar.  Historically, this has been performed by using two different separation 
mechanisms, such as ion-exchange followed by reversed phase.  More recent work has been 
performed involving the two-dimensional separation of peptides using a reversed phase 
separation in both dimensions.
5
  The orthogonality is achieved through a change in pH of the 
mobile phase, which affects the polarity and therefore the retention times of the peptides.   
The second criterion that must be met for the multiplicative nature of peak capacity to 
be realized involves the sampling of the first dimension.  For a 2D separation performed in 
space, as is the case in 2D gel electrophoresis or 2D thin layer chromatography, this becomes 
a non-issue, since the first dimension is not technically sampled, but rather transferred or 
analyzed as a whole in the second dimension.  Where this does become a major factor is in 
2D in time techniques, in which 2D-LC separations falls.  This is an issue for both on-line 
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and off-line analyses where fractions are either collected or transferred in a serial manner for 
separation in the second dimension.  In the ideal case, all resolution gained from the 
separation in the first dimension would be retained in the transfer to the second dimension.  
However, complete retention of resolution is not feasible when collecting fractions and so, 
some will inevitably be lost.  It has been suggested that in order to minimize this loss, 
fractions must be collected roughly three times across the 8σ base width of the peak in the 
first dimension.
6
  If this guideline is not followed, then there is likely to be a significant 
deviation in peak capacity from what could be achieved if the first dimension were not 
under-sampled. 
A 2D separation can be made to have much greater separation power than either 
single dimension on its own given that the conditions described above are met.  This criterion 
is less likely to be met in the case of 2D in time techniques than it would be in a 2D in space 
technique.  However, even if the first dimension of a 2D in time analysis is slightly under-
sampled and therefore does not fulfill the multiplicative rule, it is still likely to produce an 
analysis with much greater resolving power than that of a single dimension separation. 
 Previous work in comprehensive multidimensional liquid chromatographic 1.1.2
separations of intact proteins 
Multidimensional separations for work involving intact proteins can be divided into 
two categories: gel-based, and non-gel based.  The most widely used gel-based approach is 
two-dimensional gel electrophoresis (2-DE).  As this also became the most widely used gel-
based approach for differential proteomics, it is described in detail in section 1.2.3.  With 
regard to LC-based separation strategies, the first truly comprehensive approach was 
published in 1990 by the Jorgenson lab.
7
  The separation modes coupled in this experiment 
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included cation exchange chromatography in the first dimension followed by size exclusion 
chromatography in the second dimension.  A modest value of 130 was reported for the 
combined 2D peak capacity.  However, with the development of smaller particles and better-
performing columns, much progress has been made since then.  For example, in 2003, Yan 
and co-workers employed a chromatofocusing separation coupled to a reversed phase 
separation for the proteomic analysis of adenocarcinoma cell lysates.  While protein 
identification was performed after digesting each fraction, monitoring by UV absorption 
revealed more than 1000 protein bands in the 2D chromatogram.
8
  A separation coupling 
strong cation exchange with reversed phase chromatography for the analysis of intact 
proteins was reported in 2006.
9
  While the authors did not report a specific peak capacity, 
after digestion of the approximately 150 fractions collected, over 1500 proteins were able to 
be identified directly by MALDI-MS or through LC coupled to MALDI-MS. 
While there are many research groups focusing on the improvement of 2D separations 
of peptides for the purpose of bottom-up proteomics, there appear to be far less that are 
looking at 2D separations of intact proteins as a means for competing with two-dimensional 
gel electrophoresis (2-DE).  The experiments in this dissertation are targeted at addressing 
this issue. 
1.2 Differential proteomics 
 Definition and challenges 1.2.1
Differential proteomics, or differential expression proteomics, has evolved due to the 
need for a more targeted approach in the broader field of proteomics.  The qualitative global 
proteomic analyses performed over a decade ago have evolved into more quantitative, 
reproducibility-driven experiments.  Protein biomarker discovery is strong evidence of this 
trend as experiments are geared toward providing robust differential expression profiles 
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between samples that might indicate distinct biological or temporal states.
10
  The challenges 
associated with a differential proteomics experiment are similar to those associated with a 
proteomics experiment with the major obstacle being sample complexity.  For example, 
much of the work presented in this dissertation involves the analysis of cell lysates from 
Saccharomyces cerevisiae, or Baker’s yeast.  Even though this is the simplest eukaryote and 
one of the most heavily studied organisms, the protein database obtained from SwissProt still 
contains more than 6,500 protein entries.  Adding to the number of proteins is the large range 
of expression levels present.  With the understanding that there is a high likelihood that some 
of the more interesting proteins, i.e. those that change in abundance between two samples, 
will not be some of the most abundant, a technique with a large dynamic range is necessary. 
 Major categories of proteomic experiments 1.2.2
The majority of mass spectrometry-based proteomic analyses can be divided into two 
main experimental strategies: top-down (TD)
11, 12
 and bottom-up (BU)
13
 proteomics with BU 
experiments being the most widely used.  Methods are categorized by the types of ions that 
are introduced into the mass spectrometer.  If the ions are intact proteins upon introduction, 
then the analysis would fall into a TD experiment.  However, if the proteins have been 
enzymatically digested into peptides prior to MS analysis, then it would be a BU experiment.   
1.2.2.1 Bottom up proteomics 
BU proteomic experiments, which typically involve a tryptic digest of intact proteins 
prior to analysis, have been readily used over the past two decades.  There are many different 
subclasses of BU proteomics including multidimensional protein identification technology 
(MudPIT), accurate mass and time tag (AMT), and peptide mass fingerprinting (PMF).   
In a PMF analysis, peptides are usually separated prior to analysis by mass 
spectrometry.  The peptide mass list generated from the MS scan is then compared to a list of 
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calculated peptide masses from an ‘in silico’, or theoretical, digestion of a set of proteins or 
gene sequences in a specified database for protein identification.  For purified proteins or 
simple mixtures of proteins, a PMF analysis works well provided that several peptides unique 
to an identified protein are present.  The success of a PMF experiment and the confidence in 
which a protein is identified is highly dependent on the calibration and mass accuracy of the 
mass spectrometer as well.  An analysis performed solely by PMF becomes less feasible as 
the sample complexity increases.  With more proteins present and larger databases to search, 
the possibility of multiple peptides having the same mass within the calibration error of the 
instrument increases tremendously. 
Tandem mass spectrometry has been used to handle the sample complexity present in 
analyses of entire proteomes.  Peptides are fragmented online via collision induced 
dissociation (CID), which cleaves along the peptide backbone, to give a series of fragment 
ions based on the position of the cleavage and whether the charge remains on the n-terminus 
or c-terminus.  The most abundant fragmentation in a CID experiment occurs at the amide 
bond resulting in b (charge remains on n-terminus) and y (charge remains on c-terminus) 
ions.  The fragment ions can be used to determine the sequence of a short stretch of amino 
acids, which is then searched against database.  Primary sequence information gained in a 
tandem MS experiment decreases the occurrence of peptides with overlapping masses that is 
problematic in PMF searches, since overlapping peptides would also have to have the same 
sequence in order to be ambiguous.   
A MudPIT analysis employs an on-line MS/MS analysis after a two-dimensional 
separation of the peptides on a single capillary column packed with strong cation exchange 
particles in the first half and reversed phase particles in the second.  Elution of peptides off of 
 7 
the first column and onto the second column is achieved by raising the ionic strength of the 
mobile phase in a single step.  The elevated ionic strength elutes a set of peptides from the 
first half of the column and, with no organic mobile phase present, the peptides are 
essentially trapped at the head of the second half of the column.  After a set period of time, 
the ionic strength is reduced and a RP gradient of increasing hydrophobicity is flowed 
through the column to elute proteins from the RP segment.  Once the RP gradient is finished, 
the entire column is equilibrated at initial conditions.  A second step of elevated ionic 
strength is performed, this time higher in ionic strength that the first step to elute a second set 
of peptides, which are subsequently eluted from the second half of the column by a second 
RP gradient.  A series of ionic strength and RP gradient cycles are performed until all species 
are eluted off the column
14, 15
 
Lastly, the AMT approach combines both single MS and tandem MS analyses into 
one.  By using an instrument with high mass accuracy, such as a Fourier-transform ion 
cyclotron resonance (FT-ICR) MS, coupled to an LC separation with good retention time 
reproducibility, mass and time tags can be established.
16
  In the initial experiment, LC-
MS/MS data are acquired in a data-dependent manner.  The sequences from short stretches of 
amino acids obtained from the fragmentation analysis are searched against a database to 
identify a protein.  The chromatographic retention times of the peptides used to identify the 
protein as well as the peptide mass are recorded as AMT tags.  In subsequent analyses, single 
MS analysis is performed and the presence of the protein is determined by the presence of a 
peptide mass at a retention time that both match, within a specified tolerance, an AMT tag 
from the MS/MS run.  This type is most commonly employed for a higher throughput 
analysis where many similar samples will be analyzed for targeted proteins. 
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Some of the major advantages of a BU experiment include the relative ease of 
separations at the peptide level, the predictability of peptide fragmentation by collision 
induced dissociation, and the availability of commercially available software to perform 
database searching.  For these reasons, it is far more widely used than TD proteomics, 
although this type of experiment does come with some limitations.  For example, the 
sequence coverage in a bottom-up experiment can vary widely from protein to protein 
ranging anywhere from approximately 5-70%.  The major disadvantage is the lack of 
determination of the molecular weight of the intact protein.  Because many of the post-
translational modifications (PTMs) may be lost during the MS/MS fragmentation at the 
peptide level, very little about a protein is known other than its presence or absence from a 
sample.  
1.2.2.2 Top down proteomics 
In comparison with bottom-up proteomics, top-down proteomics is a relatively 
immature field.  It is based on the direct ionization of intact proteins and subsequent analysis 
by tandem mass spectrometry, usually in a data-dependent acquisition.  Protein mixtures are 
usually separated to obtain a single protein prior to ionization.  While analysis of intact 
proteins for structural information began with the invention of soft ionization techniques such 
as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI), it 
did not really take hold until the development of electron capture dissociation (ECD) in the 
McLafferty lab in 1998.
17
  In an MS/MS experiment with ECD, low energy electrons are 
captured by multiply charged protein precursor ions to produce [M + nH]
 (n-1) +·
 ions.  Rapid 
fragmentation of this species occurs at the N-αC bond to produce c and z-type ions as 
opposed to the b and y-type produced in a CID experiment.  Fragmentation occurs much 
more randomly in ECD than it does in CID and can therefore offer complementary 
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information to that of a CID experiment.  Also, because it is a nonergodic fragmentation 
process, PTM’s are more likely to be preserved in their original location and site-specific 
PTM information can be gained.
18
  However, in order to obtain favorable signal-to-noise 
ratios in ECD experiments, several spectra must be averaged, which often precludes its 
online coupling to an LC separation.  More recently, electron transfer dissociation (ETD) was 
developed which involves the transfer of an electron from an anion of low electron affinity to 
a multiply charged protein cation.  Fragmentation occurs in the same manner as in ECD, but 
in an ion trap and on an LC timescale.
19
 
Some advantages to a TD experiment include a greater possibility to increase the 
sequence coverage of a protein and determine more accurately the presence and position of 
many PTMs.  However, there are still some significant limitations encountered with this type 
of analysis.  Due to the complexity of the fragmentation spectra, this type of analysis is often 
limited to purified proteins or a small mixture.  Lastly, data analysis for this analysis is more 
labor-intensive than that of a bottom-up experiment.  There are several well-developed 
software packages that are commercially available to aid in the analysis of BU data.  In 
contrast, TD data are often analyzed manually, which is one of the factors preventing its use 
as a high throughput method. 
 Conventional method for proteomics 1.2.3
The classical method for a differential proteomic experiment involves separated gel-
based separations of the intact proteins from multiple samples for a quantitative comparison 
followed by digestion and analysis of peptides by mass spectrometry for identification.  This 
method has shown the ability to resolve several thousand proteins in a single run.
20, 21
  The 
typical separation method performed is two-dimensional gel electrophoresis (2-DE).  Intact 
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proteins are separated by isoelectric focusing in the first dimension, which separates based on 
isoelectric point (pI).  The gradient strip is then transferred to a sodium dodecyl sulfate 
polyacrylamide gel for an electrophoretic separation which roughly separates according to 
protein molecular weight.
22
  After staining, images of the gels obtained from the separation 
of differential samples are processed through image analysis software in order to determine 
which protein spots vary in intensity between the samples.  These spots are excised from the 
gel manually, or with the aid of a robotic device, digested and analyzed by MALDI- MS to 
gain accurate mass information for the resulting peptides.  The accurate mass data are then 
searched against a protein database for tryptic peptides with identical masses as is done with 
a PMF analysis.  To confirm the protein identity, a select few of the peptides used for 
identification are analyzed further by tandem mass spectrometry in order to gain more 
specific sequence information. 
While 2-DE does have the peak capacity to accommodate the sample complexity 
encountered in proteomics, it does suffer from a few critical limitations.  Namely, 
hydrophobic proteins may not enter the gel for separation, highly acidic or basic proteins are 
not as well resolved as those of intermediate pI, less abundant proteins may not be observed 
due to limitations with the various staining methods, and lastly, protein identification may be 
difficult and time consuming as spots must be excised from the gel, digested and often 
analyzed more than once to get a confident identification.  Furthermore, only a small fraction 
of the peptides used to identify a protein undergo MS/MS analysis increasing the likelihood 
of false peptide hits, especially with overlapping gel spots. 
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 The use of liquid chromatography for differential proteomics 1.2.4
Due to the limitations of gel-based differential proteomics described above, there has 
been a shift toward trying to do an equivalent analysis based on liquid chromatographic 
separations.  The general trend in this type of experiment is to use an initial separation of the 
intact proteins for fractionation in order to simplify the mixtures prior to digestion.
10, 23-25
  In 
some experiments the intact mass of the protein may be determined through analysis by mass 
spectrometry prior to digestion
23
, although this is not often the case.  By reducing the number 
of proteins present in a fraction, the number of peptides present in the sample is greatly 
reduced.  The reduction is magnified due to the fact that digestion results in multiple peptides 
per protein.  
1.3 Scope of dissertation 
The experiments and data presented here represent a novel separation strategy 
employed to determine changes in protein expression between two samples.  The classical 
approach to this is 2-DE, but, as described earlier, it suffers from some major limitations such 
as protein bias and limited dynamic range.  Recent experiments aiming to replace 2-DE are 
based mainly on BU proteomic experiments in which both the protein identification and 
quantitation is performed at the peptide level.  The molecular mass and, therefore, the protein 
isoform are never determined.  The aim of this research is to present a method that combines 
some of the advantages from both TD and BU experiments while employing some of the 
latest technology.  Relative quantitation is performed at the intact protein level, since that is 
the species actually present in the sample, while identification is achieved through the more 
reliable BU analysis after digestion.  This method will be compared with some traditional BU 
experiments as well as those in which a separation of the intact protein is performed solely to 
simplify the mixture prior to digestion.  The overlap between the differential comparisons of 
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protein abundance based on intact protein MS intensity and that based on peptide data will be 
compared to evaluate the extent of correlation. 
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 Differential proteomic analysis of the soluble fraction of proteins CHAPTER 2:
produced by cell lysates of S. cerevisiae grown under different conditions using an on-
line multidimensional separation strategy 
 
2.1 Introduction 
As discussed in the first chapter, a switch from a gel-based differential proteomics 
approach to a liquid chromatography approach would be beneficial for multiple reasons.  
Namely, an LC-based approached would be more conducive to automation due to its inherent 
fluidic nature.  In addition, the use of mass spectrometry to determine the intact molecular 
weight of the proteins during the two-dimensional (2D) separation would be a vast 
improvement over mass resolution achieved in the SDS-page separation of the gel-based 
approach. 
1
  The two main categories of proteomic analyses were also discussed: top-down 
and bottom-up proteomics.  The work presented in this chapter combines the application of 
an LC-based approach to a differential proteomic analysis.  The methodology is also a 
combination of both a top-down and a bottom-up analysis.  After performing a number of 
off-line separations of intact proteins, it was determined that a multidimensional on-line 
separation of intact proteins by anion exchange followed by reversed phase would be the best 
option to obtain the intact protein molecular weight in a top-down manner. 
2
   
The purpose of the work presented in the chapter was to examine the capabilities of 
the instrumental method for a differential proteomic analysis; it will be applied later to a less 
well-understood sample set.  When determining which type of samples to analyze, a logical 
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choice was Saccharomyces cerevisiae (baker’s yeast) due to breadth of existing knowledge 
on this single cell eukaryote in the fields of both biochemistry and cellular biology.
3, 4
  
Additionally, the yeast cell lysates have a decreased sample complexity as compared to other 
eukaryotic species that will be studied in a later chapter.  Differences in protein expression 
were induced in two separate ways: by varying the carbon source in the grown nutrient, and 
by varying at which phase during the growth cycle the cells were harvested. 
2.2 Experimental 
 Overview of experimental method 2.2.1
The overall workflow for the complete experiment is shown in Figure 2-1.  The 
instrumentation can be broken down into two separate processes; online LC-LC-MS of intact 
proteins and LC-MS/MS of peptides following digestion.  The first separation includes the 
coupling of anion exchange chromatography in the first dimension to reversed phase LC in 
the second dimension.  The majority of the effluent from the second dimension columns is 
collected by a fraction collector while a small amount is diverted to a mass spectrometer for 
determination of intact protein masses.  All samples relevant to a single differential 
proteomic experiment are analyzed by online 2D-LC of intact proteins prior to moving on in 
the workflow.  The resulting 2D chromatograms are compared to one another to highlight 
potential differences in protein expression between samples.  Once a list of differential 
protein masses has been compiled, the corresponding fractions from the online separation are 
then lyophilized, digested, and run by LC-MS/MS for identification by a BU-type 
experiment.  A comparison is then made between the differential protein mass list and the 
predicted molecular weights of proteins identified by database searching of the peptide 
MS/MS data.  Two sets of three runs each were run during this experiment.  The first 
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consisted of a triplicate analysis of the glycerol-grown yeast sample to assess analytical 
reproducibility and the second was a series of the three differential yeast samples. 
 Reagents and mobile phases 2.2.2
The chemicals used for the LC mobile phases were ammonium acetate, ammonium 
hydroxide, formic acid, LC-MS grade water and acetonitrile, all purchased from Fisher 
Scientific (Fair Lawn, NJ).  Deionized water was purified using a Barnstead Nanopure 
System (Boston, MA).  Chemicals used in the trypsin digestion were: ammonium 
bicarbonate, iodoacetamide and trifluoroacetic acid, also purchased from Sigma (St. Louis, 
MO), RapiGest SF, an acid-labile surfactant provided by Waters Corporation (Milford, MA), 
dithiothreitol (Research Products International, Mt. Prospect, IL), and TPCK-modified 
trypsin (Pierce, Rockford, IL). 
Standard proteins, which were used for intensity adjustments, were Cytochrome C, 
myoglobin and bovine serum albumin, which were all purchased from Sigma Aldrich and 
used, as received, after dilution to the desired concentration.   
 Preparation of S. cerevisiae protein extracts 2.2.3
Cytosolic yeast protein samples were prepared from S. cerevisiae cultures by 
researchers at Waters Corporation (Milford, MA).  Yeast cells were initially maintained on 
dextrose-containing agar plates purchased from Teknova (Hollister, CA).  In order to induce 
changes in protein expression three select colonies were transferred to culture flasks, two of 
which contained YPD (dextrose carbon source) and one contained YPG (glycerol carbon 
source).  After initial overnight incubation, the small scale cultures were used to inoculate 
prep scale cultures of each sample type.  Similar growth conditions were maintained across 
all samples prior to harvest by centrifugation.  The sample grown on glycerol was harvested 
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during the logarithmic phase of growth.  While one of the dextrose-grown samples was also 
harvested at the logarithmic phase of growth, the other was harvested once the growth rate 
had reached the stationary phase.  Cells were stored at -80°C prior to lysis. 
The lysis conditions have been detailed previously by Millea, et al.
5
  The final 
samples contained cytosolic yeast proteins in 25mM ammonium bicarbonate along with 
various phosphatase inhibitors.   
 Bradford protein quantitation assay 2.2.4
Total protein concentrations for the cytosolic yeast samples were determined using a 
Coomassie Plus Bradford assay kit (Pierce Biotechnology, Rockford, IL).  Protein samples 
were diluted 50-fold in order to reduce the concentration to fall within the linear range of the 
standards prepared by following the standard test tube procedure outlined in the assay kit.  A 
series of nine standard dilutions of bovine serum albumin were made for calibration.  Fifty 
µL of each protein solution was transferred to a centrifuge tube and 1.5mL of the standard 
Coomassie reagent was added.  Solutions incubated at room temperature for 10 minutes.  
Analysis was performed in triplicate for each sample and standard.  Absorbance readings 
were taken at 595 nm.  From this assay, it was determined that the concentration of the 
glycerol/log phase sample was 13.5 mg/ml, the dextrose/log phase sample was 11.0 mg/mL 
and the dextrose/stationary phase sample was 10.5 mg/mL.  All solutions were diluted to a 
final concentration of 10 mg/mL prior to analysis.  Cytochrome C and myoglobin were 
spiked into each sample at a concentration of 10 ng/mL each along with β-lactoglobulin at 20 
ng/mL in order to account for fluctuations in instrument reproducibility from day to day. 
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 On-line LC x LC instrumentation and run conditions 2.2.5
A diagram outlining the instrumentation for the on-line 2D LC separation is shown in 
Figure 2-2. The two separation modes used in the multidimensional separation were anion 
exchange in the first dimension followed by reversed phase in the second dimension.  The 
first dimension column was a series of 3 custom-packed 6.6mm ID x 40 cm Omnifit glass 
column hardware (Sigma-Aldrich, St. Louis, MO) giving an effective column length of 111 
cm.  The packing material used in the anion exchange column was expelled from a Waters 
BioSuite Q preparative scale column and consisted of 13 µm polymeric particles with 1000 
Å pores bonded with a strong anion exchange quaternary amine stationary phase.  The initial 
injection of cell lysate onto the first dimension anion exchange column was performed using 
a Valco 6-port valve (VICI, Houston, TX) equipped with a 550 µL sample loop.  The 
gradient for the first dimension was supplied by a Waters 600 quaternary gradient LC pump.   
The outlet of the anion exchange column was connected to a Valco 10-port valve 
(VICI, Houston, TX), which directed anion exchange effluent onto one of the reversed phase 
columns.  There were two identical columns used as the second dimension, which were 
Waters BioSuite pPhenyl columns with dimensions of 4.6 mm ID x 7.5 cm packed with 10 
µm, 1000 Å pore polymeric particles bonded with a phenyl stationary phase.  Figure 2-3 
outlines the operation of the on-line set-up.  When the valve was in position 1, proteins 
eluting from the anion exchange column were trapped at the head of reverse phase column B 
due to the absence of any organic modifier in the anion exchange mobile phase.  The anion 
exchange mobile phase passed through the reverse-phase column, through a small piece of 
tubing and then back through the 10-port valve prior to being diverted to waste.  Meanwhile, 
reverse phase column A received a gradient generated by a Hewlett-Packard 1050 HPLC 
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pump (Agilent, Santa Clara, CA) to elute proteins previously trapped on that column.  After a 
set period of time, 30 minutes in this experiment, the 10-port valve was switched to divert 
effluent from the anion exchange column onto reverse phase column A.  At this point, the 
proteins that had been previously trapped on reverse phase column B were eluted off the 
column by the gradient provided by the second HPLC pump.  A full 2D run was completed 
by switching the 10-port valve multiple times while proteins continued to elute from the 
anion exchange column throughout the gradient supplied by the first LC pump. 
The anion exchange gradient consisted of 10mM ammonium acetate, adjusted to pH 
9.0 with ammonium hydroxide in mobile phase A.  Mobile phase B was 750 mM ammonium 
acetate, also adjusted to pH 9.0 with ammonium hydroxide.  The mobile phases for the 
reverse phase separations consisted of water in mobile phase A and acetonitrile in mobile 
phase B, both with 0.2% formic acid added.  Table 2-1 and Table 2-2 outline the flow rates 
and gradient profiles used in the anion exchange and reversed phase separations, 
respectively. 
 UV and MS detection and fraction collection 2.2.6
The effluent from the second dimension RP columns was split such that 95% of the 
flow was directed to an Applied BioSystems 785A UV detector (Foster City, CA) set at 
193nm and then on to a fraction collector (Waters Fraction Collector II).  Sixteen 45-second 
fractions were collected from 2 minutes to 14 minutes during each of the reversed-phase runs 
for a total of 480 fractions per 2D run.  The remaining 5% of the flow was directed to a 
Waters LCT mass spectrometer for intact mass analysis by ESI-MS.  The mass spectrometer 
was operated in positive ion mode using a standard z-spray ion source.  Calibration of the 
instrument was performed daily using a solution of sodium formate.  For mass spectral 
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analysis, data were acquired at an acquisition rate of 1 Hz over the m/z range of 450-1600.  
Voltages applied to the electrospray needle and sample cone were +3000V and +35V, 
respectively.  A nitrogen flow of 250 L/hr was used as the desolvation gas. 
 Intact protein data processing and selection of fractions to be analyzed 2.2.7
Intact protein MS chromatograms were processed by AutoME, a software program 
written by Ignatius Kass at Waters Corporation to perform maximum entropy (MaxEnt) 
processing of the mass spectra in an automated manner.  AutoME divides the chromatogram 
into segments and combines all spectra within each segment before performing MaxEnt 
processing.  Protein mass spectra obtained by electrospray ionization contain a series of 
multiply charged ions on a mass/charge ratio scale.  MaxEnt is an iterative mathematical 
process designed to transform the multiply charged ion series to a single peak on a molecular 
mass scale in which all components have zero charge.
6
  Probabilistic quantitation is also 
performed using the MaxEnt approach effectively combining intensities from all charge 
states to give a single intensity at the molecular mass.  For reference, a mass spectrum from a 
peak separated in the 2D analysis of intact proteins is shown before and after AutoME 
deconvolution in Figure 2-4.The AutoME processing parameters are included in Table 2-5.  
Deconvoluted protein masses that are present as multiples of the main protein mass are 
artifacts of the deconvolution process.  They are removed by AutoME prior to the generation 
of the deconvoluted protein mass lists through the de-harmonizing function, which was set to 
remove masses within 20 Da of any multiples of the main mass.  The AutoME-processed 
mass spectra were used for the construction of the 2D plots. 
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 Lyophilization and tryptic digestion of select fractions 2.2.8
Fractions determined to have differentially expressed proteins were thawed, 
transferred to 1.5 mL centrifuge tubes, and flash frozen prior to lyophilization.  
Lyophilization was performed using a SpeedVac Concentrator (Thermo-Electron, Bellefonte, 
PA), which was pumped down to pressures between 10
-2
 and 10
-3
 Torr using an Edwards 
double-stage rotary vacuum pump.  (Wilmington, MA).  Once the fractions were lyophilized 
to dryness, they were reconstituted in 25 µL of ammonium bicarbonate.   
The standard digestion procedure provided with the RapiGest surfactant was used 
with modifications to account for the quantity of protein expected in each fraction as well as 
the desired volume after digestion.  A 1mg vial of RapiGest was reconstituted with 150 µL 
ammonium bicarbonate.  Three µL of RapiGest was added to each fraction.  Samples were 
vortexed and incubated at 80°C for 15 minutes, vortexing periodically.  Samples were 
centrifuged at 10,000 x g for 4 minutes to return condensate to the bottom of the vial.  One 
µL of 100mM dithiothreitol was added, the solutions were vortexed, and allowed to incubate 
at 60°C for 30 minutes in order to reduce disulfide bonds.  After centrifugation for 4 minutes 
at 10,000 x g, 1 µL of 200mM iodoacetamide was added to alkylate the sample and prevent 
disulfide bonds from re-forming.  Solutions were incubated, in the dark, at room temperature 
prior to centrifuging again for 4 minutes at 10,000 x g.  Finally, 10 µL of 1mg/mL trypsin in 
ammonium bicarbonate was added and digestion occurred overnight at 37°C. 
Quenching of digestion was performed by the addition of 10 µL of 10% 
trifluoroacetic acid and 40 µL of water to reduce the pH of the solution below 2. Samples 
were incubated at 37°C for 30 minutes to allow for complete hydrolysis of the RapiGest 
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surfactant.  After centrifugation at 12,000 x g for 10 minutes to remove precipitate, the 
supernatant was transferred to a sample vial for LC-MS/MS analysis. 
 Capillary RPLC-MS/MS of tryptic peptides 2.2.9
Bottom-up analysis of the selected digested fractions was performed using capillary 
RPLC-MS/MS.  A Waters Integrated CapLC/PDA system equipped with an autosampler and 
a Waters Q-TOF Micro mass spectrometer were used for analysis.  The PDA capabilities of 
the LC system were not utilized for this analysis.  The capillary column was a 150 µm ID 
capillary packed with 1.5 µm bridged ethyl hybrid C18 particles and was packed in-house to a 
length of 8 cm.  The system was operated using split flow in order to supply the low flow 
rates, roughly 500 nL/min, required by the column while shortening the gradient delay time.  
The splitter was located just prior to the inject valve in order to minimize the gradient delay 
volume without splitting the sample.  The outlet of the column was connected to a 3cm x 
20µm ID pigtail through a Teflon junction, which connected directly to the nano-electrospray 
source.  Because a sintered particle frit was used for the end of the column, the protective 
polyimide coating was removed.  This resulted in exposed silica leaving the end of the 
column very brittle.  The Teflon junction and pigtail were used to preserve the column outlet 
as the Teflon junction produced less stress on the column the traditional ferrule-type fitting 
used in the electrospray interface would have produced.  The small inner diameter of the 
pigtail was selected to reduce extra column band-broadening that may have been caused by a 
larger piece of capillary.  The gradient profile and flow rate information is given in Table 
2-3. 
The nano-electrospray interface was equipped with a pulled, uncoated silica spray tip 
(New Objective, Woburn, MA), which had a 20µm ID pulled to 10 µm at the tip orifice.  The 
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MS/MS analysis of the peptides was performed using a data-directed analysis method (DDA) 
on a Q-TOF Micro mass spectrometer (Waters). In a DDA method, there are two types of 
scans that take place, a survey scan and a product scan.  In a survey scan, the quadrupole is 
set to allow all m/z values to pass through to the collision cell, which is set at a low voltage 
(+7V) so as not to fragment anything before entering the TOF analyzer.  Once a survey scan 
is taken (400-1600 m/z), the two most intense ions above a user-defined threshold (25 counts) 
are selected, one at a time, to be subjected to an MS/MS analysis.  A three-scan collision 
energy profile was used with each precursor ion selected, each with a different collision 
energy based on the precursor m/z as described in Table 2-4.  Fragment ion scans were 
acquired from m/z 50-1800 at a scan rate of 1Hz. After the three product scans for each of 
the precursor ions selected have occurred, another survey scan at low collision energy is 
performed.  In order to prevent a precursor ion from being selected multiple times for 
MS/MS analysis, after an MS/MS scan was taken for each peptide, the peptide m/z was 
added to a dynamic exclude list for one minute.  This allowed MS/MS analysis of some of 
the lower intensity co-eluting peptides. Applied voltages for the capillary, sample cone and 
extraction cone were +2000V, +30V, and +2V, respectively.  The rate of acquisition was 1 
Hz for both survey and product scans.   
 Protein identification by database searching of MS/MS data 2.2.10
Identification of the proteins based on the MS/MS data was performed using the 
ProteinLynx Global Server 2.3 search platform (PLGS2.3, Waters Corporation), which 
allows for the automated processing of raw MassLynx data and searching of peptides against 
protein databases.  PLGS processing is broken down into two steps.  The first involves the 
background subtraction, de-isotoping, and centroiding of the raw data acquired by 
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MassLynx.  Searching of the processed mass spectrum obtained in step one against a protein 
database occurs in the second step.  The database that was used for identification was the 
entire yeast protein database obtained from the Swiss-Prot protein knowledgebase release 
54.2 (http://us.expasy.org/sprot) with trypsin added as well.  Appended to the end of the 
database was a 1x randomization of the yeast proteins in order to determine a false discovery 
rate.  A number of parameters are defined in both processing steps and can be found in Table 
2-6. 
2.3 Results 
 Replicate analysis of yeast samples for evaluation of analytical reproducibility 2.3.1
In order to assess the reproducibility of the 2D intact protein separation, a series of 
three injections of the yeast sample grown on glycerol were performed.  The full 2D 
chromatograms from these separations are shown in Figure 2-5.  Upon visual inspection, the 
general pattern of peaks is almost identical.  There are some slight variations in retention 
time likely due to the evaporation of ammonia from the mobile phase reservoirs throughout 
the runs, thereby reducing the mobile phase pH.  These differences appear to affect all of the 
peaks within a run in a similar fashion.  Because the determination of protein differences is 
performed visually, slight changes in retention time should not hinder this.  Also apparent are 
slight differences in peak intensity, represented in false color in the plots.  The peak 
intensities in each chromatogram have been adjusted based on the intensity of the 
cytochrome C that was spiked into the original sample.  The purpose of the addition of 
cytochrome C was to account for day-to-day MS intensity fluctuations.  Therefore, all 
changes in peak intensities between these replicates are due to differences imposed by the 
method itself. 
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In order to quantify the experimental error to determine if protein intensity 
differences are significant when comparing differential samples, a plot was made to visualize 
the differences in intensity between replicates.  For this plot, the intensity of a single protein 
in one replicate was compared to the intensity of the identical mass in a second replicate.  
The data was plotted on a log scale to better visualize the large range of protein intensities.  
This plot can be seen in Figure 2-6 in which the intensity of a protein in one replicate is 
plotted against the intensity in another.  Since there are three replicates, the data is plotted in 
the following manner: replicate 1 vs. replicate 2, replicate 2 vs. replicate 3, and replicate 3 vs. 
replicate 1.  Also included in this plot is the line y=x, where all points would fall given ideal 
conditions.  The data follow this line fairly well at high intensity, within 10-20%.  However, 
as the intensity decreases, the data points deviate from linearity more and more so that near 
the detection limit, the differences reach a 100-fold change.  The trend of increasing 
deviation from linearity with decreasing intensity closely follows a line with the equation y= 
mx + b in the linear scale.  Experimentally, this equation takes into account a constant level 
of uncertainty, b, and a response factor uncertainty component, m, which is dependent on the 
signal intensity.  Variations of this equation are plotted along with the replicate data in Figure 
2-6 along with the mirror image of these lines across the line y=x.  Along with the equation 
of each line, the legend also includes a percentage value in parentheses.  This number 
corresponds to the percentage of replicate data points that fall within the two lines associated 
with that equation.  To a first approximation, the value can be used as the percent certainty 
that the difference is real and not a product of the method.  
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It was arbitrarily decided that the curve with the equation y = 1.2x + 10
4.4
, which 
contains 96.5% of the replicate data points, was an acceptable threshold for determining if a 
change in protein intensity between differential samples was significant. 
 Molecular weight distribution of intact protein masses from online LC-LC-MS 2.3.2
analysis 
One of the issues commonly seen with the analysis of intact proteins with ESI-MS is 
the bias that occurs towards proteins below a molecular weight of approximately 50 kDa.  
Proteins above this limit are less likely to be seen with ESI.  To evaluate this phenomenon, a 
histogram demonstrating the molecular weight distribution of the detected protein masses 
was plotted with the actual molecular weight distribution of all yeast proteins as reported in 
the database.  The histogram is included in Figure 2-7 A.  In order to better see both 
distributions on the same scale, the number of counts for each molecular weight bin was 
divided by 5 for the distribution of all yeast proteins.  As expected, there is a definite bias to 
proteins with lower molecular weights, but overall, the trends of the distributions are quite 
similar. 
An artifact of the processing is also apparent in the molecular weight distribution and 
can be easily seen in Figure 2-7 B.  The increase in the number of proteins detected with 
molecular weights greater than 50 kDa is actually the summation of low intensity noise 
present in almost every AutoME-deconvoluted mass spectrum.  This high molecular weight 
noise does not affect the selection of protein masses with varying intensities due to the visual 
comparison that is performed on the mass slice chromatograms, which was described in 
section 2.2.7.  In the 2D chromatograms, a low intensity background that is visible in mass 
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slices above 60 kDa is likely the source the majority of the masses in this range of the 
histogram.   
 Differential analysis of intact protein 2D chromatograms 2.3.3
2D chromatograms from the on-line separation of intact proteins of the differential 
yeast samples are shown in Figure 2-8.  As was the case with the replicate analysis, there is 
great similarity between all three plots with regard to the general pattern of protein peaks.  
This is not unexpected, since the samples were all generated from the same organism.  
However, unlike the replicate data, there are clearly some strong differences in peak 
intensities.  Also, there are a greater number of instances in which a peak is present in one 
sample and absent in another.  Some intensity differences are easy to pick out from the full 
2D chromatograms, but for a more thorough analysis of the data requiring a simplification of 
the plots was necessary. 
All intact protein chromatograms in Figure 2-5 and Figure 2-8 contain proteins with 
molecular weights over the entire mass range of the AutoME output.  Because the molecular 
weight of each peak in the chromatogram is known to within 2Da (the resolution defined by 
the AutoME parameters), the plot can be simplified so that only a limited range of masses are 
shown.  Any range of masses could be chosen, but to limit the total number of slices 
generated while still decreasing the complexity, a mass range of 1 kDa was chosen.  A side-
by-side comparison of two ‘mass-slice’ chromatograms can be found in Figure 2-9.  In this 
mass slice comparison all of the possibilities are highlighted: one where protein intensity 
does not appear to change significantly, one in which the intensity was greater in the glycerol 
sample, two where the intensity is greater in the dextrose sample, and one where a protein is 
present in the glycerol sample, but absent in the dextrose sample.  After going through all of 
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the 1 kDa mass slices from 5 to 80 kDa and comparing both the glycerol/log phase sample to 
the dextrose/log phase sample and the dextrose/log phase sample to the dextrose/stationary 
phase sample, a total of 164 protein masses were selected for further analysis by LC-MS/MS 
of the digests for protein identification.  Because some fractions contained multiple 
differential protein masses, it was only necessary to analyze 125 of the 1440 total fractions 
collected (<9%). 
The use of the mass slice 2D chromatograms to visually pick out changes in protein 
intensity facilitated the selection of differential proteins.  However, in order to determine if 
the protein difference was significant, a more mathematical approach was necessary.  This 
was accomplished by creating log-log intensity plots identical to those used for the replicate 
analysis.  The logical comparisons were between the glycerol/log phase sample and the 
dextrose/log phase sample and the dextrose/log phase sample and the dextrose/stationary 
phase sample.  By plotting the differential protein data on the replicate data, the significance 
of the protein differences can be determined.  This is shown in Figure 2-10.  Fifty-two of the 
76 differential proteins (68%) that were identified by the peptide LC-MS/MS were 
determined to be significantly different based on the 96.5% confidence threshold discussed in 
the previous section. 
For proteins that were detected in both of the samples used in a comparison, 
determination of the significance is straight-forward as described above.  However, for 
proteins that were only found in one sample, this becomes more challenging.   The limit of 
detection for the online 2D separation of intact proteins was estimated to be roughly 500 
counts.  Therefore, the axes of the plots were set accordingly.  Proteins that were only 
identified in one sample were plotted such that the intensity in the sample in which it was not 
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detected was set at 500 counts.  This value should represent the greatest signal intensity that a 
protein could generate without being detected. 
 Protein identifications based on LC-MS/MS data of protein digests 2.3.4
When a differential protein was identified from the intact 2D LC separation, the 
corresponding fraction from the sample in which it was most intense was lyophilized and 
reconstituted for identification from the bottom-up portion of the analysis.  Peptides were 
analyzed using capillary RPLC-MS/MS and MS/MS data was processed and searched 
against the SwissProt yeast proteins using ProteinLynx Global Server 2.3.  In the 125 
fractions that were found to contain potential differential proteins, 230 unique proteins were 
identified (766 proteins including redundant hits).  Not all of the yeast proteins identified 
from the peptide data were differential proteins, but rather identification indicated the 
presence of a protein in a particular fractions.  The proteins identified by PLGS were entered 
into the Compute pI/MW tool on the ExPASy website (http://us.expasy.org) in order to 
determine the theoretically processed molecular weight, which takes into account all known 
cleavages of the protein as well as other modifications.  The molecular weights of the 
‘processed’ proteins were then compared to the molecular weight of the differential protein 
as determined by the intact protein MS analysis.  After comparing these two lists on a 
fraction-by-fraction basis, 76 of the proteins had similar masses.  With 162 differential 
proteins selected from the intact protein data, approximately 53% were successfully 
identified.  Fifty-two of the 76 differential proteins identified were also found to have a 
significant difference in expression at the 96.5% threshold.  Of the 766 total proteins 
identified by PLGS from the MS/MS data, 44 were hits for proteins from the randomized 
database, which leads to a false discovery rate of 5.7%. 
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The proteins that were both successfully identified from the peptide LC-MS/MS data 
and had significant differences in expression are shown in Table 2-7 for the comparison 
between the glycerol-grown and dextrose-grown samples and in Table 2-8 for the 
comparison between the log-phase and stationary-phase samples.  In addition to the protein 
description, the Swiss-Prot entry and the gene that encodes the protein are included.  The 
number of peptide hits indicates the peptides that were used to identify the protein by PLGS 
and the intact mass is that which was calculated from the intact protein MS data by AutoME.  
The fold change was calculated by dividing the intensity of the protein in the sample in 
which it was most intense by the intensity in the sample in which it was least intense.  For 
proteins that were detected in only one sample no fold change could be calculated.  The 
percent probability signifies the outermost confidence line in Figure 2-10 that the protein fell 
outside.  
2.4 Discussion 
 Evaluation of this technique in terms of analytical merit 2.4.1
A clear limitation of this technique is the fact that there was limited overlap between 
the differential proteins that were ‘searched for’ as a result of the intensity differences of the 
intact proteins and the identification of proteins at the peptide level.  Even so, more than half 
(53%) of the target proteins were identified and this is in agreement with previously 
published literature attempting to correlate top-down and bottom-up analyses
5, 7, 8
.  Some of 
the reasons that the overlap is so limited are the same for this technique as they are with 
many others.  The major limiting factors include differences in selectivity of electrospray 
ionization of intact proteins and peptides, difficulty to detect low abundance proteins, and 
undocumented post-translational modifications on the intact proteins.  The last limitation 
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could also be seen as an area for this technique to grow into.  For example, if a specific PTM 
was known, two differential samples could be compared with an offset in the mass of one 
sample compared to the other corresponding to the mass difference imposed by a particular 
PTM.  An intact protein analysis with high mass accuracy would be critical for that type of 
analysis.  Due to the fact that undocumented PTM’s, or unknown clips were excluded from 
the comparison in this technique, it is actually quite promising that the overlap was still 
greater than 50%. 
 Statistical analysis of significance of difference 2.4.2
For the purpose of this analysis, the statistical analysis was the best option for 
determining the significance of the changes in protein intensity.  The replicate data of the 
glycerol/log phase sample appears to have adequately represented the scatter in the data 
caused by the method itself.  Given that each intact protein 2D separation took 15 hours to 
complete and consumed greater than 2 mg total protein, it was not feasible to perform 
replicate analysis of each sample.  Furthermore, in order to increase confidence that the 
differences in protein intensity are due to real changes caused by the different carbon sources 
or growth phases, an analysis of biological replicates would be ideal.   
 Biological relevance of differential proteins as compared with literature 2.4.3
Of the differentially expressed yeast proteins which were successfully identified, 
many are involved in metabolic pathways.  It is logical to expect that such proteins would be 
well-represented in this analysis, since two of the samples were grown using different carbon 
sources, which would be anticipated to cause differences in metabolic processes within the 
yeast cells
9
.  Likewise, the transition from logarithmic to stationary growth phase is 
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associated with a saturation of the growth medium with cells and a depletion of the readily 
available carbon source, which would also be expected to induce changes in metabolism. 
Figure 2-11 illustrates the major metabolic pathways of yeast.  The five major 
pathways are color-coded and include glycolysis, the pentose phosphate pathway (PPP), the 
citric acid cycle, the glyoxylate cycle, and anaerobic respiration.  Figure 2-12 and Figure 
2-13 highlight the metabolic proteins which were differentially expressed in the 
dextrose/glycerol and log/stationary comparisons, respectively.  In Figure 2-12, it is 
particularly notable that numerous enzymes, including the malate dehydrogenases (MDHM 
and MDHC), citrate synthase (CISY1), isocitrate dehydrogenase (IDH2), and succinyl CoA 
ligase (SUCA), which are involved in the citric acid and glyoxylate cycles, are up-regulated 
in the yeast grown on glycerol media.  Yeast is unable to derive energy from glycerol via 
fermentation to ethanol, as is possible with dextrose, and therefore must use the citric acid 
and glyoxylate cycles.  It is therefore logical that enzymes involved in these cycles would be 
present in larger quantities in the glycerol sample that in dextrose.  The fermentative 
enzymes, alcohol dehydrogenase (ADH1) and aldehyde dehydrogenase (ALDH4), were also 
found to be up-regulated in the glycerol-grown yeast sample.  Initially, this appears to 
contradict the evidence that yeast cannot ferment glycerol to produce ethanol.  However, 
because the glycerol-grown sample was initially grown on dextrose, it is possible that these 
enzymes were up-regulated in order to use the ethanol produced by the initial fermentation of 
dextrose as a secondary carbon source in addition to glycerol
10
.  In the comparison between 
growth phases, it would be expected for proteins involved in glycolysis to be up-regulated in 
the log phase due to the fact that all of the growth nutrient would have been consumed in the 
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stationary phase.  This is indeed the case for the glycolytic enzymes phosphoglycerate 
mutase (PMG1) and phosphoglycerol kinase (PGK).
11, 12
 
Figure 2-12 also illustrates the up-regulation of proteins involved in the pentose 
phosphate pathway (PPP) in the glycerol-grown sample, namely transketolase (TKT1), 
transaldolase (TAL1), and phosphoglucose isomerase (G6PI).  It has been shown that a 
metabolic shift from oxidative to fermentative growth causes a redirection from the PPP 
towards glycolysis
13
.  A shift towards the PPP during the stationary phase has also been 
noted, explaining the up-regulation of G6PI and TAL1 in the stationary phase yeast sample 
as shown in Figure 2-13
14
.  Some metabolic proteins are up-regulated in the dextrose sample.  
For example, the protein PMG1 is known to be unnecessary from growth on glycerol, which 
explains the fact that it was detected as being more abundant in the dextrose sample
15
.   
Aside from proteins directly involved in metabolic pathways of yeast, several other 
proteins which were detected as being differentially expressed can be associated with 
biochemical changes caused by growing yeast under different conditions.  For instance, 
mitochondrial matrix factor 1 (MMF1) and its homologue HMF1, were detected as being up-
regulated in the glycerol sample.  These proteins are known to be essential for the growth of 
yeast on non-fermentable carbon sources, such as glycerol
16
.  Likewise, mutants lacking 
aspartate aminotransferase (AATC), which is involved in amino acid biosynthesis, NADPH 
dehydrogenase (OYE2), and ribonucleoside diphosphate reductase (RIR4) exhibit growth 
defects when grown on non-fermentable carbon sources indicating that they are necessary 
from growth on these media
17
.  The protein alanine: glyoxylate aminotransferase 1 (AGX1), 
which is involved in the biosynthesis of glycine, was detected as being more abundant in the 
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glycerol sample.  This observation correlates with the fact that expression of this protein is 
known to be repressed when yeast is grown on a dextrose-containing medium
18
. 
Related to the metabolic pathways and as a direct result of the increased use of the 
glyoxylate cycle, serine hydroxymethyltransferase (GLYM) was up-regulated in the glycerol-
grown yeast sample.  GLYM uses the components of the glyoxylate cycle for the 
biosynthesis of serine
19
.  The dextrose-grown sample also exhibited an up-regulated protein 
involved in amino acid biosynthesis, cystathionine gamma lyase (CYS3).  A CYS3 mutant 
has been shown to have reduced fitness in a dextrose medium
20
.  A final example is NADPH 
dependent methylglyoxal reductase (GRE2), which catalyzes the reduction of methyl 
glyoxal, a cytotoxic compound.  This protein was found to be up-regulated in the stationary 
phase-harvested sample, which is logical given that accumulation of waste products is likely 
to occur when the growth medium reaches saturation with yeast cells
21
.  The same logic can 
also be used to explain the up-regulation of the mitochondrial manganese superoxide 
dismutase (SODM) in the stationary phase
22
.  
Many of the proteins that were differentially expressed in the comparison between the 
log phase and stationary phase dextrose samples can be attributed to the fact that in the 
stationary phase, cells are no longer growing or replicating
23
.  This holds true for guanylate 
kinase (KGUA), which is involved in the synthesis of purine and pyrimidine nucleosides, 
acetyl-CoA binding protein (ACBP), and tubulin specific chaperone A (TBCA), which is 
involved in microtubule formation
24, 25
.  The 14-3-3 proteins BMH1 and BMH2 are involved 
in vesicular transport and cell cycle regulation, which would be expected to be up-regulated 
in cells that are actively growing and replicating as is shown by their up-regulation in the log 
phase yeast samples
26
.  In the stationary phase of yeast, not only is the carbon source 
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completely consumed, but the ethanol produced by initial fermentation may also be 
consumed as a secondary carbon source.  The uncharacterized protein MRP8 has been shown 
to be up-regulated during ethanol stress.  Due to the lack of ethanol in the stationary phase, it 
would follow that the protein would be potentially up-regulated in the log phase, which is in 
agreement with what was found here
27
. 
Roughly one quarter of the proteins which were detected as being differentially 
expressed in the samples have no obvious link to changes which would be expected to occur 
due to the differences in the growth medium or a shift from logarithmic growth to stationary 
phase.  The expression of these proteins could be related to metabolic changes in an indirect 
manner.  Alternatively, it is possible that some instances in which a protein was detected as 
being marginally up or down regulated were due to random variation between samples rather 
than significant biochemical changes.  Inclusion of biological replicates in future studies 
would improve certainty in interpretation of the data.  Nevertheless, the fact that numerous 
well-documented changes in protein expression were detected using this method 
demonstrates its ability to reveal useful information when used for differential analysis of 
cell lysates containing water-soluble proteins. 
2.5 Summary and Conclusions 
A multidimensional liquid chromatography separation strategy was developed for the 
identification and relative quantification of differential proteins in complex mixtures.  This 
method is based on the improved separation of proteins prior to enzymatic digestion to 
produce less complicated peptide mixtures that can be used to simplify the identification.  
Complex protein mixtures were separated using an online two-dimensional technique, which 
included an anion exchange separation followed by a reverse phase separation.  Detection 
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and analysis by mass spectrometry was performed for intact protein molecular weight 
information.  Two-dimensional differential chromatograms were constructed to identify areas 
in the chromatogram that contained proteins with varying expression levels.  After enzymatic 
digestion of the proteins of interest, the resulting peptides were analyzed by tandem mass 
spectrometry and identified using the ProteinLynx Global Server 2.0 algorithm.  Using this 
strategy, differential yeast proteome samples were analyzed to identify proteins that vary in 
intensity between samples.  Through the use of a replicate analysis of a single sample the 
statistical significances of the differential proteins were determined.  A comparison of the 
differential proteins to the expected differences based on the literature was made; a large 
percentage of the differential proteins identified at a 96.5% confidence level were validated 
by the literature.  Overall, while the LC-based approach is still time consuming, it maintains 
an advantage over the gel-based approach in that the intact molecular weights of the proteins 
as they exist in the cell are available for further comparison and analysis.  This feature was 
not explored fully in this experiment, but may be essential in future, more targeted analyses. 
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2.8 Tables 
 
 
 
Time (min) % mobile phase B 
0 0 
20 7 
600 67 
675 67 
680 0 
 
Table 2-1 : AXC gradient used for the on-line intact protein separation.  Mobile phase A 
consisted of 10 mM ammonium acetate adjusted to pH 9 with ammonium hydroxide.  Mobile 
phase B consisted of 750 mM ammonium acetate adjusted to pH 9 with ammonium 
hydroxide.  The flow rate for the separation was 0.2 mL/min. 
 
 
 
 
Time (min) % mobile phase B 
0 5 
2 20 
5 30 
15 45 
15.5 90 
16 90 
16.5 5 
 
Table 2-2 : RP gradient used for the second dimension of the on-line intact protein 
separation.  Mobile phase A consisted of water with 0.2% formic acid and mobile phase B 
consisted of acetonitrile with 0.2% formic acid.  The flow rate for the separation was 1 
mL/min. 
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Time (min) % mobile phase B 
0 1 
20 35 
20.5 65 
22 65 
22.5 1 
 
Table 2-3 : Gradient profile for the capillary RPLC separation of the digested protein 
fractions.  Mobile phase A consisted of water with 0.2% formic acid and mobile phase B 
consisted of acetonitrile with 0.2% formic acid.  The flow rate for the gradient was 10 
µL/min which was split down to 500nL/min prior to the injection valve. 
 
 
 
From Mass To Mass CE 1 CE 2 CE 3 
400 500 26 22 31 
500 600 28 24 33 
600 700 30 26 35 
700 800 32 28 37 
800 900 35 30 39 
900 1600 37 32 42 
 
Table 2-4 : Collision energy (CE) profile used in the MS/MS data-directed analysis of the 
digested protein fractions from the on-line 2D intact protein separation. 
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Processing MaxEnt 1 
  
Chromatogram  
Scan interval 5 
Scan range 100-800 
TIC threshold 20,000 counts 
  
Raw data processing  
Background subtraction None 
Smooth None 
Center None 
  
MaxEnt 1 parameters  
Input mass range 600 – 1600 m/z 
Output mass range 5000 – 80,000 Da 
Mass resolution 2 Da 
Damage model Gaussian: w1/2 = 0.75 Da; 33% either side 
Completion option Maximum 50 iterations 
  
Post processing  
Subtraction None 
Lockmass calibration None 
De-harmonization 20 Da 
 
Table 2-5: AutoME processing parameters for deconvolution of protein mass spectra. 
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Processing Parameters Value 
Mass Accuracy No lockspray calibration 
Noise reduction (electrospray 
survey and MS/MS) 
Adaptive 
Perform de-isotoping Yes 
Deisotoping type Slow (MaxEnt 3) 
Maximum iterations 40 
  
Workflow Template Value 
Search engine type PLGS 
Databanks Yeast proteins and trypsin with a 
1x randomization 
Species None specified 
Peptide tolerance 100 ppm 
Fragment tolerance 0.1 Da 
Estimated calibration error 0.005 Da 
Molecular weight range 0-100,000 Da 
pI range 0-14 
Minimum peptides to match 1 
Maximum hits 20 
Primary digest reagent Trypsin 
Secondary digest reagent None 
Missed cleavages 2 
Fixed modifications None 
Variable modifications Oxidation M, Carbamidomethyl C 
Validate Yes 
Filter None 
 
Table 2-6: Parameters used to process the MS/MS runs of the digested protein fractions using 
ProteinLynx Global Server 2.3 (Waters). 
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Swiss- 
Prot 
Name 
Ordered 
Locus 
name 
Description 
Pep. 
Hits 
Intact 
Mass 
Up-
reg 
in 
Fold 
change 
% 
Prob. 
Diff. 
TPIS YDR050C Triosephosphate isomerase 4 26666.3 Dex 1.7 99.5 
YCO26 YCL026C-B 
Uncharacterized protein 
YLC026C B 
2 20906.2 Dex 9.3 99.5 
MRS1 YIR021W RNA splicing protein MRS1 1 41078.3 Dex 14 99.5 
PMG1 YKL152C Phosphoglycerate mutase 1 8 27480.7 Dex 2.0 98.7 
CYS3 YAL012W Cystathionine gamma lyase 5 42414.4 Dex - 98.7 
GLRX1 YCLO35C Glutaredoxin 1 4 12245.7 Dex 22 98.7 
BMH1 YER177W Protein BMH1 10 30004.2 Dex 1.8 98.0 
SODC YJR104V Superoxide dismutase Cu Zn 1 15722.9 Dex 1.9 96.5 
OYE2 YHR179W NADPH dehydrogenase 2 7 44884.2 Dex 9.6 96.5 
TRX2 YGR209C Thioredoxin 2 3 11202.1 Dex - 96.5 
ACBP YGR037C Acyl CoA binding protein 1 9930.17 Dex 1.5 96.5 
MDHM YKL085W 
Malate dehydrogenase 
mitochondrial 
5 33836.2 Gly 6.3 99.5 
ADH1 YOL086C Alcohol dehydrogenase 1 36646.2 Gly - 99.5 
ALDH4 YOR374W Aldehyde dehydrogenase 15 53979.1 Gly - 99.5 
SUCA YOR142W Succinyl CoA ligase 4 33222.7 Gly 15.4 98.7 
IPB2 YNL015W Protease B inhibitors 2 and 1 2 8459.6 Gly 8.6 98.7 
AATC YLR027C Aspartate aminotransferase 5 45893.4 Gly 7.5 98.0 
TKT1 YPR074C Transketolase 1 8 73677.7 Gly - 98.0 
YM71 YMR226C 
Unchar. Oxidoreductase 
YMR226C 
6 29071.6 Gly 5.3 98.0 
TAL1 YLR354C Transaldolase 6 36951.3 Gly 11 98.0 
CISY1 YNR001C Citrate synthase mitochondrial 7 49221.9 Gly 36 98.0 
MDHC YOL126C 
Malate dehydrogenase 
cytoplasmic 
2 40604.2 Gly - 98.0 
HMF1 YER057C Protein HMF1 1 13775.5 Gly 4.7 98.0 
AGX1 YFL030W 
Alanine glyoxylate 
aminotransferase 
6 41778.4 Gly - 96.5 
GLYM YBR263W Serine hydroxymethyltransferase 3 51605.7 Gly - 96.5 
IDH2 YOR136W Isocitrate dehydrogenase NAD 3 37802.1 Gly - 96.5 
PROF YOR122C Profilin 1 13589.5 Gly 12 96.5 
G6PI YBR196C Glucose 6 phosphate isomerase 12 61216.9 Gly 1.3 96.5 
RIR4 YGR180C 
Ribonuleoside diphosphate 
reductase 
4 40130.7 Gly 5.1 96.5 
BMH2 YDR099W Protein BMH2 10 30974.2 Gly 1.6 96.5 
 
Table 2-7 : List of proteins determined to have significant intensity differences between the 
dextrose-grown and glycerol-grown yeast samples.  Swiss-Prot Name: Protein entry in 
SwissProt database followed by ‘_YEAST’.  Ordered Locus Name: Predicted gene that 
encodes the protein sequence.  Description:  Brief description of the protein.  Pep. Hits: 
Number of peptides hits used to identify the protein in PLGS2.3.  Intact Mass: AutoME-
deconvoluted molecular weight of the intact protein.  Up-reg in: The sample in which the 
protein was most intense.  Fold-change: The degree to which a protein was up-regulated 
expressed as multiples of the intensity of the protein in the sample in which it was least 
intense.  The absence of a fold change signifies the protein was only present in one sample.  
%Prob. Diff: Confidence of the significance of the difference as determined through the 
analysis of replicate data  
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Swiss- 
Prot 
Name 
Ordered 
Locus 
name 
Description 
Pep. 
Hits 
Intact 
Mass 
Up-
reg 
in 
Fold 
change 
% 
Prob. 
Diff. 
BMH2 YDR099W Protein BMH2 15 30968.7 Log - 99.5 
PMG1 YKL152C Phosphoglycerate mutase 1 8 27477.9 Log 2 99.5 
KGUA YDR454C Guanylate kinase 1 20906.2 Log 7.1 99.5 
PGK YCR012W Phosphoglycerate kinase 16 44652.7 Log - 99.5 
G3P3 YGR192C Glyceraldehyde 3 phosphate 
dehydrogenase 3 
11 32617.8 Log 122.6 99.5 
HSP12 YFL014W 12 kDa heat shock protein 5 11604.6 Log 373.1 99.5 
CH10 YOR020C 10 kDa heat shock protein 
mitochondrial 
3 11283.9 Log 29.5 98.7 
ACBP YGR037C Acyl CoA binding protein 1 9930.17 Log 2.5 98.7 
BMH1 YDR099W Protein BMH1 10 30004.2 Log - 98.7 
CYS3 YAL012W Cystathionine gamma lyase 5 42414.4 Log 18.5 98.0 
SODC YJR104C Superoxide dismutase Cu Zn 1 15722.9 Log 1.8 96.5 
TBCA YOR265W Tubulin specific chaperone A 3 12248.4 Log - 96.5 
PNC1 YGL037C Nicotinamidase 2 24993.9 Log 17.9 96.5 
MRP8 YKL142W Uncharacterized protein MRP8 6 25004.8 Log - 96.5 
G6PI YBR196C Glucose 6 phosphate isomerase 24 61202.9 Stat 1.7 99.5 
DHOM YJR139C Homoserine dehydrogenase 10 38404.9 Stat 2.2 99.5 
COFI YLL050C Cofilin 12 15809.9 Stat 1.9 98.7 
YL364 YLR364W Glutaredoxin like protein 
YPR364W 
2 12066.0 Stat 2.0 98.7 
MRS1 YIR021W Mitochondrial RNA splicing 
protein MRS1 
1 41070.4 Stat 1.4 98.0 
G3P1 YJL052W Glyceraldehyde 3 phosphate 
dehydrogenase 1 
11 35742.1 Stat - 98.0 
SODM YHR008C Superoxide dismutase Mn 4 23083.0 Stat 3.7 98.0 
TAL1 YLR354C Transaldolase 5 36942.8 Stat 7.4 96.5 
 
Table 2-8: List of differential proteins from the comparison between yeast samples harvested 
at either the log phase or stationary phase of growth.  Only proteins with differences 
significant at greater than 96.5% are included.  Swiss-Prot Name: Protein entry in SwissProt 
database followed by ‘_YEAST’.  Ordered Locus Name: Predicted gene that encodes the 
protein sequence.  Description:  Brief description of the protein.  Pep. Hits: Number of 
peptides hits used to identify the protein in PLGS2.3.  Intact Mass: AutoME-deconvoluted 
molecular weight of the intact protein.  Up-reg in: The sample in which the protein was most 
intense.  Fold-change: The degree to which a protein was up-regulated expressed as 
multiples of the intensity of the protein in the sample in which it was least intense.  The 
absence of a fold change signifies the protein was only present in one sample.  %Prob. Diff: 
Confidence of the significance of the difference as determined through the analysis of 
replicate data 
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2.9 Figures 
 
Figure 2-1: Experimental workflow for on-line differential analysis of intact proteins. 
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Figure 2-3 : Illustration outlining the fluidic pathways made by switching the 10-port valve 
from A) Position 1 to B) Position 2. 
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Figure 2-4: Example of AutoME deconvolution of intact protein mass spectra.  A) Raw mass 
spectrum obtained from the online LC-LC-MS analysis of intact proteins.  B) Deconvoluted 
masses spectrum illustrating the summation of the protein charge envelope into a single 
protein mass. 
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Figure 2-5 : 2D chromatograms of Auto-ME deconvoluted intact protein mass spectra.  Each 
replicate injection was a 2.25 mg of the glycerol-grown yeast sample. 
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Replicate 3 
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Figure 2-6 : Log-log intensity plot of the triplicate analysis of lysates of yeast cells grown on 
glycerol harvested at the log phase of growth.  The lines indicated confidence intervals based 
on the percentage of data points encapsulated by the curves. 
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Figure 2-7: Distribution of protein molecular weights detected in the online LC-LC-MS 
analysis of proteins.  A) Molecular weight distribution as it compares to the distribution of all 
of the yeast proteins in the database. B) Molecular weight distribution with the cumulative 
number of detected molecular weights appended to the plot. 
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Figure 2-8 : 2D chromatograms of the on-line intact protein separations of the differential 
yeast samples.  A) Glycerol-grown harvested during the logarithmic growth phase. B) 
Dextrose-grown harvested during the logarithmic growth phase. C) Dextrose-grown 
harvested during the stationary growth phase.  All injections were 2.25mg of total protein as 
determined by the Bradford assay with a BSA standard. 
 
A 
B 
C 
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Figure 2-9 : Representative comparison of mass slice chromatograms for visual identification 
of differential proteins.  The mass range of proteins included in the plots was limited to 11 to 
12 kDa.  A) Glycerol/log phase sample.  B) Dextrose/log phase sample. 
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Figure 2-10 : Addition of differential proteins identified by visual inspection to the log-log 
plot of the replicate data.  Differential proteins which were detected in only one of the 
samples were plotted at the detection limit (500) of the sample in which it was not detected. 
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Figure 2-11: Metabolic pathways of S. cerevisiae. The following pathways are highlighted: 
Glycolysis in green, the pentose phosphate pathway in yellow, anaerobic respiration in 
orange, the citric acid cycle in red, and the glyoxylate cycle in blue.  Proteins shared between 
the citric acid and glyoxylate cycles are highlighted in purple. 
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Figure 2-12 :  Differential proteins identified in the comparison between S. cerevisiae cell 
lysates.  Proteins determined to be up-regulated in the glycerol grown sample are highlighted 
in red, while those found to be up-regulated in dextrose-grown cells are highlighted in blue. 
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Figure 2-13 :  Differential proteins identified based on changes in the growth phase at which 
cell harvesting was performed.  Protein highlighted in red were significantly more abundant 
in yeast cells harvested at the stationary growth phase, while proteins highlighted in blue 
were up-regulated in the sample harvested during the logarithmic growth phase.  For one 
enzyme, highlighted in green, there were two isozymes identified; one was up-regulated in 
the log phase sample and one was up-regulated in the stationary phase sample. 
.
 Traditional bottom-up analysis of S. cerevisiae cell lysates grown under CHAPTER 3:
various growth conditions without pre-fractionation 
 
3.1 Introduction 
 Bottom-up proteomics for use in a differential proteomic experiment 3.1.1
Bottom-up (BU) proteomic analysis is currently the most widely-used approach to 
mass spectrometry (MS) based experiments.  It involves the introduction of enzymatically 
digested proteins into the mass spectrometer as opposed to top-down (TD) proteomics in 
which intact proteins are analyzed directly by MS.  Peptides are more easily separated than 
intact proteins and tandem mass spectrometry data is commonly used to unambiguously 
identify proteins based on database searching.  Historically, it has been favored over top-
down proteomics due to the following shortcomings of a TD approach: (1) the complexity of 
the fragmented intact protein spectra limit analysis to isolated proteins; (2) the required high 
resolution instruments (Fourier transform- ion cyclotron resonance (FT-ICR), hybrid ion trap 
FT-ICR, or hybrid ion trap-orbitrap) are costly; (3) it tends to be biased towards proteins less 
than 50 kDa; (4) the favored dissociation techniques (electron-transfer dissociation, ETD, 
and electron-capture dissociation, ECD) are slow processes not necessarily amenable to on-
line coupling to a liquid chromatography (LC) separation; (5) the mechanism of dissociation 
is not as well understood as it is in BU proteomics limiting the availability of searchable 
databases and bioinformatic tools.
1
  Conversely, the main drawback of a BU experiment is 
that the molecular weight of the intact species is never determined, limiting the identification 
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of post-translational modifications that are often lost during the collision-induced 
dissociation (CID) of the peptide fragments.  In spite of this, both the availability of 
advanced LC/MS instrumentation and the ever-improving development of software have 
continued to make BU proteomics the method of choice. 
 MSE peptide analysis  3.1.2
In BU proteomics, there are two main tandem mass spectrometric methods employed 
in label-free experiments.  These include a data dependent acquisition, DDA, and a data 
independent acquisition, DIA.  In the experiment described in Chapter 2, MS/MS data 
acquisition was performed in a data dependent manner through a repeating cycle of one 
survey scan followed by a series of fragment ion scans of selected m/z values at higher 
collision energies.  As discussed previously, only the two most abundant peptides in a survey 
scan are subsequently fragmented in the product ion scans before another survey scan is 
performed.  This serial nature of this analysis increases the likelihood of missing less 
abundant peptides or peptides that elute during the higher collision energy scans.  Also, there 
is no guarantee that fragmentation will occur at or near the chromatographic apex, the point 
at which the intensity of fragment ions would likely be highest.  In order to limit the 
probability of missing peptides and increase sequence coverage, it is common practice for 
samples to be run multiple times and the data merged prior to processing.  This can be time 
consuming since the multiple runs performed are not merely replicate analyses that can be 
used to evaluate reproducibility but rather complementary analyses that, when combined, 
give a more comprehensive analysis.   
Recently, a new form of MS/MS data independent acquisition has been designed, 
MS
E
 data acquisition.
2
  This form of analysis is parallel in nature as opposed to the serial 
 61 
DDA experiments in which intense peptides are sequentially fragmented and analyzed.  In an 
experiment of this form, accurate mass LC-MS data are collected in alternating low collision 
energy (MS) and elevated collision energy (MS
E
) scans.  Analysis is performed on a 
quadrupole time-of-flight (Q-TOF) mass spectrometer with the quadrupole essentially acting 
as another ion guide, passing all ions through to the collision cell in both MS and MS
E
 scans.  
The fragmentation of all species present in a low energy scan produces highly complex 
fragmentation spectra, which then have to be processed post-acquisition to assign fragment 
ions to the appropriate precursor ions.  A novel processing algorithm patented by Waters 
Corporation in 2005 has made this type of analysis possible.
2, 3
   
A detailed progression of the processing algorithms can be found in a series of patents 
filed by Waters from 2005 to 2009.
4-8
  Briefly, fragment ions are assigned to precursor ions 
based on both intensity and peak apex retention time.  The apex of the chromatographic peak 
of the fragment ions must match that of the precursor ion within the time error associated 
with the duty cycle of the MS runs.  For example, if the scan time of each MS or MS
E
 scan is 
0.7 sec, with a 0.1 sec interscan delay, the duty cycle of the MS acquisition would be 1.6 sec, 
or 0.027 min, so the chromatographic apices must not differ by more than 0.027 min.  With 
regard to ion assignment based on intensity, fragmentation of the most intense precursor ion 
should give some of the most intense fragment ions and low intensity precursor ion 
fragmentation should give fragment ions of lower intensity.  Likewise, highly abundant 
fragment ions would not be assigned to precursor ions of low abundance and vice versa.  
This form of analysis allows for the simultaneous acquisition of both quantitative and 
qualitative data. 
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 Label-free absolute quantitation of proteins based on MS intensity of peptides 3.1.3
Numerous studies have been performed for differential analyses employing an LC 
separation followed by MS detection.  In these studies, relative quantitation is performed 
primarily through the use of stable-isotope labeling of one sample or the use of isotopically-
labeled internal standards.
9-12
  Frequently, one of two differential samples is treated with the 
isotope labeling reagents while the other is untreated.  The two samples are mixed and 
relative quantitation is contingent upon the observation of mass shifts caused by the labeling.  
Drawbacks to this approach include the reliability of labeling to completion as well as the 
doubling of sample complexity when the two samples are added together.   
In the past decade, there has been a growing trend towards the use of label-free 
quantitation strategies.  For a semi-quantitative analysis, the spectral counting method is most 
commonly used.  This method is based on a the use of a DDA in which 1-5 of the most 
abundant precursor ions are selected from the MS survey scan for subsequent fragmentation.  
There are no limits set to the number of times that a precursor ion may be selected.  
Therefore, the intensity of a peptide, represented by its precursor ion in the mixture, is 
directly related to the number of times that it was selected for MS/MS analysis.  The spectral 
counts for all peptides of a given protein are then averaged to give a protein abundance 
index.  A major limitation of this strategy is the lack of error rates in these index values.  
Many times, improperly identified peptides as well as peptides found in multiple proteins, 
such as in highly conserved regions, are given equal weight to the overall protein abundance.  
There are steps being taken to remedy this shortcoming, such as weighting the spectral 
counts of a peptide based on its identification score from the database search however it is 
still primarily used for semi-quantitative studies.
13, 14
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The second type of label-free quantitation is based on the measurements of changes in 
peptide ion intensity between samples.  Work published by Silva and co-workers addressed 
the shortcomings historically associated with the use of MS signal intensity for quantitation 
including the non-linearity of signal response and the effects that ion suppression may have 
on the response.
2
  Known concentrations of standard protein digest mixtures were spiked into 
a human serum digest and the intensity of multiple peptides were measured.  A response 
curve for this data resulted in a straight line across the 2 orders of dynamic range investigated 
in the study with an R
2
 value of 0.9995.  Intensity values for all peptides used to identify a 
protein are summed to give a value of protein abundance.  A standard of a tryptically 
digested protein is spiked in for use as an internal standard.  Calculated protein intensities in 
each sample are normalized to the sum of all of the peptides used for identification of the 
standard protein.  A necessity for this type of analysis is the presence of an ample number of 
peptide hits per protein and a comprehensive analysis of a peak as it elutes, usually 10 MS 
cycles per peak.  This would not be possible with a DDA where cycle times are several 
seconds each, so only a DIA such as MS
E
 can be used.  The work presented in this chapter 
focuses on this approach to quantitation utilizing a data independent acquisition. 
3.2 Experimental 
 Outline for experimental method 3.2.1
The workflow for the experiment can be found in Figure 3-1.  The soluble fractions of 
cell lysates from differential samples of S. cerevisiae were digested with trypsin without any 
further fractionation.  Digested samples were analyzed in triplicate by capillary RPLC-MS
E
.  
Raw data were processed using ProteinLynx Global Server 2.4, Release Change 7 (PLGS2.4) 
for identification and absolute quantitation.  Proteins identified in more than one replicate 
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were subject to a quantitative analysis, whereas those that did not replicate could only be 
analyzed qualitatively. 
 Chemicals and S. cerevisiae sample preparation 3.2.2
Most of the reagents used in this experiment were identical to those used in the 
previous chapter.  Optima grade water and acetonitrile and LC-MS grade formic acid and 
ammonium bicarbonate were purchased from Fisher Scientific (Fair Lawn, NJ).  Sequencing 
grade modified trypsin by Promega (Sigma-Aldrich, St. Louis, MO) was used in place of the 
Pierce trypsin used previously.  The MassPrep BSA digest used for absolute quantification 
and the acid-labile surfactant, RapiGest SF, were provided by Waters Corporation (Milford, 
MA).  The S. cerevisiae samples used in this experiment were the same as used in the 
previous chapter.  The complete preparation procedure can be found in section 2.2.3. 
 Trypsin digestion 3.2.3
All solutions were prepared using 50 mM ammonium bicarbonate.  For each sample, 
an aliquot from the stock was diluted to 50 µL to give a final concentration of 1 µg/µL total 
protein.  Reconstituted RapiGest SF was added to give a final surfactant concentration of 
0.1%.  After vortexing, solutions were incubated for 15 minutes at 80°C with periodic 
vortexing.  Solutions were centrifuged at 10,000 x g for 4 minutes to return condensate to the 
bottom of the centrifuge tube.  To reduce disulfide bonds, 100 mM dithiothreitol was added 
to give a final concentration of 10 mM.  The reduction was allowed to take place at 60°C for 
30 minutes.  After centrifugation, 200 mM iodoacetamide was added to give a final 
concentration of 20 mM and prevent reformation of disulfide linkages.  Incubation took place 
in the dark at room temperature for 30 minutes.  Samples were then centrifuged again and 
trypsin was added at a 1:50 enzyme: protein ratio.  Digestion occurred overnight at 37°C.  
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Quenching of the digestion and hydrolysis of the surfactant was performed by the addition of 
TFA to a final concentration of 1%.  Samples were incubated at 60°C for 2 hours.  After 
centrifugation at 14,000 x g for 20 minutes, the supernatant was transferred to sample vials 
for analysis.  MassPrep BSA digest was added at a concentration of 25 fmol/µL thereby 
injecting 100 fmol on column for a 4µL injection. 
 Instrumentation and run conditions 3.2.4
Samples were analyzed in triplicate by capillary ultra-high performance LC-MS
E
 
(UPLC-MS
E
) using a nanoAcquity LC system and a QTOF Premier mass spectrometer, both 
from Waters (Milford, MA).  Mobile phase A consisted of water with 0.1% formic acid and 
mobile phase B consisted of acetonitrile with 0.1% formic acid.  The system was run in 
trapping mode, with a 20 mm x 180 µm ID trap column packed with 5 µm C18 Symmetry 
particles.  Loading of the sample onto the trap column was performed by flowing 0.5% 
mobile phase B at 15 µl/min through the inject valve and onto the trap column with the outlet 
of the trap column diverted to waste.  Once the sample was properly loaded, the flow was 
decreased to 300 nL/min and the mobile phase composition changed to 5% B.  The trapping 
valve was switched at this point such that the outlet of the trap column was sent directly to 
the analytical column.  Separations were performed on an analytical column with dimensions 
of 250 mm x 75 µm ID packed with 1.7 µm BEH-C18 particles.  Connection with the mass 
spectrometer was achieved by connecting a 20 µm ID capillary from the outlet of the column 
directly to a nanoflow lockspray-ESI source fitted with a 20 µm ID tip pulled down to 10 µm 
at the orifice.  The standard solution for the reference channel of the nano-lockspray was 200 
fmol/µL glu-fibrinopeptide, which was delivered by an auxiliary pump on the nanoAcquity 
system at 0.5µL/min.  The full gradient profile for the separation is specified in Table 3-1. 
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The QTOF Premier was operated in positive ESI mode with the lockspray enabled 
and the reflectron operated in V-mode.  The capillary, sample cone, and extraction cone were 
held at +3000V, +35V, and +4V, respectively throughout the analysis.  In order to prevent 
water cluster formation, the source temperature was held at 100°C.  The scan time for the low 
energy, elevated energy, and reference scans was 0.7 seconds across the m/z range from 50 to 
1990.  The collision energy was held at 5V for the low energy scans, 6V for the reference 
scans, and ramped from 15V-40V during the elevated energy scan.  The reference channel 
was sampled every 30 seconds to allow for dynamic calibration. 
 Protein identification and quantification using PLGS2.4 3.2.5
The raw data acquired on the Q-TOF Premier for each fraction was processed using the 
latest version of ProteinLynx Global Server, PLGS2.4 RC7 (Waters, Milford, MA).  
Processed mass spectra were searched against a SwissProt database composed of the non-
redundant yeast proteins, porcine trypsin, bovine serum albumin, and five human keratin 
proteins that have been the most abundant contaminants in previous experiments.  A 1x 
randomized database was generated within PLGS2.4 and added to the end of the yeast 
database.  For quantitation purposes, the known concentration of the standard BSA digest 
was added to the workflow.  This allowed for absolute quantification of yeast proteins based 
on peptide intensity.  A complete listing of the values for processing the raw data and 
searching against the database can be found in Table 3-2. 
3.3 Results 
 Protein identifications based on MSE data 3.3.1
The raw data obtained from the LC-MS
E
 analysis of the differential yeast samples 
was processed directly by PLGS2.4.  With the addition of the lockspray source a dynamic 
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mass calibration was performed to account for ambient temperature fluctuations.  Data 
processing was performed on the calibrated mass spectra.  Table 3-3 describes the protein 
identification statistics as output from PLGS2.4 for all three differential samples.  In the 
glycerol sample, there were a total of 776 yeast protein identifications across all three 
replicate injections.  In PLGS2.4, the results were automatically curated to have values of 2, 
1, or 0, which correspond to identification probabilities of 95%, 50%, and ‘not probable’, 
respectively.  For the 776 proteins identifications in the glycerol sample, 694 were identified 
with 95% probability, 65 were identified at 50% probability, and 17 were likely false 
identifications.  After removal of redundant proteins across the replicates, there were a total 
of 365 unique proteins identified.  In order for an identification to be considered ‘real’, it had 
to fulfill one of two requirements: it had to have been identified at 95% confidence in at least 
one sample, or, if it was only identified at 50% confidence, then it had to replicate in at least 
two of the three analyses.  After removal of proteins that did not fulfill either of these criteria, 
there were 302 unique proteins identified, with 241 of them replicating.  On average, proteins 
were identified with approximately 15 peptides.  The median value of peptide hits was 
slightly lower at 10.  The corresponding values for the dextrose-grown log phase sample and 
dextrose-grown stationary phase sample can also be found in Table 3-3. 
The distribution of the intact molecular weights of the proteins identified in the 
bottom-up analysis across all 3 differential samples is shown in Figure 3-2.  This distribution 
will be compared to the distribution obtained from the on-line top-down analysis of intact 
proteins in Figure 2-5 from Chapter 2 later in this chapter. 
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 Repeatability based on replicate analysis  3.3.2
Each sample, while only digested once, was run in triplicate by LC-MS.  The overlap 
of proteins identified in multiple runs can be seen in Figure 3-3.  All of the non-replicating 
proteins not identified with a 95% confidence have been removed; only curated protein hits 
are present in this figure.  On average, only 8% of all of proteins identified in each sample 
were identified in only one replicate with a confidence of 95%.   
The Venn diagrams illustrate the high reproducibility of the bottom-up analysis with 
regard to protein identification, but do not lend any insight into the reproducibility of the 
absolute quantitation, a critical aspect of a differential analysis.  In order to assess 
quantitative reproducibility, a log/log plot of protein intensities across replicates was 
constructed just as was done previously in section 2.3.1.  The replicate log/log plots of each 
sample are shown in Figure 3-4.  Only proteins identified in at least 2 replicates are included 
in the plots.  Overall, the replicate points fall closely along the line y=x.  There does appear 
to be a similar increase in scatter at the lower intensities, but due to the decrease in data 
points as compared to the replicate data taken in the previous chapter, it was not feasible to 
include error curves.  Figure 3-5  shows all of the replicate data points from the differential 
samples in the comparison between the glycerol-grown sample and dextrose-grown sample 
in A, and the comparison of the log phase sample versus the stationary phase sample in B.  In 
both plots, replicate data is plotted in gray and the differential comparison is in red.  There is 
not an immediately apparent cut-off that could be used to determine which differences should 
be considered significant.  However, with the addition of replicate analysis for each sample, 
comparisons can be made on a protein-by-protein basis.  If the intensity of a single protein is 
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consistent within the replicate runs, then it should be easier to compare the intensity of the 
protein to that of the identical protein in another sample.   
 Determination of differential proteins and significance of the difference 3.3.3
Two different methods were investigated in order to determine proteins that were 
significantly different in intensity.  The first was an extension of the use of a Log/Log 
intensity plot used in Chapter 2.  From the replicate analysis, error bars were added in order 
to see if a difference in intensity was indeed significant.  Error bars, normally plotted at +/- 
one standard deviation in the linear scale, are plotted as relative errors so as not to give a 
skewed view of the true error in the measurement.  The derivation of this as an acceptable 
form of error representation is as follows.  The intensity value plotted, z, is different than the 
measured quantity, y. 
z = log (y) 
The error, dz, of z would then be 
dz = d[log (y)] 
Based on the assumption that errors are relatively small, the differential analysis gives 
y
dy
y
dy
yddz 434.0
303.2
1
)][log(   
Therefore, dz can be expressed as a relative error in y: 
y
dy
dz 434.0  
This can be seen in Figure 3-6.  From this plot, it is easy to pick out some proteins that are 
clearly differential because they do not fall near the line y=x and have small error bars.  
Some of these points have been highlighted in the figure.  The protein identity of each of the 
data points is known, so correlating a point on the plot to a yeast protein is straightforward.  
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Difficulty arises, however, when trying to determine if differences are significant when the 
average intensities of a protein in each sample are close, or when proteins are identified in 
the replicate analysis in only one of the samples. 
In order to facilitate the selection of differentially expressed proteins without 
imposing any bias that might arise from the use of logarithmic plots, the data were plotted in 
bar graph format with both the averages and standard deviations of the protein intensity in 
fmols plotted in the linear scale.  Figure 3-7 and Figure 3-8 show the differences in intensity 
between the proteins identified in at least two out of three replicates that were identified in 
both the glycerol-grown and dextrose-grown samples.  Proteins with non-overlapping error 
bars can be easily selected as having significant differences.  A list of all of the differentially 
expressed proteins in the comparison of growth media can be found in the Appendix.  A 
shortened list containing only those proteins that were found to be differential in this 
experiment as well as the combined online top-down/bottom-up analysis described in the 
previous chapter is included in Table 3-4.  All headings are identical to those described in the 
previous chapter with the exception of the last 4 columns.  The ‘Bottom-up’ columns 
correspond to the fold change and sample in which the protein was most intense as 
determined by the data presented in this experiment.  The ‘On-line Top Down’ columns refer 
to the corresponding fold change and sample in which a protein was up-regulated as 
determined by the differences in intensity from the intact protein MS intensity in the previous 
chapter.  Figure 3-9, Figure 3-10, and Table 3-5 show the equivalent data and comparisons 
between the yeast samples harvested during different stages of growth. 
For proteins identified by replicate analysis in both samples used for comparison, the 
determination of whether or not the intensity difference is significant is made easy due to the 
 71 
addition of error bars.  However, when proteins either do not replicate, or are identified in 
only one of the samples, the distinction of significance is less clear.  In the case where a 
protein is identified in multiple replicates of one sample, but either never identified or 
identified in only one replicate in the other sample, the data can be plotted in bar graph 
format, just as was done when a protein replicated in both samples.  Figure 3-11 and Figure 
3-12 show these proteins in the glycerol/dextrose and log/stationary phase comparisons, 
respectively.  If the protein was identified at all in the other sample, the intensity is added to 
the plot.  A protein is considered to be a potential differential protein if the error bars do not 
span below zero and, in the event that a protein was identified in just one replicate in the 
comparative sample, the intensity of that protein must not fall within the error of the intensity 
of the protein in the replicating sample.  Through this analysis, 111 out of the 116 proteins 
that replicated only in the glycerol-grown sample are considered to be differentially 
expressed.  Likewise, 58 of the 60 proteins that replicated only in the dextrose-grown sample 
are differential.  In the log/stationary phase comparison, 63 out of 67 proteins that replicated 
only in the log phase sample are significant, and 24 out of 27 proteins that replicated only in 
the stationary phase sample are significant. 
A final case of protein identification occurs when a protein is only identified in one 
replicate at a confidence of 95% in one or both samples used for comparison. Due to the fact 
that the protein was identified at that high of a confidence level, it is safe to conclude that the 
protein is indeed present. However, there is no error associated with the intensity; it was only 
used in a qualitative aspect.  This is supported by the lower number of peptides used to 
identify non-replicating proteins when compared to that of proteins that did replicate (median 
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value of 6 peptides/protein as compared to 12 for the replicating proteins).  Because of this, it 
is likely that there would be greater variation in the intensity values. 
3.4 Discussion 
 Protein Identification 3.4.1
As stated previously, peptide tandem MS was performed using a data independent 
acquisition, MS
E
, instead of a data dependent acquisition as was used in the previous chapter.  
Fragment ions are paired with precursor ions in the data processing step as opposed to during 
the acquisition by limiting the fragmentation to that of a single ion as is done in DDA.  As a 
result, multiple precursor ions can be fragmented simultaneously, limiting the need for 
multiple runs to adequately sample the data.  This is demonstrated in the number of peptides 
that are used to identify each protein.  Looking just at the differential proteins identified in 
the on-line analysis in Chapter 2, the average number of peptides used to identify each 
protein across all three samples is just 5.8 compared to 16.4 peptide hits per protein in the 
bottom-up MS
E
 data.  Furthermore, because the proteins were selected as differential from 
the top-down data, which is likely less sensitive than the bottom-up and so is representative 
of some of the more abundant proteins, a value of 5.8 actually overestimates the average 
peptide hits per protein when taking into account all protein hits.  Looking back at all of the 
proteins identified in just the fractions containing potential differentially expressed proteins, 
on average only 3.2 peptides were used to identify all proteins.  That is a drastic difference 
from the data presented in this chapter with greater than 15 peptide hits per protein.  
Presumably, if the fractions analyzed in the previous chapter had been run more than once, 
the data could have been merged into one file prior to data processing and database searching 
in order to improve the total number of precursor ions, or peptides, selected for 
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fragmentation.  Replicate analysis by DDA MS would still likely fall short in terms of 
peptides/protein than a single MS
E
 analysis, due to the limitations addressed in the 
introduction. 
Figure 3-2 shows the molecular weight distribution of the proteins identified in the 
bottom-up only experiment and Figure 2-5 shows the same distribution for the proteins 
detected in the on-line top-down analysis.  Comparing these two histograms highlights one of 
the major limitations of intact protein electrospray-MS in that electrospray efficiency tends to 
decrease for proteins above 50 kDa.  It is worth pointing out that the scaling of the x-axis is 
significantly different between the two plots.  In the TD histogram, the maximum molecular 
weight is 80 kDa, whereas in the BU plot, the range extends all the way out to 230 kDa.  This 
is due to the absence of reliably detecting intact proteins above 80 kDa in previous 
experiments in our lab, so the AutoME processing parameters were set to only deconvolute 
spectra up to this threshold.  There is no such need for setting a threshold of this type with 
digested proteins, since the majority of proteins, regardless of size, give similar peptide 
molecular weight profiles and are not subject to a bias from electrospray ionization.  To 
examine the skew of the data, the cumulative number of proteins in each bin is plotted on the 
axis to the right.  If the mass range at which 50% of the proteins have been identified is 
compared between the two methods, the bottom-up data would have a slightly higher median 
molecular weight of 45 kDa than that of the top-down data with a median value of 35 kDa.  
Admittedly, this a modest difference compared to what might be expected, however it should 
also be noted that the intact protein deconvolution tends to have a higher background at 
higher molecular weights.  The upward trend of protein counts above 60 kDa is likely due to 
increased noise at the higher molecular weight range instead of actual protein signal.  
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Therefore, it is likely that the median molecular weight range is less than the 35 kDa reported 
here. 
 Evaluation of reproducibility of bottom-up analysis 3.4.2
The reproducibility of protein identification is shown in Figure 3-3.  Roughly 69% of 
all proteins across all three samples were identified in more than one replicate.  This value 
includes those identified at all probability thresholds.  If all non-replicating proteins with 
probabilities less than 95% are removed, this percentage increases to 82%.  Removal of these 
proteins was deemed acceptable due the description of a ‘0’ in PLGS as being ‘not probable’ 
in the scoring scheme. 
There was also high reproducibility in the absolute quantitation data; average and 
median percent relative standard deviation (%RSD) were 21.5 and 12.5%, respectively, for 
replicating proteins across all three samples.  This is along the same lines as the 15 and 20% 
that has been reported in this type of absolute quantitation based on MS
E
 analysis.
3, 15
  The 
full distribution of %RSD across all three samples can be found in Figure 3-13.  The 
distribution is heavily skewed towards low %RSD values, which is advantageous when 
trying to compare intensities between differential samples.  Smaller %RSD values result in 
greater confidence of small changes in protein intensity between differential samples. 
 Identification of differentially expressed proteins 3.4.3
The identification of differentially expressed proteins was straightforward in the cases 
where a protein was identified in replicate analyses in both samples.  If the difference in 
intensity was great enough to prevent overlap between the error bars, then it was considered 
significant.  However, if a protein was only identified in the replicate analysis of one sample, 
and either not identified in the other, or only identified in one replicate, the determination of 
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it being a differential protein is not as certain.  As the intensity decreases down to near zero, 
it becomes less clear whether the protein was present and just not detected in the other 
sample, or was indeed below the level of quantitation. 
 Comparison of protein intensities and correlation between those identified in 3.4.4
Chapter 2 
The overlap between the differentially expressed proteins found in the data presented 
in this chapter compared with the differential proteins from the previous chapter is shown in 
Table 3-4 and Table 3-5.  Proteins that are not highlighted are identified as being up-
regulated in the same sample between the glycerol-grown and dextrose-grown comparison, 
however were only detected in one of the samples in one or both experiments and so a 
comparison of the fold change could not be determined.  Proteins highlighted in green are 
those with similar fold changes, differing by a factor less than 1.5, between the two methods 
and show a correlation between bottom-up based differences and top-down based changes in 
intensity.   
The proteins highlighted in yellow and red are of the greatest interest when comparing 
between the two data sets.  Yellow highlighting signifies proteins that are shown to be up-
regulated in the same sample between the two methods, but by different amounts.  Red 
indicates that the sample in which a protein was determined to be up-regulated was not 
consistent between the two analysis methods.  For example, alcohol dehydrogenase, ADH1, 
was found to be up-regulated in the dextrose-grown sample in the bottom-up analysis, but 
was more abundant in the glycerol-grown samples based on the top-down data.  One reason 
that the two methods may not give correlating fold changes is due to the post translational 
processing that occurs in the form of post-translational modifications (PTMs).  For example, 
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in a bottom-up experiment of this type with no pre-fractionation, all forms of a single protein 
will be summed into one intensity value, thus negating any information that may be gained 
by looking at changes in the cellular processing of a protein between two conditions.  When a 
separation is performed on the intact proteins prior to digestion, different forms a protein 
may be separated from one another if the post-translational modification is one that elicits a 
change in the chemical property probed by the separation mechanism.  An example of this 
would be the phosphorylation of a protein changing its charge and therefore its retention time 
in an anion exchange separation. 
3.5 Summary and Conclusions 
The data presented in this chapter was obtained through a traditional bottom-up 
proteomic experiment.  The soluble fractions of baker’s yeast cell lysates were enzymatically 
digested prior to any further separation or fractionation.  Protein digests were analyzed in 
triplicate by UHPLC-MS
E
.  The transition from a DDA acquisition to MS
E
, a DIA, allowed 
for the parallel analysis of MS/MS peptide fragmentation as opposed to the serial analysis of 
a DDA acquisition.  Thus, the average number of peptides used to identify each protein was 
almost three times greater in the MS
E
 analysis.  This also facilitated the use of MS
E
 as a tool 
for absolute quantitation, which was critical for the differential analysis shown here. 
Overall, as compared to the on-line 2D-LC data presented in the previous chapter, there 
was good alignment between the comparisons.  Thirty-nine of 43 differentially expressed 
proteins identified in both methods are shown to be up-regulated in the same sample, with six 
of them having almost identical fold changes.  The proteins with large differences in fold 
change and even opposing values are also interesting.  One possibility for this difference is 
the grouping of all forms of a single protein into one intensity value in the BU data, while 
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they may be separated by LC prior to MS analysis in the TD-based differential analysis 
yielding two different intensities for the multiple species.  Even if they are not separated by 
LC, analysis by MS gives an added dimension of separation by separating by the intact 
protein MW.  This is not meant to demonstrate whether one method is better than the other, 
rather that complementary information can be gained from both techniques. 
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3.7 Tables 
Time (min) % Mobile phase B 
0 5 
60 40 
65 85 
70 85 
73 5 
 
Table 3-1: RPLC gradient condition for the analysis of digested fraction from the anion 
exchange column. Mobile phase A was water with 0.1% formic acid and mobile phase B was 
acetonitrile with 0.1% formic acid. The flow rate was 300 nL/min. 
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Processing Parameters Value 
Chromatographic peak width Automatic 
MS TOF resolution Automatic 
Lock Mass for charge 1 - 
Lock Mass for charge 2 785.8426 Da/e 
Lock mass window 0.25 Da 
Low energy threshold 200 counts 
Elevated energy threshold 75 counts 
Retention time window Automatic 
Elution start time - 
Elution stop time - 
Intensity threshold 1500 counts 
Workflow Template Value 
Search engine type PLGS 
Databank Yeast proteins with trypsin, BSA, 
and 5 human keratin proteins with 
a 1x randomization 
Peptide tolerance Automatic 
Fragment tolerance Automatic 
Minimum ions per peptide 3 
Minimum ions per protein 7 
Minimum peptides per protein 1 
Maximum protein mass 250,000 Da 
Primary digest reagent Trypsin 
Secondary digest reagent None 
Missed cleavages 1 
Fixed modifications None 
Variable modifications Acetyl N-term, Carbamidomethyl 
C, Deamidation N, Oxidation M 
False positive rate 4 
Calibration protein P02769 (BSA) 
Protein concentration on column 100 fmol 
 
Table 3-2: PLGS 2.4 RC7 processing parameters used for raw data processing and database 
searching. 
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 Glycerol/Log Dextrose/Log Dextrose/Stat 
Total proteins ID’s 776 560 449 
ID confidence (2/1/0) 694/65/17 516/41/3 402/43/4 
Unique proteins 365 248 197 
Non-replicating 1’s and 0’s 
removed 
302 221 166 
Avg. peptides/protein 14.4 18.6 17.0 
Median peptides/protein 10 12 10 
Replicating proteins 241 181 140 
 
Table 3-3: Protein identification statistics of PLGS2.4 processing of traditional bottom-up 
analysis.  Total protein ID’s: the total number of proteins identified across all three 
replicates.  ID confidence: the confidence level output by PGLS2.4 based on the individual 
peptide sequencing assignments.  Unique protein: the number of protein hits with the 
redundant protein identifications across replicates removed.  Non-replicating 1’s and 0’s 
removed: number of proteins identified not including proteins with confidence values of 0 
and 1 that did not replicate removed.  Avg. peptides/protein: the average number of peptide 
hits used to identify each protein in a sample.  Median peptides/protein: the median number 
of peptides used for each protein identification.  Replicating proteins: the number of 
proteins that were identified in at least two of the three replicates. 
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Swiss 
Prot 
Name 
Description Intact 
Mass 
Bottom up On-line, Top-Down 
Up-
Reg. 
In 
Fold 
Change 
Up-Reg. 
In 
Fold 
Change 
AGX1 
Alanine glyoxylate 
aminotransferase 
41778 GLY N/A GLY N/A 
ALDH4 
Potassium activated aldehyde 
dehydrogenase 
56688 GLY 28 GLY N/A 
CISY1 Citrate synthase, mit. 53327 GLY 4.8 GLY 36 
COFI Cofilin 15890 GLY 1.3 GLY 1.3 
EF1A Elongation factor 1 alpha 50001 GLY 2.6 GLY N/A 
FKBP FK506 binding protein 12150 GLY 1.4 GLY 2.9 
HMF1 Protein HMF1 13776 GLY N/A GLY 4.7 
IDH2 Isocitrate dehydrogenase 2 37802 GLY N/A GLY N/A 
IPB2 Protease B inhibitors 2 and 1 8460 GLY N/A GLY 8.6 
MDHC Malate dehydrogenase cyt. 40604 GLY N/A GLY N/A 
MDHM Malate dehydrogenase mit. 35627 GLY 6.5 GLY 6.3 
RIR4 
Ribonucleoside diphosphate 
reductase 
40028 GLY 2.5 GLY 5.1 
SUCA Succinyl CoA ligase 35010 GLY 7.5 GLY 15.4 
TAL1 Transaldolase 37013 GLY 1.7 GLY 11 
TKT1 Transketolase 73759 GLY 1.4 GLY N/A 
ADH1 Alcohol dehydrogenase 36799 DEX 2.8 GLY N/A 
CYS3 Cystathionine gamma lyase 42516 DEX 2.1 DEX N/A 
ENO1 Enolase 1 46773 DEX 3.4 GLY N/A 
GLRX1 Glutaredoxin 1 12246 DEX N/A DEX 22 
OYE2 NADPH dehydrogenase 2 44884 DEX N/A DEX 9.6 
PGK Phosphoglycerate kinase 44710 DEX 1.7 DEX 2.0 
SODC Superoxide dismutase Cu Zn 15844 DEX 2.0 DEX 1.9 
TPIS Triosephosphate isomerase 26778 DEX 1.8 DEX 1.7 
TRX2 Thioredoxin 2 1196 DEX 3.8 DEX N/A 
TRXB1 Thioredoxin reductase 34216 DEX 6.9 DEX 3.2 
 
Table 3-4: Proteins determined to be differentially expressed in both the traditional bottom-
up and combined top-down/bottom-up online analyses of the comparison between growth 
media.  Proteins in green were consistently up-regulated in the same yeast sample and at 
roughly the same fold-change.  Protein in yellow were up-regulated in the same sample, but 
at differing extents.  Proteins in red were found to be up-regulated in opposite yeast sample.  
Un-highlighted proteins were only identified in one of the samples used for comparison and 
therefore, a fold change could not be computed nor compared. 
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Swiss 
Prot 
Name 
Description 
Intact 
Mass 
Bottom-up Online, Top Down 
Up. 
Reg 
In 
Fold 
Change 
Up. 
Reg 
In 
Fold 
Change 
ACBP Acyl-CoA-binding protein 10055 LOG 1.4 LOG 2.5 
BMH1 Protein BMH1 30072 LOG 1.9 LOG N/A 
CH10 10kDa heat shock protein 11284 LOG N/A LOG 30 
CYS3 Cystathionine gamma lyase 42414 LOG N/A LOG 19 
G3P3 
Glyceraldehyde 3 phosphate 
dehydrogenase 3 
35742 LOG 2.2 LOG 123 
HSP12 12kDa heat shock protein 11605 LOG N/A LOG 373 
KGUA Guanylate kinase 20906 LOG N/A LOG 7.1 
MRP8 Uncharacterized protein MRP8 25005 LOG N/A LOG N/A 
PGK Phosphoglycerate kinase 44710 LOG 3.3 LOG N/A 
PNC1 Nicotinamidase 24977 LOG 1.9 LOG N/A 
THRC Threonine synthase 54738 LOG 1.9 LOG N/A 
G3P1 
Glyceraldehyde 3 phosphate 
dehydrogenase 1 
35727 STAT 3.0 STAT N/A 
G6PI Glucose-6-phosphate isomerase 61261 STAT 1.4 STAT 1.7 
GRE2 
NADPH-dependent methylglyoxal 
reductase 
38145 STAT 1.9 STAT N/A 
HBN1 Putative nitroreductase 20980 STAT 5.4 STAT 7.1 
HSP31 Probable chaperone protein 25654 STAT 1.4 STAT N/A 
PMG1 Phosphoglycerate mutase 1 27591 STAT 1.4 LOG 2.0 
SODC Superoxide dismutase Cu Zn 15844 STAT 1.1 LOG 1.8 
 
Table 3-5: List of differential proteins that were identified in both the traditional bottom-up 
and combined top-down/bottom-up online analyses for the comparison between phases of 
growth. Proteins in green were consistently up-regulated in the same yeast sample and at 
roughly the same fold-change.  Protein in yellow were up-regulated in the same sample, but 
at differing extents.  Proteins in red were found to be up-regulated in opposite yeast sample.  
Un-highlighted proteins were only identified in one of the samples used for comparison and 
therefore, a fold change could not be computed nor compared. 
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Figure 3-1: Workflow of traditional bottom-up proteomic analysis. 
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Figure 3-2: Distribution of the molecular weight of proteins detected. A) Proteins identified 
in the experiment presented in this chapter through a completely BU analysis of differential 
yeast samples.  B) Distribution of protein masses detected from the online LC-LC-MS 
analysis of intact proteins performed in the previous chapter.  Figure 2–7B is reprinted here 
for comparison 
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Figure 3-3: Replication of proteins identified by PLGS2.4 for the triplicate analysis of each 
differential sample.  All replicating proteins and only non-replicating proteins identified at a 
95% confidence are included. 
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Figure 3-4: Log/log plots of replicate analysis of each sample.  A) Bottom-up replicate 
analysis of glycerol/log phase sample.  B) Replicate analysis of dextrose/log phase sample.  
C) Replicate analysis of dextrose/stationary phase sample. 
A) 
B) 
C) 
Glycerol 
Log Phase 
Dextrose 
Log Phase 
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Figure 3-5: Log/Log plots of replicate data with differential comparisons appended.  Only 
proteins identified in both differential samples are included.  Replicate data and comparative 
data are given on a single plot for the comparison between the growth nutrient samples in A, 
and growth phase at the time of harvest in B. 
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Figure 3-6: Log/Log intensity plot of differential sample comparison with error bars.  
Highlighted data points are representative points that are straightforward to designate as 
having significant differences. 
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Figure 3-7: Bar graph comparison of replicating proteins identified in both the glycerol, log 
phase sample and the dextrose, log phase sample.  A) Protein intensity in fmol full scale. B) 
Zoomed in view of protein intensity to better illustrate differences of proteins of lower 
intensities. 
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Figure 3-8: Continuation of replicating proteins identified in both the glycerol, log phase 
sample and the dextrose, log phase sample.  The y-axis scaling is the same as in the previous 
figure.  A) Protein intensity in fmol full scale. B) Zoomed in view of protein intensity to 
better illustrate differences of proteins of lower intensities. 
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Figure 3-9: Bar graphs of replicating proteins identified in both the dextrose, log phase and 
dextrose, stationary phase samples. A) Protein intensity in fmol full scale. B) Zoomed in 
view of protein intensity to better illustrate differences of proteins of lower intensities. 
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Figure 3-10: Continuation of replicating proteins identified in both dextrose, log phase and 
dextrose, stationary phase samples. A) Protein intensity in fmol full scale. B) Zoomed in 
view of protein intensity to better illustrate differences of proteins of lower intensities. 
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Figure 3-11: Replicating proteins identified in either the glycerol, log phase sample or the 
dextrose, log phase sample, but not both.  A and B include the proteins which replicated in 
the glycerol, log phase sample only.  C includes the proteins which replicated in only the 
dextrose, log phase sample. 
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Figure 3-12: Replicating protein identified in either the dextrose sample harvested at the log 
phase or the dextrose sample harvested at the stationary phase.  A and B contain proteins 
which replicated only in the log phase.  C contains proteins which replicated only in the 
stationary phase. 
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Figure 3-13: Distributions of %RSD of protein intensity by a bottom-up UPLC-MS
E
 analysis.  
The plot includes errors from all three differential yeast samples analyzed. 
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4.1 Introduction 
 Background and previous work comparing top-down and bottom-up proteomic 4.1.1
methodologies 
As addressed in Chapter 1, there are two main analytical strategies in mass 
spectrometry (MS) based proteomics, top-down (TD) and bottom-up (BU).  While TD 
proteomics is increasing in popularity due to advances in ionization techniques and data 
processing, by far the majority of proteomic analysis is performed in a BU manner.  Several 
studies have emerged that are similar in nature to the combined approach described in 
Chapter 2 whereby the mass of a protein is determined after some form of separation at the 
intact protein level followed by digestion and analysis of the resulting peptides by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS).  Protein identification is 
performed by searching the BU data against a protein database and masses from the database 
are compared to those determined from the intact protein MS experiment.  The first studies 
employing this strategy used it strictly as a protein mapping approach in order to identify as 
many proteins as possible in a single sample.
1-5
  The overlap between protein masses from 
the intact MS data to the masses from the proteins identified from the database searching was 
generally low, around 30%, even when additional post-translational processing was factored 
in.  While these studies were integral for the determination of some post-translational 
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modifications (PTMs), later work applied experiments utilizing a hybrid approach to 
differential proteomics.  Differential expression of proteins in two or more samples was 
determined from a TD analysis based on protein MS intensity and compared to a list of 
protein identifications generated from digestion of a fraction containing the differential 
protein.
6, 7
  These studies, however, do not address how the differential expression might 
change if analysis was performed as a completely BU experiment.  Essentially, the question 
that needs to be addressed  is how well does a fold change based on intact protein MS signal 
intensity compare to a fold change based on peptide MS intensity following digestion. 
With the increase in TD proteomics, namely in the realm of differential proteomics, it 
is essential to examine if the differential expression determined by this type of proteomics 
gives similar or contradicting results to those obtained from a BU study of the same samples.  
The experiments presented in this chapter are aimed at addressing this issue. 
 Separations of intact proteins at ultra-high pressures 4.1.2
Historically, intact proteins have behaved poorly in reversed-phase liquid 
chromatography (RPLC) separations.  There have been numerous reports of issues such as 
limited resolution, poor peak shape, and protein carryover or ‘ghosting’.  Previous work in 
the Jorgenson Lab has shown an improvement in the behavior of intact proteins when 
separated at pressures greater than 20,000 psi.
8
  When comparing capillary columns operated 
at conventional pressures, 2,200 psi, and ultra-high pressures (UHP), 23,000 psi, protein 
recovery at UHP was 60% greater than that observed at conventional pressures.  
Furthermore, while the main goal of the study was to investigate protein carryover and 
ghosting, an improvement in peak shape and resolution of adjacent protein peaks was also 
observed. 
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The work presented in this chapter is aimed at investigating the similarities between a 
differential expression study based on both TD and BU proteomic analyses.  Experiments 
performed in a TD nature utilized the UHPLC separation of intact proteins in order to 
improve the peak capacity of the RP separation.  Fewer co-eluting peaks would then allow 
for a reduction in overlap of protein charge envelopes in the mass spectrum and result in 
improved mass spectral deconvolution. 
4.2 Experimental 
 Outline for experimental method 4.2.1
The experimental method for the analysis presented in this chapter included both a 
top-down analysis and a bottom-up analysis as illustrated in Figure 4-1.  The difference 
between the methodology presented here and that presented in Chapter 2 is that here, the 
analysis was performed in an off-line fashion.  Also, instead of performing two dimensions 
of separation at the intact protein level prior to digestion, the intact proteins were only 
separated by anion exchange prior to digestion.  After vacuum centrifugation and 
reconstitution, each anion exchange fraction was split in half; one half was analyzed in a top-
down manner and the other was analyzed in a bottom-up manner.  For the bottom-up 
analysis, after digestion with trypsin, samples were analyzed by LC-MS
E
 and the data 
processing with ProteinLynx Global Server.  For the top-down analysis, proteins are 
analyzed by UHPLC-MS using a custom LC set-up capable of delivering flow at pressures 
up to 40,000 psi.  The abundance comparison between differential samples was made with 
both sets of data, the TD and the BU.  Once all analysis of the individual halves was 
complete, the expression changes that were found in each half were compared. 
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 Reagent and sample preparation 4.2.2
Optima grade water and acetonitrile and LC-MS grade formic acid, ammonium 
bicarbonate, and ammonium acetate were purchased from Fisher Scientific (Fair Lawn, NJ).  
Sequencing grade modified trypsin by Promega, iodoacetamide, and dithiothreitol were 
purchased from Sigma-Aldrich (St. Louis, MO).  The digestion standard, MassPREP BSA 
digest, and the acid-labile surfactant, RapiGest SF, were provided by Waters Corporation 
(Milford, MA).  The soluble fraction from Baker’s yeast cell lysates were the same as have 
been used in previous chapters and were also provided by Waters.  While all three samples 
were analyzed by anion exchange, fractions were collected and analyzed only for the samples 
grown on different carbon sources and harvested at the log phase of growth. 
 Instrumentation and run conditions for anion exchange separation 4.2.3
The anion exchange separation was performed on a commercially available Waters 
BioSuite Q strong anion exchange column with dimensions of 75mm x 7.5mm ID.  The 
packing material was almost identical to that used in the long anion exchange column from 
Chapter 2.  The only difference was that the particle diameter was slightly smaller at 10 µm 
as opposed to a 13 µm diameter for the long anion exchange column.  Gradients were 
delivered using a Waters 600 quaternary gradient LC pump at a flow rate of 0.5mL/min.  The 
mobile phase composition of both mobile phases A and B was ammonium acetate adjusted to 
pH 9.0 with ammonium hydroxide.  The ammonium acetate buffer concentration of A was 10 
mM and the concentration in B was 750 mM.  The full gradient profile can be found in  
Table 4-1.  Monitoring of the separation was performed by UV detection on a Waters 
2487 dual wavelength detector set at a wavelength of 280 nm.  One-mL fractions were 
collected every two minutes beginning two minutes after injection through to 72 minutes 
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after injection for a total of thirty-five fractions collected per sample.  The dextrose-grown 
stationary phase sample was analyzed first without fraction collection followed by the 
glycerol-grown and dextrose-grown log phase samples with fraction collection. 
Fractions were lyophilized by vacuum centrifugation and reconstituted in 50 µL of 50 
mM ammonium bicarbonate.  Twenty-five µL was withdrawn from each centrifuge tube and 
placed in a sample vial for intact protein analysis.  An additional 25 µL of DI water was 
added to each sample vial to dilute the buffer concentration and increase the volume.  The 
increase in volume was necessary to allow for at least two possible injections of each fraction 
in the event that instrumentation difficulties arose. 
 Capillary UHPLC of intact protein fractions at elevated pressures 4.2.4
The instrumentation of the gradient UHPLC system has been described previously.
8-10
  
A diagram of this system is provided in Figure 4-2.  Briefly, the complete system is 
composed of multiple commercially available components in addition to a custom-built 
hydraulic amplifier, which was designed and fabricated by Waters Corporation for the 
production of gradients at pressures up to 40,000 psi.  The commercially available 
components include a Waters integrated CapLC-PDA system, which is comprised of an 
autosampler, CapLC pump, and a PDA detector (not used), and a Waters 1525 binary 
gradient pump.  The custom-built pump provided by Waters is a hydraulic amplifier that 
receives working fluid from the 1525 binary gradient pump.  Brake fluid was used as a non-
compressible working fluid.   
In the operation of the gradient UHPLC system, the integrated CapLC system is used 
to both load a gradient onto the gradient storage loop and perform the sample injection in an 
automated manner.  The status of all valving and direction of flow during this process is 
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illustrated in Figure 4-2 A.  The gradient is loaded first in reverse as a pre-column 
conditioning method in the software, followed by a sample plug from the injection cycle.  
While there is no valve preventing the sample from entering either the flow splitter or the 
analytical column, the flow restriction provided by these paths is roughly 200 times and 
8,000 times, respectively, that of the gradient storage loop.  Once the gradient and sample 
have been loaded past the 4-port micro-volume cross, the flow from the CapLC is diverted to 
waste and both of the pin valves are closed.  The hydraulic amplifier flow is initiated and the 
sample and gradient are forced onto the column in that order as shown in Figure 4-2 B.  After 
the run is finished the vent valve is opened to release the pressure slowly while still isolating 
the CapLC from the high pressures.  Once the hydraulic amplifier pressure drops below 
1,000 psi, the CapLC vent valve is opened and the system is ready for another gradient 
loading and injection cycle. 
The capillary column used for the separation was 15 cm x 50 µm ID packed with 1.5 
µm bridged ethyl hybrid (BEH) C18 particles from Waters.  Mobile phase A was comprised 
of 0.2% (v/v) formic acid in water and mobile phase B was acetonitrile, also with 0.2% (v/v) 
formic acid.  The gradient was loaded such that the hydraulic amplifier would produce a 30 
minute gradient from 20 to 60% B at a flow rate of 4 µL/min.  The flow was split at a 10:1 
ratio such that only 400 nL/min flowed through the column. 
 Mass spectrometric analysis of intact proteins 4.2.5
The outlet of the column is connected to a pulled glass capillary spray tip (New 
Objective, Woburn, MA) to which 2 kV is applied only when the hydraulic amplifier is 
flowing to preserve the integrity of the tip and achieve electrospray ionization for analysis on 
a Micromass LCT mass spectrometer scanning from m/z values of 450-1600.  Data are 
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acquired from the time the hydraulic amplifier flow is initiated until the system is 
depressurized.  Analysis of the mass spectra is performed in an automated fashion using 
AutoME just as was done in Chapter 2.  The processing parameters for the maximum entropy 
deconvolution are shown in  
Table 4-2.  The AutoME output is loaded into Igor Pro graphing and analysis 
software (Wavemetrics, Lake Oswego, OR) for further summing and duplicate removal 
across scan ranges and fractions.  The output from all of the processing is a mass list with a 
corresponding intensity and retention time of all of the detected proteins.  Intensity values 
from the protein lists generated from each of the yeast samples are compared within specified 
retention time (3 min), fraction range (3 fractions) and molecular weight tolerances (10 Da) 
to determine differentially expressed proteins. 
 Digestion of intact proteins and analysis of resulting peptides by UPLC-MSE 4.2.6
The digestion conditions were identical to those used in the previous chapter with 
minor differences to account for the different amounts of protein likely to be present in each 
fraction.  The amount of trypsin to add was determined by using a 25:1 protein: enzyme ratio 
with a protein amount corresponding to what would be present in each fraction assuming 
equal distribution of protein across all fractions.  This is not what actually occurs, but has 
served as a good approximation in previous experiments.  LC-MS
E
 was performed on a 
Waters nanoAcquity LC system coupled to a Q-TOF Premier mass spectrometer, also from 
Waters.  The LC system was run in trapping mode with the separation occurring on a 25 cm 
x 75 µm ID analytical column packed with 1.7 µm BEH-C18 particles.  Mobile phases A and 
B consisted of 0.1% (v/v) formic acid in water and 0.1% (v/v) formic acid in acetonitrile, 
respectively.  A 60 minute gradient program was used ranging from 5 to 40% mobile phase B 
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before ramping up to 85 % B for a short period to clean off the column.  Mass spectrometric 
analysis was performed in a data-independent manner using MS
E
.  Data were processed 
using ProteinLynx Global Server 2.4 RC7 with the same parameters as described in the 
previous chapter in order to gain both identification and absolute quantification of the 
proteins.  Only replicating proteins were used for further analysis so that the significance of 
fold changes in the comparison between differential samples could be determined.  The 
output from PLGS was loaded into excel to sum duplicates across fractions.  The list of 
protein identity and absolute quantitation was compared to an equivalent list generated from 
another sample to identify differences in protein expression.  All fractions were analyzed in 
duplicate as a measure for both fractionation and system reproducibility. 
 Comparison of quantitation based on both top-down and bottom-up data 4.2.7
The comparison of quantitative data obtained from the two proteomic strategies was 
done in two different ways.  The first was on a fraction-by-fraction basis.  The sample 
complexity of each fraction should be much less than the sample as a whole and should be 
easier to compare across methods.  Because only the bottom-up analysis gives absolute 
quantitation data, relative changes in intensity across the differential samples must be 
compared.  For example, the fold change of protein ‘A’ across fraction ‘X’ in the bottom-up 
comparison would be compared to the fold change of a protein with a similar intact mass in 
the same fraction.  The second method of comparison was done with the summation of 
intensities of identical proteins in the bottom-up analysis and in the top-down analysis 
whereby protein intensities of equivalent molecular weight (± 10 Da) and similar retention 
time (± 3 min.) were summed. 
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4.3 Results 
 Anion exchange fractionation of intact proteins 4.3.1
UV chromatograms of the anion exchange separations are shown in Figure 4-3.  
Vertical lines designate the fractionation that was performed on the samples.  For this 
analysis, fractions were collected only for the glycerol-grown yeast sample and the dextrose-
grown yeast sample that were harvested at the log phase.  The lysate of cells harvested at the 
stationary phase was analyzed initially to determine the range over which fractions should be 
collected for subsequent analyses.  The UV trace of all three samples is shown in Figure 4-3 
A.  In this plot, the three chromatograms are overlaid in order to examine overall changes in 
UV intensity.  In Figure 4-3 B, the samples harvested at the log phase are plotted with an 
offset to better visualize the individual chromatograms.  As stated in the experimental 
section, fractions were collected at 2 minute intervals starting 2 minutes after injection and 
continuing to 72 minutes for a total of 35 fractions per sample. 
 Reversed-phase separation and analysis of intact proteins 4.3.2
After lyophilization and reconstitution of anion exchange fractions, half of each 
fraction was analyzed by UHPLC-MS to determine the intact molecular weights of proteins 
in the complex mixtures.  The separation was performed at ultra-high pressures (23 kpsi) on 
capillary columns (50 µm ID) as opposed to standard HPLC operating pressures of less than 
6 kpsi on standard bore stainless steel columns (4.6 mm ID).  For comparison, two 
chromatograms are shown in Figure 4-4, one from a standard HPLC intact protein separation 
and one from a UHPLC intact protein separation.  In both cases, the sample analyzed was of 
a fraction from an anion exchange separation.  The HPLC separation was performed online, 
so the injection was a continuous 30 minute stream of the effluent from the long anion 
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exchange column.  This in contrast to the UHPLC separation in which anion exchange 
fractions were collected, lyophilized, reconstituted, and injected onto the capillary column 
using an autosampler equipped with an injection loop.  The asterisk in each chromatogram 
denotes the same protein peak in each analysis. 
 Differential comparison of 2D intact protein chromatograms 4.3.3
LC-MS data from the analysis of the intact portion of each protein fraction were 
processed with AutoME and subjected to the same data analysis strategies as described in 
Chapter 2 for the on-line 2D separation of intact proteins.  The 2D chromatograms 
reconstructed from the UHPLC separations of individual anion exchange fractions are shown 
in Figure 4-5 with the dextrose-grown yeast shown in A and the glycerol-grown yeast shown 
in B.  The maximum intensity for a deconvoluted protein peak was over 300,000 counts; 
however these chromatograms are plotted at a z-axis maximum intensity of 50,000 in order 
to be able to see some of the less intense peaks.   
A mass list was generated of proteins that appeared to change in intensity based on 
color changes seen in the comparison of 1 kDa mass slices.  This list of protein masses is 
included in Table 4-3.  The fraction in which the protein was most intense in each sample is 
included, along with the deconvoluted mass.  Intensity values are a summation of the 
intensity in the fraction indicated and the intensities in the two neighboring fractions.  A fold-
change was determined by dividing the greater of the two intensities by the lesser of the two.  
To determine the significance of the protein intensity differences, a log/log intensity scatter 
plot was constructed of the differential proteins from the mass slice comparison with the 
confidence lines from Chapter 2 included.  This is shown in Figure 4-6.  The percent 
probability that the intensity difference is significant based on these error curves is included 
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in the last column of the data.  From Chapter 2, the confidence threshold at which intensity 
differences were considered significant was arbitrarily set at 96.5%.  Using the same 
threshold, three masses that appeared to show a significant change in color in the mass slice 
chromatograms fell inside the 96.5% confidence lines. 
 Identification of differential proteins based on molecular weight 4.3.4
The identification of proteins determined to have differential expressions based on the 
intact protein MS data was performed at the peptide level after digestion by LC-MS
E
.  The 
remaining half of each anion exchange fraction was used for this purpose.  After analyzing 
each sample and processing the data with PLGS2.4, masses of the identified proteins were 
compared with those determined to have differential expressions from the TD data.  The 
masses used from the BU data were the average masses of the protein, as opposed to 
monoisotopic, and included the removal of the N-terminal methionine, if known to occur, 
and any other reviewed modifications.  If the two protein masses differed by less than 100 
Da, they were considered the same, although the average difference was less than 25 Da with 
a median difference under 5 Da.  Of the 39 masses determined to differ in intensity between 
the two samples, 22, or 56%, were successfully identified.  Two out of the three highlighted 
proteins in Table 4-3 that had intensity differences that were not deemed to be significant 
were also not identified in the BU analysis of the same fraction. 
 Protein identification and differential comparison based on peptide data 4.3.5
Half of each anion exchange fraction was digested and subjected to analysis by LC-
MS
E
 to identify as many proteins as possible in each sample.  Every fraction was analyzed 
regardless of whether or not a potential differentially expressed protein mass was detected in 
that fraction from the intact protein analysis.  A small amount of a MassPREP BSA digest 
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was added to each digested fraction as a means to obtain absolute quantitation of the proteins 
present in each fraction and sample.  Each fraction was analyzed twice to determine the 
reproducibility of the absolute quantitation.  A log/log plot was created to compare the 
changes in quantitation in each of the replicate analyses.  This is shown in Figure 4-7 A along 
with a comparison in the replication from the un-fractionated BU experiment discussed in 
Chapter 3 in Figure 4-7 B.  Statistics of the BU analysis are given in Table 4-4. 
The initial runs of each sample were acquired over a time period of one week.  The 
replicate runs were acquired over the same period of time roughly three weeks later.  For the 
purpose of the statistics shown in the table, the initial runs of the 35 fractions from the 
dextrose-grown yeast sample are grouped to give the data under the ‘Dextrose 1’ column and 
the replicated runs of the fraction were grouped separately under the ‘Dextrose 2’ column.  
The same grouping was performed on the glycerol-grown fractions.  The total number of 
proteins identified includes redundant proteins found in more than one fraction.  The total 
peptide mass injected was calculated by summing the amounts output by PLGS2.4 across all 
35 fractions.  The mass accounted for was determined by multiplying the total mass injected 
by 57 to account for a 1 µL injection of the 57 µL of sample present after digestion.  On 
average, 177 µg of the 1.11 mg of total protein was accounted for (only half of each fraction 
from the original 2.22 mg injection was digested). 
 Comparison of relative protein abundance between both methods on a fraction-4.3.6
by-fraction basis 
A flow diagram for the data processing used to compare fold changes from the TD 
and BU data for each fraction individually is shown in Figure 4-8.  In order to determine 
protein abundance in each fraction from the BU data, the replicates of each fraction from 
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both samples` were compared to determine the average abundance in fmol of a protein in 
each fraction.  Proteins that replicated between the two runs of each fraction from the 
dextrose-grown yeast sample were then compared on a fraction-by-fraction basis to the 
proteins that replicated in the glycerol-grown yeast sample.  A list was generated that 
compared the average protein abundance in each fraction to determine a fold change. 
Due to the fact that the TD data does not have a unique identifier associated with each 
protein, such as is the case with the SwissProt name for the BU data analysis, windows 
needed to be used to sum intensities of masses within a specified range.  A retention time 
window was also set to insure that only intensities from identical proteins would be 
compared.  To generate protein lists for each sample, the AutoME-processed data was 
analyzed such that the intensities of protein masses less than 10 Da apart and eluted within a 
retention time window of 3 minutes would be summed.  This was performed individually for 
each anion exchange fraction. 
Overall, there were 67 proteins that were identified in both BU replicates of both 
differential yeast samples that had masses matching those from the AutoME deconvolution 
of the intact protein MS data.  A list of these proteins with the corresponding fold changes 
determined form each analysis method is included in Table 4-5 (proteins with greater 
abundance in dextrose in the BU analysis) and Table 4-6 (proteins more abundant in the 
glycerol sample from the BU data).  To facilitate the comparison of fold changes between the 
two methods, a bar graph was constructed where the fold changes of each protein in both 
forms of analysis were plotted side by side.  This is shown in Figure 4-9.  Fold changes in 
which the proteins were more abundant in the dextrose sample are shown as positive values 
and those determined to be more abundant in the glycerol sample were plotted as negative 
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values.  To see the differences of the lower fold changes, three protein fold changes were 
allowed to go off scale.  The true fold change for these proteins is written in the plot area. 
 Comparison of relative protein abundance at the whole sample level 4.3.7
The plots described in the previous section include no designation of whether or not the 
fold change of the differential proteins would have been considered significant in either 
comparison.  Figure 4-10 includes only those proteins that were both considered significantly 
different in the TD comparison and identified in both samples of the BU analysis.  All but 
one of these proteins was also considered significantly different in the summation of protein 
abundance across three fractions in the bottom-up data.  Also, only one protein did not have 
significant intensity differences when total abundance across all 35 fractions was summed.  
Fold changes that were not considered significant are designated with an asterisk in the 
figure. 
4.4 Discussion 
 Use of the short anion exchange column for fractionation 4.4.1
The initial separation of the differential yeast cell lysates was performed using a 
different anion exchange column than the one used in the online separation from Chapter 2.  
In an online separation, the first dimension is often operated at a decreased flow rate in order 
to allow time for the second dimension separation to occur.  The longer anion exchange 
column held an advantage of the short column when operated in this manner since it showed 
less decrease in the performance than did the short column when operated a lower flow rates.  
This is very important for separation performed in an online manner since, ideally, all 
resolution gained in the first dimension would be preserved in the transfer to the second 
dimension.  Contrastingly, in theory, offline separations are not limited by the time needed to 
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perform the second dimension separation.  Practically speaking, however, there is a time 
frame in which it would be preferred to be able complete an experiment.  Because the 
combined TD/BU offline separation performed here required that each sample be analyzed at 
least twice (a TD LC-MS analysis and a BU LC-MS
E
 analysis), a realistic number of 
fractions to be collected was around 30. 
In order to have a faster, more reproducible anion exchange separation, a shorter 
column was used.  By using the shorter column in an offline separation, a flow rate near the 
optimum for the column could be used as opposed to slowing down the separation to wait for 
the second dimension as was done for the online separation.  Also, the gradient was 
programmed such that an equivalent number of column volumes would be used as were used 
with the long column.  The separation could be performed much more rapidly since the 
volume of the column was smaller, and a faster flow rate could be used.  Using this strategy, 
all three differential yeast samples were separated by ion exchange in a single day versus one 
sample per day with the long column online separation. 
One of the drawbacks of using a shorter column is that there is usually some loss in 
efficiency.  However, the long anion exchange column was under-sampled so the slightly 
better efficiency offered was lost in the fractionation step.  In looking at the anion exchange 
fractionation shown in Figure 4-3, peaks generally eluted over 3 fractions or less, which is 
closer to the recommended sampling rate for multidimensional separation of three times 
across the 8 σ width at the base of the peak.11 
Initially, the dextrose-grown yeast cell lysate that was harvested at the stationary 
phase was analyzed to verify that thirty-five 2 min fractions would be sufficient to collect all 
proteins eluting from the column.  The gradient described in Table 4-1 was used for this 
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initial analysis and was also used for the subsequent analyses of the differential yeast 
samples.  In Figure 4-3 B, the two yeast samples that differed in preparation by growth 
nutrient are plotted with an offset to see if a similar peak pattern was present as was seen in 
the 2D chromatograms from the online experiment.  Looking at just one dimension of 
separation, while there are some similarities between the samples, the extent is not as readily 
apparent as it was in the 2D chromatograms in Chapter 2 or even in Figure 4-5 of the intact 
protein separation from this analysis. 
 Reversed-phase separation of intact proteins after fractionation by anion 4.4.2
exchange 
The advantages of using a UHPLC separation for intact proteins over a standard 
HPLC separation were discussed in section 4.1.2 and include improved protein recovery, 
decreased protein carryover, and improved peak shape.  Due to pressure limitations of 
commercially available valves and pumping systems, it was not feasible to couple this to an 
online separation strategy.  For the offline separation, however, the application of a UHPLC 
separation was attractive.  Two chromatograms are shown in Figure 4-4, the first from the 
online 2D separation of the dextrose-grown yeast sample and the second from the second 
dimension UHPLC separation in the offline analysis of the same sample.  The chromatogram 
shown in A is the 14
th
 anion exchange fraction from the online separation and in B, it is the 
16
th
 fraction from the offline separation.  These fractions were selected for comparison due to 
the presence of the same protein peak in both fractions.  The protein peak with an intact mass 
of 9,930 Da is designated with an asterisk in both chromatograms.  The peak width of the 
protein in A was 30 sec and in B it was 20 sec.  These peak widths correspond to peak 
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capacities of roughly 30 for the HPLC separation and 60 for the UHPLC separation taking 
into account the amount of time over which peaks actually eluted during the gradient.   
Protein carryover observed in subsequent blank injections that is often seen with the 
analysis of proteins on silica-based reversed phase columns was not detected with these 
UHPLC separations.  For the online separation, the polymer-based columns were selected 
due to the requirement for no protein carryover, since the use of blank gradients to clean off 
columns between each run was not feasible.  The low pressure limitation of the polymeric 
particles (450 psi) limited the speed at which the separation could be performed.  Through 
the use of ultra-high pressures (23 kpsi), protein carryover was eliminated and fractions were 
able to be analyzed without the need for blank runs in between to clean off the column.  If 
carryover was present and blank gradients were needed, the analysis time would have 
doubled. 
 Differential analysis of 2D chromatograms from TD analysis 4.4.3
2D chromatograms were constructed from the UHPLC-MS analysis of the intact 
portion of the anion exchange fractions.  These 2D chromatograms are analogous to those 
shown in Figure 2-4 from the online separation.  A visual comparison of the mass slice 
chromatograms was performed to identify identical masses (+/- 10 Da) with different 
intensities in the two samples by picking out peaks that changed color.  Comparison of the 
dextrose-grown sample to the glycerol-grown sample resulted in the selection of 39 masses 
with changing intensities with 13 more intense in the glycerol-grown sample and 26 more 
intense in the dextrose-grown sample.  The list of differential protein masses is included in 
Table 4-3.  Over half, 22, of the differential protein masses eluted from the anion exchange 
 115 
column over the fraction range from 10 to 15 indicating that it may have been better to run a 
shallower gradient over this elution time. 
The determination of whether or not the difference in intensity was significant was 
performed using the replicate data from Chapter 2.  This analysis was performed using the 
same mass spectrometer, LCT classic, and thus would have the same instrumental variability.  
The error curves discussed in section 2.3.2 were used to determine a cutoff for whether or not 
a difference was significant.  These are plotted in Figure 4-6 with the intensities of the 
differential protein masses selected in this experiment.  Unlike in Chapter 2, all but one of the 
masses had intensity differences that were significant above the 96.5% threshold.  Even the 
three proteins that fell inside the 96.5% confidence lines, highlighted in the table, had a 
difference that fell outside the 94.0% confidence line. 
One reason for this improved rate of the selection of significantly different protein 
masses through the visual comparison of mass slices is related to the purpose of this 
experiment, which is to examine the relationship between protein fold changes identified in a 
TD experiment and those calculated in a BU experiment.  For this reason, differential protein 
masses were only selected from the mass slices if there was a corresponding peak in the same 
mass range and location in the separation space of both samples, since only relative changes 
in intensity could be compared.  This improvement would likely not be seen if proteins 
present in only one sample were included in the list as they were usually lower in intensity 
and therefore likely contained more error in the measurement. 
 Identification of proteins in the BU proteomic analysis 4.4.4
After removing an aliquot of the reconstituted anion exchange fraction for TD 
analysis, the remainder was digested and analyzed by LC-MS
E
 with the addition of a small 
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amount of a standard BSA digest to allow for absolute quantitation.  The protein 
identification statistics are included in Table 4-4  The total number of proteins identified and 
number of unique proteins identified is higher than seen for the un-fractionated analysis 
discussed in Chapter 3.  This was to be expected since the individual anion exchange 
fractions should have been greatly simplified compared to the original sample.  The numbers 
of replicating proteins were roughly twice that observed in Chapter 3, even with just two 
replicates analyzed for each sample as opposed to three in the un-fractionated analysis.  The 
average number of fractions in which a protein was identified was 2, which indicates that the 
sampling of the anion exchange separation was less than recommended.  One potential 
advantage to under-sampling would be that proteins would be more abundant in each fraction 
and therefore be more likely to be detected. 
Based on the addition of a standard protein digest, the average amount of protein 
present in the original samples was 177 µg.  The amount in the original sample was 
calculated based on 1.75% of each anion exchange fraction being injected for LC-MS
E
 
analysis.  This is just over 15% of the actual 1.11 mg that was actually in the sample based 
on the Bradford assay of the sample prior to fractionation.  With an average of 531 unique 
protein identifications, which equates to approximately 8% of the total 6,500 entries in the 
yeast database, it is likely that the remainder of the protein is spread across many of the 
unidentified proteins.  These proteins were not identified either because they were present 
below the limit of detection for this method or because they were overshadowed by peptides 
from the more abundant proteins. 
There was a concern of whether or not fractionation of the sample would increase the 
error in absolute quantitation in comparison to analysis of the samples without fractionation.  
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To investigate this, the replicate data from this experiment were plotted along with the 
replicate data from the experiment in Chapter 3 shown in Figure 4-7 B.  Visual inspection of 
the scatter plot does not indicate that there is a significant decrease in the reproducibility of 
absolute quantitation upon fractionation of a sample.  The calculation of correlation 
coefficient confirms this with a value of 0.94 for the fractionated analysis and 0.91 for the 
un-fractionated experiment. 
 Comparison of fold changes observed for identified proteins selected as 4.4.5
differentially expressed in the TD experiment 
In order to generate protein mass lists from the AutoME deconvoluted data in the TD 
analysis, thresholds had to be set to determine which protein masses would be considered 
equal and subsequently summed.  Unlike in a BU experiment where the identity of each 
protein is known and can be used as a unique identifier to compare multiple lists, the TD 
data, which includes deconvolution of 10 sec increments in each RP run to obtain a protein 
mass and an associated error close to 150 ppm, comparison of protein intensities between 
samples was not so straightforward.  With regard to the summation of intensities within each 
fraction, a retention time window was set to 3 minutes.  It is unlikely that a protein would be 
spread across this broad a retention time window given that most of the peaks were less than 
1 minute wide.  It is even more unlikely that a second protein with a deconvoluted mass 
within 10 Da of the first protein would be present within this window.  The determination of 
the number of anion exchange fractions that a protein would elute into was based on the peak 
widths from the anion exchange fractionation.  The threshold was set such that a 3 fraction 
window was used to sum intensities across fractions.  This should be sufficient to encompass 
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the entire protein peak from the 2D separation space.  Protein intensities and fold changes of 
the TD data in Table 4-3 and Figure 4-10 are the result of this thresholding. 
In order to include a relevant comparison of the fold changes calculated after mass 
slice comparison in the TD analysis, the absolute protein abundance determined by PLGS2.4 
searching of BU data of each fraction was summed in the same manner using the values from 
the same 3 fractions used in the TD analysis.  In Figure 4-10, this fold change is reported in 
blue.  As an additional source for comparison, the fold change calculated using the total 
protein abundance in each sample without the 3 fraction limitation, is also included as the 
green bars.  Also, the error associated with the replicate analysis of the BU fractions was 
used to determine whether or not the fold change was significant.  Fold changes where the 
error bars associated with the abundance of a protein in both samples of the BU analysis 
overlapped are denoted with an asterisk and are not significant. 
Overall, the fold changes from the TD analysis are greater in magnitude than those 
from either BU processing strategy.  The average fold change for the comparison of intact 
protein MS intensity was 12.3 regardless of which sample the protein was most abundant.  
This is in contrast to the average fold changes from the summation of 3 fractions of BU data 
and total protein abundance across all fractions in the BU analysis which were 3.9 and 2.8, 
respectively.  The smaller average fold change for the total protein abundance in the BU 
analysis is not surprising since all isoforms of a given protein would be combined into one 
intensity value.  If there were a differential regulation of the downstream processing of the 
protein, this would be overlooked by an analysis of this type.  Therefore, it is more likely that 
fold changes calculated from the summation of protein abundance in 3 anion exchange 
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fractions would follow the same trend of the fold changes from the TD data than would the 
total protein abundance across all fractions in which it was present. 
Looking only at the first two types of analysis in Figure 4-10, there should be better 
alignment as compared to the total BU analysis.  Overall, 20 of the 21 proteins identified as 
significantly from the TD data were also determined to be significantly different in the 3 
fraction BU analysis.  Fifteen of these 20 proteins were also up-regulated in the same yeast 
sample.  The five proteins that had conflicting fold changes based on the different analyses 
also tended to have a greater difference in the theoretically computed MW and the 
experimentally determined intact MW.  The average difference between the two was 48.6 Da 
for proteins with opposite direction of fold change in contrast to 17.7 Da for proteins that 
were determined to be up-regulated in the same sample across both methods.  This may be an 
indication that the protein identification of the differentially expressed intact mass was 
incorrect and the comparison is actually being made for different proteins. 
Overall, 75% of the differentially expressed proteins identified in the TD experiment 
were determined to be up-regulated in the same yeast sample in the BU experiment; 
however, there was generally a difference in magnitude.  Nevertheless, the fold changes were 
considered significant in both forms of analysis and individual TD and BU experiments 
would have produced the same outcome for the generation of the list of differential proteins.  
For proteins that had significant fold changes in both analyses, but were up-regulated in 
opposite yeast samples, the overall increase in the difference between the theoretically 
computed MW and the experiment MW indicates that the correlation of identified proteins in 
the BU analysis and the masses from the TD analysis may not have been correct. 
 120 
 Comparison of protein fold changes determined from the TD data with those 4.4.6
determined by BU proteomics on a fraction-by-fraction basis 
In the previous section, only proteins that had significant changes in intensity in the 
TD experiment were analyzed.  Data processing involving the summation of protein 
intensities across multiple anion exchange fractions to account for splitting of a protein peak 
across multiple fractions was performed in order to look at the change in the expression of a 
protein across the entire sample.  While this approach is valid and necessary to identify 
differentially expressed proteins, it still involved looking at the 2D separation as a whole.  In 
this chapter, where the goal was to determine the correlation of fold changes between TD and 
BU data rather than to identify differential proteins, this was not necessary.  The anion 
exchange fractionation was meant to decrease the sample complexity and potentially separate 
out protein isoforms that may not have been separated in a complete BU analysis, such as the 
one performed in Chapter 3.  Therefore, for the purpose of looking at protein fold changes in 
both types of analyses, it was useful to compare the changes on a fraction-by-fraction basis. 
Essentially, each anion exchange fraction was treated as a separate sample.  For 
example, the intensity of a protein in fraction X of one sample was only compared to the 
intensity of the same protein in fraction X of another sample.  This comparison was 
performed for both the TD and BU experiments with similar mass and retention thresholds 
used for the summation of TD protein intensities.  There was no bias as to whether or not 
changes in protein abundance were significant or not.  The list of all of the proteins identified 
and the fraction in which each was identified is shown in Table 4-5 and Table 4-6 and a bar 
graph comparison of fold changes is shown in Figure 4-9.  While there were 67 proteins that 
were identified in both replicates of both samples in the BU data and both samples in the TD 
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data, there are redundant proteins within that list.  This is due to the comparison being made 
at the anion exchange fraction level.  Proteins split over more than one fraction are treated 
separately in this comparison strategy. 
As plotted, proteins on the left were consistently up-regulated in the dextrose-grown 
sample and those on the right were consistently up-regulated in the glycerol-grown sample.  
There is a greater similarity in the magnitude of the fold changes for protein up-regulated in 
dextrose; the median factor of the difference in fold changes was 1.2 for the proteins up-
regulated in dextrose and 2.1 for the proteins up-regulated in glycerol.  The proteins up-
regulated in glycerol in both analyses showed the same trend as was mentioned in the 
previous section, where the magnitude of the difference is greater in the TD comparison than 
it is in the comparison of BU abundance.   
Proteins centrally located in the graph are those which were up-regulated in 
conflicting samples between the two forms of analysis.  These account for 17 of the 67 
proteins in the plot, or 25% of the proteins identified in all analyses.  This follows the same 
trend as was seen in the comparison of only the differentially expressed proteins from the TD 
in the previous section.  While not as different as was seen in the previous section, proteins 
with conflicting fold changes were seen to have a slightly higher difference in the computed 
MW as compared the experimental MW with an average difference of 18.8 Da as opposed to 
15.4 Da for proteins with consistent up-regulation. This difference is relatively small 
compared to previous section so a higher instance of misidentification is likely not the cause.   
A potential cause for the discrepancy of which sample a protein was up-regulated in 
could be the uncertainty of the intensity or abundance measurements.  For example, in the 
BU analysis, there was greater occurrence of protein fold changes that were not statistically 
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significant in the proteins that had conflicting directions of differential expression.  Five 
proteins located in the center of the plot had intensity differences that were not considered 
significant based on the replicate analysis.  Only six of the proteins that were up-regulated 
consistently in the same sample in both the TD and BU analyses had fold changes that were 
not statistically significant.  Proteins that were up-regulated in opposing samples in two types 
of analyses are indicated with an asterisk in Figure 4-9. 
4.5 Summary and Conclusions 
BU proteomic experiments have been the most widely used in the field of differential 
proteomics for the past two decades.  However, there has been a recent surge in the use of 
TD proteomic strategies due to improved instrumentation and data analysis software.  Even 
with the prevalence of both methodologies, little work has been done to compare the results 
obtained with both techniques when performed on the same set of samples.  An anion 
exchange separation of intact proteins was performed on both the glycerol-grown and 
dextrose-grown yeast cell lysates to simplify the complex mixtures.  Fractions were split in 
half such that each fraction could be analyzed separately both in a TD analysis of the intact 
proteins by UHPLC-MS and in a BU analysis of the digested proteins by LC-MS
E
. 
For the analysis of the intact protein half of the fraction, a UHPLC separation was 
performed due to the improved recovery of proteins seen at these pressures along with an 
improvement in peak shape.  Both of these phenomena were observed in this experiment 
when compared to the RP intact protein separations performed as part of the on-line 
separation of intact proteins.  The end result of these improvements was a doubling of the 
peak capacity and the absence of the need to run blanks in between each sample injection to 
clean off the column.  As a result, the potential analysis time was cut in half. 
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The comparison of protein differential expression was made in two ways.  The first 
involved the initial selection of differentially expressed protein masses as determined through 
the comparison of mass slice chromatograms generated from the TD experiment.  A fold 
change was calculated by summing the intensity values from the AutoME deconvolution of 
protein with a mass range of 10 Da, and anion exchange fraction of +/- one, and a retention 
time window of 3 minutes.  The fold change determined from this analysis was then 
compared to the fold change observed when the total protein abundance from the BU data 
was used and when just the selected three fractions were used.  Regarding the fold changes 
that were determined for the differentially expressed proteins that were identified in the TD 
analysis, it appears that there is a good correlation with the fold changes calculated from the 
BU analysis.  While the magnitude of the fold change quite often differed, 75% of the 
differentially expressed proteins were found to be most abundant in the same differential 
yeast sample and had changes that were significant in both cases.  Those that differed in the 
direction of differential expression were more apt to have been proteins that had greater 
differences between the experimental and computed MWs.   
Analyzing the data on a fraction-by-fraction basis offered the opportunity to remove 
the bias of whether or not a protein was differentially expressed and just look at the 
differences in relative protein abundance between the two methods.  Through this 
comparison there were a total of 67 instances in which a protein mass was detected by TD 
analysis in the same fraction in both samples and matched the mass (within 100 Da) of a 
protein identified in both replicates of both samples in the BU experiment.  The percentage of 
these proteins that were up-regulated in the same sample in both the TD and BU analyses 
was 75%, the same as was observed looking only at the differentially expressed proteins 
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from the TD data.  A greater percentage of BU fold changes were considered insignificant for 
proteins that had opposing fold changes compared to those based on TD data than did 
proteins found to be up-regulated in the same sample in both types of analysis.  This 
indicated that some opposing fold changes were a result of error in the quantitation rather 
than differences TD and BU proteomics. 
Overall, there was a good correlation in the selection of differentially expressed 
proteins when comparing the fold changes observed in TD and BU experiments.  While the 
magnitude was often different, the fold changes were considered significant in both cases and 
followed the same pattern of up-regulation between the two samples. 
An experiment that would more accurately evaluate the correlation between TD and 
BU proteomics involves the introduction of standard proteins to the complex mixtures.  
Multiple standard proteins that would elute at various times in the anion exchange separation 
would be spiked into two cell lysates.  Proteins would be spiked in at various known levels to 
each sample.  Concentrations of the standard proteins would be different in each cell lysate to 
cause a specific ratio in abundance between samples.  For example, one protein would be 
spiked into sample A at an amount four times greater than it was spiked in sample B.  An 
equivalent hybrid TD/BU offline analysis would be performed, analyzing the same amount 
of cell lysate, and the fold change of the standard proteins determined both by TD and BU to 
see which analysis more closely matched the actual fold change based on the amounts 
initially spiked into the samples. 
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4.7 Tables 
Time (minutes) % Mobile Phase B 
0 0 
2 7 
60 67 
65 100 
85 100 
90 0 
 
Table 4-1: Gradient conditions for the anion exchange fractionation.  The pump was operated 
at a flow rate of 0.5 mL/min.  Mobile phases A and B both consisted of ammonium acetate 
buffer adjusted to pH 9.0 with ammonium hydroxide.  The buffer concentrations for mobile 
phases A and B were 10 mM and 750 mM, respectively. 
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AutoME Processing Parameter Value 
Processing type MaxEnt 1 
Scans to sum 10 
Scans to process 270-3540 
Threshold to process 20,000 counts 
Subtract/smooth/center No raw data processing 
Input mass range 600-1600 m/z 
Output mass range 5000-80,000 Da 
Mass resolution 2 Da 
Damage model Gaussian; w1/2 = 0.75 Da 
Minimum 33% left and 33% right 
Maximum iterations 30 
Post-process subtraction Not performed 
Sum based on Area 
De-harmonizing 20 Da 
 
Table 4-2: Processing parameters used for AutoME deconvolution of intact protein mass 
spectra. 
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Fraction Deconvoluted Mass Intensity N-fold 
Change 
%  
Prob Dextrose Glycerol Dextrose Glycerol Dextrose Glycerol 
9 10 33228.8 33226 512 26700 51 96.5 
17 16 10971.1 10972.6 566 22700 40 94.0 
3 3 13944.2 13944.2 3830 39600 10 96.5 
10 10 58148.3 58148.5 4620 30500 6.6 94 
12 12 35618.8 35619.4 14000 70000 5.0 98 
12 12 11116.5 11117.5 14300 63200 4.4 98 
28 27 23471.8 23472.4 15000 66600 4.5 98 
10 10 16045.7 16045.8 15700 118000 7.5 98.7 
11 11 24538.3 24538.6 16200 66000 4.1 98 
11 10 24170.3 24169.9 16400 125000 7.6 99.5 
16 15 54135 54134.8 16800 142000 8.5 99.5 
11 11 11377.9 11343.6 16800 43600 2.6 94 
24 24 30614.4 30616.1 17400 866000 5.0 98 
14 14 23087.8 23087.7 20500 441000 22 99.5 
12 12 11087.1 11088.1 22800 55300 2.4 96.5 
11 11 33868.2 33836.5 26800 365000 14 99.5 
10 10 8460.0 8460.0 27400 128000 4.7 98.7 
13 14 30889.8 30880.3 31000 2120 15 96.5 
3 2 38424.6 38422.8 31000 84300 2.7 98 
14 15 27499.8 27494.4 39800 719 55 96.5 
21 21 12249.3 12248.8 39900 1340 30 96.5 
15 15 9948.1 9947.63 40900 12700 3.2 96.5 
28 27 23585 23584.9 41200 183000 4.4 99.5 
8 8 17304.6 17304.4 45900 84700 1.8 96.5 
10 10 11855.7 11855.9 49400 97600 2.0 96.5 
15 15 41084.3 41084.7 59200 3010 19 95 
14 14 15815.5 15815.3 59300 112000 1.9 96.5 
23 23 31279.7 31279.7 67500 167000 2.5 98.7 
32 32 22619.6 22622.4 67800 138000 2.0 98 
3 2 8575.27 8575.09 86500 3660 24 98.7 
10 10 20907.8 20908 111000 33400 3.3 98.7 
12 12 11072.1 11072.4 111000 41100 2.7 98 
12 12 11621 11621.5 117000 243000 2.1 98.7 
12 12 27499.1 27489.8 133000 11400 12 99.5 
2 2 8559.46 8559.59 162000 103000 1.6 96.5 
15 14 9932.38 9932.14 164000 10700 15 99.5 
12 12 26668.5 26669.2 209000 69100 3.0 99.5 
10 10 15724 15723.7 300000 186000 1.6 98 
9 9 44657.2 44657.4 578000 829000 1.4 98 
Table 4-3: Intact protein masses and deconvoluted MS intensities of differentially expressed 
proteins selected from the visual comparison of mass slices.  Fraction: the anion exchange 
fraction in which the mass was most intense.  Deconvoluted Mass: mass from the AutoME-
deconvolution of the protein charge envelope.  Intensity: intensity of protein after 
deconvolution.  N-fold change: Fold change of mass calculated such that it was greater than 
1.0.  Red shading indicates that the protein intensity would not be considered significant 
based on replicate data from Chapter 2. 
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 Dextrose 1 Dextrose 2 Glycerol 1 Glycerol 2 
Total proteins 2,329 1,946 2,444 2,060 
Avg. pep/prot. 9.9 9.9 9.3 9.4 
Med. pep/prot. 8 8 7 7 
Total mass inj. 3.2 µg 3.0 µg 3.1 µg 3.0 µg 
Mass acc. for 184µg 173µg 180 µg 171 µg 
Unique prot. 514 440 605 566 
Avg frac/prot 4.5 4.4 4.0 3.6 
Med frac/prot 2 2 2 2 
Replicating 365 450 
Found in both 303 
 
Table 4-4: Identification statistics from PLGS2.4 processing of the LC-MS
E
 data obtained in 
the bottom-up analysis of the anion exchange fractions. 
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Frxn Entry 
Comp 
MW 
Exp. 
MW 
Bottom-up Data Top-down Data 
Fmol 
Dex 
Fmol 
Gly 
FC 
Up 
reg 
in 
Dex 
Int 
Gly 
Int 
FC 
Up 
reg 
in 
14 ACBP 9930.2 9931.6 95.3 25.6 3.7 D 26900 9950 2.7 D 
16 ACBP 9930.2 9931.6 48.1 15.0 3.2 D 1750 672 2.6 D 
9 CYPH 17259.5 17304.5 137 52.0 2.6 D 13500 12200 1.1 D 
11 ENO1 46670.9 46694.2 102 42.0 2.4 D 2450 1190 2.1 D 
14 ENO1 46783.0 46793.6 66.8 25.1 2.7 D 2900 1630 1.8 D 
11 ENO2 46783.0 46792.7 67.0 27.3 2.5 D 1560 928 1.7 D 
12 ENO2 46783.0 46795.8 658 281 2.3 D 51500 33000 1.5 D 
16 MET17 48540.5 48550.9 148 141 1.1 D 27500 22000 1.2 D 
12 OYE2 44879.5 44861.6 210 33.2 6.3 D 1660 929 1.8 D 
13 OYE2 44879.5 44878.8 93.5 14.9 6.3 D 1700 907 1.9 D 
8 PGK 44607.2 44657.6 747 409 1.8 D 121000 54400 2.2 D 
9 PMG1 27477.4 27485.8 63.2 12.5 5.1 D 11000 2800 4.0 D 
10 PMG1 27477.4 27486.9 661 382 1.7 D 529000 365000 1.4 D 
12 PMG1 27477.4 27499.1 901 101 8.9 D 57300 9040 6.3 D 
9 SODC 15723.4 15724.2 165 86.8 1.9 D 64800 35600 1.8 D 
10 SODC 15723.4 15724.3 756 477 1.6 D 206000 135000 1.5 D 
11 SODC 15723.4 15724.2 267 110 2.4 D 31000 19300 1.6 D 
11 TPIS 26664.3 26668.3 987 501 2.0 D 109000 46100 2.4 D 
12 TPIS 26664.3 26668.5 562 88.8 6.3 D 164000 60600 2.7 D 
13 TPIS 26664.3 26669.6 322 34.4 9.4 D 43400 9610 4.5 D 
12 TRX2 11072.7 11072.1 812 307 2.6 D 84500 30000 2.8 D 
13 TRX2 11072.7 11072.6 542 200 2.7 D 26300 11100 2.4 D 
16 TRXB1 34106.9 34111.6 60.0 19.5 3.1 D 5130 1330 3.9 D 
23 TSA1 21458.5 21425.5 63.2 37.2 1.7 D 2610 1860 1.4 D 
3 UBIQ 8556.8 8559.4 395 7.8 50.5 D 34400 9660 3.6 D 
3 CYPC 17567.0 17573.1 63.8 5.5 11.6 D 1370 17700 12.9 G 
3 CYPH 17260.0 17306.5 590 6.7 88.3 D 76700 86800 1.1 G 
8 CYPH 17260.0 17304.6 315 283 1.1 D 32400 72600 2.2 G 
15 CYS3 42410.9 42420.3 304 197 1.5 D 7930 18900 2.4 G 
3 DHOM 38502.1 38424.6 83.6 6.5 12.9 D 12900 32100 2.5 G 
12 ENO1 46670.9 46693.1 89.0 30.7 2.9 D 1790 2590 1.5 G 
12 G4P1 42084.0 42069.9 20.8 16.9 1.2 D 631 949 1.5 G 
15 HXKB 53811.3 53821.3 86.6 60.9 1.4 D 564 4970 8.8 G 
9 PGK 44607.2 44657.2 1500 1252 1.2 D 343000 600000 1.8 G 
11 PMG1 27477.4 27486.1 1050 637 1.6 D 99500 248000 2.5 G 
14 SODC 23083.0 23087.8 89.5 43.3 2.1 D 9120 344000 37.7 G 
15 SODM 23083.0 23088.4 102 86.1 1.2 D 7700 876000 11.4 G 
16 SODM 23083.0 23087.3 45.6 14.7 3.1 D 1840 5010 2.7 G 
28 TCTP 18741.1 18741.7 147 143 1.0 D 17400 29800 1.7 G 
12 TKT1 73674.5 73674.4 36.5 23.8 1.5 D 1530 3620 2.4 G 
10 TPIS 26664.3 26668.2 1130 1000 1.1 D 1340000 1580000 1.2 G 
 
Table 4-5: List of proteins found in both differential yeast samples in both the TD and BU 
analysis of anion exchange fractions that were up-regulated in the dextrose sample of the BU 
comparison.  Frxn: anion exchange fraction. Entry: SwissProt entry followed by _YEAST. 
Comp MW: average molecular weight including reviewed modifications. Exp. MW: 
AutoME deconvoluted molecular weight from TD data. FC: Fold change.  
 
 131 
Frxn Entry 
Comp 
MW 
Exp. 
MW 
Bottom-up Data Top-down Data 
Fmol 
Dex 
Fmol 
Gly 
FC 
Up 
reg 
in 
Dex 
Int 
Gly 
Int 
FC 
Up 
reg 
in 
15 ACBP 9930.2 9932.4 497 592 1.2 G 136000 703 190 D 
11 CH10 11372.3 11344.9 38.7 62.4 1.6 G 16800 43600 2.6 G 
11 CISY1 49216.3 49223.8 50.0 321 6.4 G 742 6030 8.1 G 
8 CYC1 12050.8 12071.0 11.0 40.2 3.6 G 631 4770 7.6 G 
8 DHOM 38502.1 38419.7 28.2 42.9 1.5 G 12500 18200 1.5 G 
12 G3P3 35615.5 35618.8 801 823 1.0 G 9870 51000 5.2 G 
13 G3P3 35615.5 35621.3 265 292 1.1 G 4150 15900 3.8 G 
11 GLRX2 11833.6 11833.9 157 160 1.0 G 20800 34300 1.6 G 
31 IF5A2 16983.1 16951.3 26.3 31.6 1.2 G 1270 3200 2.5 G 
10 IPB2 8458.6 8460.0 73.8 400 5.4 G 27400 105000 3.8 G 
11 MDHM 33832.8 33838.2 100 724 7.2 G 24800 279000 11 G 
12 MDHM 33832.8 33836.8 83.9 361 4.3 G 2020 64000 32 G 
13 MDHM 33832.8 33842.7 38.1 112 2.9 G 774 16600 21 G 
8 MMF1 13939.9 13941.6 72.3 444 6.1 G 760 18700 25 G 
9 MMF1 13939.9 13941.8 40.4 51.7 1.3 G 775 2880 3.7 G 
19 SMT3 11261.7 11252.8 89.8 93.4 1.0 G 2620 2890 1.1 G 
13 SODM 23083.0 23085.6 48.1 57.5 1.2 G 3680 8790 2.4 G 
16 SYV 119994.9 119932 21.0 121 5.8 G 723 1600 2.2 G 
10 TAL1 36905. 36953.3 94.7 263 2.8 G 1070 8160 7.6 G 
9 TKT1 73674.5 73725.5 41.4 89.7 2.2 G 3250 3770 1.2 G 
27 TPM1 23540.7 23586.1 40.4 90.0 2.2 G 15800 128000 8.1 G 
28 TPM1 23540.7 23585 51.3 52.6 1.0 G 20400 54300 2.7 G 
12 TRX1 11103.8 11116.5 258 451 1.7 G 14300 58800 4.1 G 
7 UBIQ 8556.8 8559.5 23.2 26.9 1.2 G 1260 2120 1.7 G 
8 UBIQ 8556.8 8558.3 208 368 1.8 G 21200 32500 1.5 G 
10 YMN1 39976.1 40001.8 25.0 30.3 1.2 G 1520 1880 1.2 G 
 
Table 4-6: List of proteins found in both differential yeast samples in both the TD and BU 
analysis of anion exchange fractions that were up-regulated in the glycerol sample of the BU 
comparison.  Frxn: anion exchange fraction. Entry: SwissProt entry followed by _YEAST. 
Comp MW: average molecular weight including reviewed modifications. Exp. MW: 
AutoME deconvoluted molecular weight from TD data. FC: Fold change. 
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4.8 Figures 
 
Figure 4-1: Instrumentation workflow for off-line combined top-down/bottom-up 
experiment.  1) Soluble fractions of cell lysates are fractionated by anion exchange.  2) 
Fractions are lyophilized to remove volatile anion exchange buffer and reconstituted in a 
smaller volume before being split in half.  3) One half of each reconstituted fraction is run on 
a gradient UHPLC-MS instrument for intact mass measurement and relative quantitation.  4) 
The remaining half of each fraction is tryptically digested.  5)  Identification and quantitation 
is made at the peptide level by UPLC-MS
E
. 
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Figure 4-2: Instrument diagram for gradient UHPLC system.  A) With both pin valves open 
and the hydraulic amplifier not pumping, the gradient and sample are loaded onto the 
gradient storage loop by the CapLC.  B) Closing both valves and initiating flow from the 
hydraulic amplifier pushed the sample and gradient off of the storage loop and into the 
analytical column. 
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Figure 4-3: Anion exchange fractionation of the intact proteins from cell lysates of Baker’s 
yeast samples grown on different carbon sources.  Fraction collection is denoted by the 
vertical lines. A) Overlaid chromatograms from all three differential yeast samples.  B) 
Chromatograms of the glycerol, log phase and dextrose, log phase samples plotted with an 
offset for comparison. 
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Figure 4-4: Comparison of chromatograms from the RP-LC separation of intact proteins.  A) 
RP-LC separation of the 16
th
 fraction taken from the long anion exchange column during the 
online 2DLC analyses of the dextrose-grown yeast cell lysate reported in Chapter 2.  B) 
UHPLC separation of the 14
th
 fraction collected from the short anion exchange column in the 
offline separation described in this chapter.  The highlighted peak in each chromatogram 
represents the same protein. 
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Figure 4-5: Intact protein 2D chromatograms showing AutoME deconvoluted data.  Protein 
intensities are plotted in false color.  A) 2.22 mg injection of dextrose-grown yeast cell 
lysate.  B) 2.22 mg injection of glycerol-grown yeast cell lysate. 
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Figure 4-6: Log/Log intensity scatter plot of deconvoluted intact protein intensity from the 
TD analysis of anion exchange fractions.  Confidence curves constructed in Chapter 2 based 
on replicate data from the online intact protein separation are included. 
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Figure 4-7:  Log/Log plot of absolute quantitation of replicating proteins from PLGS2.4 
processing of BUD data in dextrose-grown and glycerol-grown yeast cell lysates.  A) 
Intensity comparison of proteins found in both replicates of either sample.  B) Comparison of 
the replicate data from both samples from the BU half of the analysis in this chapter, plotted 
in red, versus the replicate analyses performed in Chapter 3, plotted in gray. 
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Figure 4-8: Data processing strategy to compare differential expression of proteins from BU 
and TD data on a fraction-by-fraction basis. 
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 Bottom-up analysis of anion-exchange fractionated S. cerevisiae cell CHAPTER 5:
lysates grown under varying growth conditions 
 
5.1 Introduction 
 The overall trend for differential proteomics includes fractionation of the complex 
mixture prior to digestion for the purpose of simplifying the resultant peptide mixtures.
1-3
  
The previous experiments described in Chapters 2 and 4 were aimed at combining this 
approach with mass spectrometric analysis of the intact proteins to get molecular weight 
information.  However, this is not standard, but rather an added dimension to the 
experimental method.  The work presented in this chapter will follow what is commonly 
reported in literature in which an MS analysis of the intact proteins is not performed, but 
rather a separation of the proteins followed by digestion and MS analysis of the resulting 
peptides.  Proteins are fractionated to a greater extent than described in earlier chapters.  The 
purpose of this was to evaluate the increase in proteins identified upon further fractionation.  
Also, because the data is fully reliant on the identification and quantification of the proteins 
based on peptide intensity following digestion, it would be advantageous to further decrease 
the sample complexity prior to digestion. 
5.2 Experimental 
 Overview of experimental method 5.2.1
 The overall workflow of this technique is shown in Figure 5-1.  The first dimension 
of separation for this off-line bottom-up analysis was the same as was used in Chapter 2.  
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Intact proteins were separated initially by charge on a meter-long anion exchange column 
and detected by UV absorbance.  The effluent of the anion exchange column was directed 
towards a fraction collector.  All fractions collected were lyophilized and reconstituted prior 
to a trypsin digestion.  The protein digests were spiked with a standard tryptic digest of BSA 
and analyzed by UPLC-MS
E
.  Quantitation and identification were performed simultaneously 
using ProteinLynx Global Server 2.4 RC7.  Differential proteins were assigned based on the 
changes in absolute protein abundance as determined from ProteinLynx Global Server 
processing of the digested fractions. 
 Samples and reagents used 5.2.2
 The majority of the reagents used were identical to those described previously in 
section 2.2.2.  The cytosolic fractions from yeast cell lysates that were analyzed in the 
previous chapters were the same samples used for this analysis.  These included yeast grown 
on glycerol, harvested at the log phase; yeast grown on dextrose, harvested at the log phase; 
and yeast grown on dextrose, harvested at the stationary phase.  A detailed description of the 
sample preparation can be found in section 2.2.3.  A tryptic digest standard of bovine serum 
albumin (BSA) was used as the standard for quantitative data (MassPREP BSA from Waters, 
Milford, MA). 
 Anion-exchange separation of intact proteins 5.2.3
 Yeast cell lysates were diluted from the stock solutions to 10 mg/mL total protein 
concentration as determined by the Bradford protein assay with BSA as the standard protein.  
Injections of 225 µL (2.25 mg total protein) of each sample were performed.  A Waters 600 
pump (Milford, MA) provided the gradient which consisted of 10mM ammonium acetate in 
mobile phase A and 750 mM ammonium acetate in mobile phase B, both adjusted to pH 9.0 
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with ammonium hydroxide.  Because this separation was not performed on-line and is 
therefore not influenced by the time required for a second dimension separation, the gradient 
was condensed down to six hours from ten hours, and the flow rate increased to provide an 
equivalent gradient volume.  The exact gradient conditions can be found in Table 5-1.  
Detection was performed by a Waters 2487 dual wavelength detector (Milford, MA) set at 
280nm. 
 Fractionation and trypsin digestion 5.2.4
 Fractions were collected by a Waters Fraction Collector II every 4.75 min starting 40 
minutes after the injection through to 420 minutes for a total of 80 fractions.  After 
lyophilization to dryness by vacuum centrifugation, proteins were reconstituted with 50 µL 
of 50 mM ammonium bicarbonate and only half of each fraction was used for digestion.  The 
digestion protocol was similar to that described in section 2.2.7 except for the amount of 
trypsin added and the quenching step following overnight digestion.  The amount of trypsin 
that was added gave a 28:1 protein: enzyme ratio. This ratio is based on the assumption that 
the 2.25 mg of protein injected would be spread equally over all 80 fractions.  The amount of 
protein actually present in each fraction varied considerably, which is why such a high ratio 
of trypsin was used.  It was presumed that it would be better to have the autolysis of trypsin 
rather than undigested protein.  Trifluoroacetic acid (TFA) was added to bring the acid 
concentration up to 1% in each fraction.  Fractions were incubated for 2 hours at 60°C to 
allow for proper hydrolysis of the RapiGest surfactant.  After digestion, fractions were 
centrifuged at 14,000 x g for 20 minutes to completely remove precipitate from the 
hydrolysis of the surfactant.  Seventy-five µL of each fraction were transferred to sample 
vials for analysis.  A 1 nmol vial of MassPREP BSA standard digest was reconstituted with 1 
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mL of 30% acetonitrile in water with 0.1% formic acid.  A small amount of the BSA digest 
standard (0.77 µL) was added to each fraction such that the final concentration of BSA was 
10 fmol/µL.  Fractions were frozen at -20°C prior to analysis. 
 UPLC-MSE of protein digests 5.2.5
 Analysis of the digested proteins was performed using a Waters nanoAcquity UPLC 
system coupled to a QTOF Premier mass spectrometer, also from Waters (Milford, MA).  
The LC conditions as well as the MS
E
 parameters were identical to those described in detail 
in section 3.2.4.  Briefly, the LC system was operated in trapping mode with a 20 mm x 180 
µm ID trap column packed with 5 µm C18 Symmetry particles from waters.  The analytical 
column was a Waters nanoAcquity BEH-C18 capillary column with dimensions of 250 mm x 
75 µm ID packed with 1.7 µm particles. 
 Protein identification and quantitation based on MS/MS data 5.2.6
 The raw data from the peptide separations was processed by PLGS2.4.  The full list 
of processing parameters is shown in Table 5-3.  The main difference between the parameters 
used for processing in Chapter 3 is the amount of BSA standard digest injected on-column.  
In Chapter 3, BSA digest was added to a final concentration of 50 fmol/µL and 100 fmol of 
BSA digest was injected on-column by performing a 2 µL injection.  For this experiment, 4 
µL sample injections were performed after spiking in BSA digest standard to a final 
concentration of 10 fmol/µL.  This provided 40 fmol injection of the standard BSA digest. 
 Unique protein lists for each sample were generating by removing proteins that were 
identified across several fractions.  The intensities from each fraction were summed in order 
to allow for quantitation across the entire 80 fractions.  The number of fractions that each 
protein was identified in was also determined.  After preparing unique proteins lists for each 
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sample, two comparisons were made: one between proteins identified in the glycerol-grown 
log phase sample and those identified in the dextrose-grown log phase sample, and one  
between the proteins identified in the dextrose-grown log phase sample and those identified 
in the dextrose-grown stationary phase sample.  A fold change was then calculated from the 
summed intensities in each sample. 
5.3 Results 
 Fractionation of intact proteins by anion exchange chromatography 5.3.1
The soluble fraction of cell lysates from Baker’s yeast cells were analyzed directly by 
anion exchange chromatography.  Effluent from the column was directed through a UV 
detector set at 193 nm for monitoring purposes prior to fraction collection.  The resulting UV 
chromatograms for each differential sample are shown in Figure 5-2.  The samples were 
analyzed on consecutive days in the following order: (1) glycerol-grown/log phase, (2) 
dextrose-grown/log phase, (3) dextrose-grown/stationary phase.  Blank gradients were run in 
between each fraction in order to properly clean off the column prior to the next sample 
injection.   
 Protein identifications based on MS/MS data 5.3.2
 Raw data acquired by UPLC-MS
E
 on the nanoAcquity-QTOF premier instrument 
were processed using PLGS2.4.  The protein list output from the processing of each fraction 
was combined in order to remove duplicates between fractions from the same sample prior to 
making a comparison between samples to identify differential proteins.  Overall, there were 
4,191 yeast protein identifications in the 80 glycerol/log phase fractions, 4,646 identifications 
in the dextrose/log phase fractions, and 3,519 identifications in the dextrose/stationary phase 
fractions.  Removing the duplicate proteins across fractions from the same sample gives 701 
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unique proteins in the glycerol/log phase sample, 604 proteins in the dextrose/log phase 
sample, and 504 proteins in the dextrose/stationary phase sample.  Proteins were generally 
identified with multiple peptide hits.  The average peptide hits used to identify a protein in 
the glycerol/log phase, dextrose/log phase, and dextrose stationary phase samples were 15.9, 
17.5 and 14.4, respectively.  These parameters, along with more detailed analysis of the 
protein identifications can be found in Table 5-4.  The total mass of protein accounted for is 
also included for each set of fractions from each sample.  This value was calculated by 
summing the absolute quantitation of each protein in every fraction while accounting for the 
percentage of the total volume of each fraction that was injected.  Four µL out of the 80 µL 
remaining at the conclusion of the digestion procedure were injected for LC-MS
E
 analysis, 
thus the total quantity of proteins in each fraction from PLGS2.4 processing was multiplied 
by 20 to account for all of the protein in a given fraction.  The total mass of intact protein 
injected onto the anion exchange column for each sample was the same based on the protein 
concentration determined from the Bradford assay.  One would expect that the mass 
accounted for would also be equal.  Another way to look at the consistency of mass injected 
across samples is to look at the slope of the best fit line for the log/log scatter plot.  The 
scatter plots are included in Figure 5-3 and Figure 5-4.  Ideally, the value for the y-intercept, 
b, would be zero, and the slope of the line, m, would be 1. 
 Differential protein identifications based on absolute quantitation from MS/MS 5.3.3
data 
 After the protein identifications were summed to removed duplicates, the resulting 
protein list for the glycerol/log phase sample was compared the list for the dextrose/log phase 
sample.  From the 481 unique proteins identified in the glycerol sample and the 390 proteins 
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identified in the dextrose sample, 385 proteins were found in both of the samples.  The 
overlap between the two samples is shown in Figure 5-3 along with a log/log plot of the 
intensities of the proteins that were identified in both samples.  Figure 5-4 shows the 
comparison between the two dextrose-grown samples harvested at different stages of growth.  
The line y=x and the replicate data from the experiment discussed in Chapter 4 are plotted on 
the log/log plots as well for reference. 
 In order to determine whether fold changes were consistent, the replicate analysis 
from Chapter 4 was used to infer the relative error in the quantitation measurements 
performed in this chapter.  In Figure 5-5, the data points in red are based on this analysis.  
The error associated with the absolute quantitation of all proteins that were identified in both 
replicates was calculated for abundances across all thirty-five fractions.  The average relative 
difference in the concentration determined through analysis by PLGS was plotted against the 
greatest number of peptides that was used to identify the protein between the two replicate 
analyses.  This was calculated as follows: 
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Where A1 is the abundance of a protein in one replicate and A2 is the abundance of the same 
protein in another replicate.  Relative differences calculated in this manner were then 
averaged for all proteins identified with the same number of peptides.  This average is plotted 
in Figure 5-5. 
 As expected, there is an inverse relationship between error in quantitation and the 
number of peptides used for identification.  Initially, the data were divided up into groups of 
10 peptides/protein (1-10, 11-20, 21-30, etc.).  A threshold was set at the median of the 
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average relative errors for proteins identified with a number of peptides within that range.  
This threshold was used to infer the relative error in the quantification measurements 
performed in this chapter.  For example, in the replicate data plotted over the range of 11 to 
20 peptides/proteins, the median relative error was 12%.  Therefore, all proteins identified 
with 11 to 20 peptides in the fractionated bottom-up analysis presented in this chapter were 
assumed to have a relative error in the absolute quantitation of 12%.  There was a large span 
of average relative error in the range from 1 to 10 peptides, so it was split into 5 peptide 
spans. 
5.4 Discussion 
 Intact Protein fractionation 5.4.1
As stated previously, the anion exchange fractionation of the proteins is shown in 
Figure 5-2.  Upon inspection of the UV chromatograms, it appears that there was a 
significant increase in the background signal with each sample injection.  Considering the 
UV detector was auto-zeroed prior to each injection, it would have been expected for the 
traces to align somewhat better overall.  The injection amounts for this analysis were based 
on a Bradford assay, so roughly the same mass of total protein was injected each time.  One 
possibility for the increased background would be protein ghosting on the column.  Because 
the UV detector was auto-zeroed prior to each injection, this forced  an initially equivalent 
background betweens runs, but if ghosting occurred, it would cause an increase in overall 
signal as the gradient progressed and eluted carry-over proteins.  If this were the case, one 
would expect that the amount of protein in each fraction of the dextrose/stationary phase 
sample would be much greater than that found in the first sample analyzed, which was the 
glycerol/log phase sample.  When looking at the identification statistics, the number of 
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proteins identified with each successive injection does not exhibit an upward trend.  
However, what is more indicative of potential ghosting effects is the increase in the overall 
protein abundance detected.  Looking only at the proteins that were identified above 95% 
confidence, the total amount injected across all 80 fractions for the glycerol/log phase, 
dextrose/log phase, and dextrose/stationary phase samples gives 203, 244, and 302 µg, 
respectively.  From the Bradford assay and the dilution from digestion, this should have been 
closer to 1.125 mg for all three samples.  The fact that the amount of protein accounted for in 
the analysis is only ~20% of the total is not a cause for concern given that less that 10% of 
the yeast proteins were identified.  It is somewhat concerning, however, that this value 
increases with each injection.   
For the purposes of the differential analysis, ghosting would only cause a problem if 
there was a significant skew in the log/log plots indicating that a majority of the proteins 
were found to be up-regulated in the sample fractionated second in the comparisons.  For 
example, in the comparison between growth phases at the time of cell harvest, the ghosting 
would appear to have affected the comparison if the stationary phase proteins were generally 
found to be up-regulated in comparison with the log phase proteins since the stationary phase 
sample was run last.  Figure 5-4 shows a line of best fit to the comparison data.  As 
mentioned previously, a slope of 1 would be desirable to ensure that the same amount of 
protein was analyzed in both cases.  For the growth phase comparison, the slope was less 
than 1 at 0.72.  Because the slope is less than one, it indicates that overall, the log phase 
proteins are slightly more intense than the stationary phase proteins.  This is in contrast to 
what we might expect based on the higher UV absorbance seen in the anion exchange 
separation of the stationary phase sample and the greater amount of total protein detected as 
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well.  While this slope is still not ideal, for the purposes of the differential comparison, it 
discredits protein ghosting as the main factor affecting the differences in protein expression. 
Also noticeable in Figure 5-2 is the retention time shift that occurred between the 
runs.  Each of the samples generates the same general peak pattern, which makes it easy to 
pick out these shifts.  For example, the peak with a retention time of 200 minutes in the 
glycerol/log phase sample elutes at 192 minutes in the dextrose/log phase sample, and even 
earlier still at 185 minutes in the dextrose/stationary phase sample.  The drift in retention can 
be attributed to the change in pH of the mobile phase.  The ammonium acetate buffer was 
selected for the anion exchange mobile phase due to its volatility which allowed for fairly 
rapid lyophilization and removal of the buffer from the system prior to digestion and LC-
MS/MS analysis.  The volatility that is a benefit for interfacing with a mass spectrometric 
analysis is a detriment to the reproducibility of the chromatographic retention times due to 
the evaporation of ammonia, reducing the mobile phase pH.  For this experiment, the 
identified proteins and their intensities were summed across all 80 fractions, so exact 
retention time reproducibility was not as important as it might be when attempting to 
quantify based on intact protein MS intensity.  If the comparisons had been made on a 
fraction-by-fraction basis as was performed in Chapter 4, this would have been prohibitive. 
 Protein Identification Statistics 5.4.2
Parameters describing the identification of proteins based on PLGS2.4 searching of 
the MS
E
 data are included in Table 5-4.  The ‘Total protein hits’ in the first row corresponds 
to the number of total protein identifications from all eighty fractions of a sample without the 
removal of duplicates.  After the removal of proteins identified in multiple fractions within a 
sample and summing the intensities of each protein, the number of unique proteins identified 
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at a confidence of 95% or greater resulted in 481 proteins in the glycerol-grown yeast 
sample, 390 proteins in the log phase dextrose-grown sample, and 385 proteins in the 
stationary phase dextrose-grown sample.  Corresponding values for the completely bottom-
up analysis without fractionation discussed in Chapter 3 were 302, 221, and 166, 
respectively.  Through the fractionation of the intact proteins from the cell lysate prior to 
digestion, between 1.6 and 2.3 times the number of proteins were identified at 95% 
confidence.  The average number of peptides used to identify each protein was slightly lower, 
approximately 10 peptides per protein across all three samples as compared to 15 peptides 
per protein in the un-fractionated analysis.  A reduction in this value is not surprising given 
that the additional proteins identified in the fractionated approach are likely some of the less 
abundant proteins that were overshadowed by peptides from more abundant proteins in 
Chapter 3.   
A statistic that was initially surprising was the average number of fractions in which a 
protein was identified in.  This value ranged from just under 7 for the glycerol-grown sample 
up to almost 10 for the dextrose-grown log phase sample.  The number of fractions 
containing a specific protein should follow the chromatographic efficiency obtained in the 
anion exchange separation.  From the UV chromatograms, it appeared that proteins would 
have only been spread across 3 or 4 fractions at most.  Upon closer inspection of the data and 
calculation of the median number of fractions in which a protein was identified, which was 2 
or 3, it was determined that a small number of proteins that were identified in more that 60 of 
the 80 fractions were skewing the average.  The majority of the proteins identified in almost 
all fractions were heat shock proteins.  A likely cause for the widespread identification is the 
high sequence homology present in the heat shock protein (HSP) family.  For example, 
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proteins that are members of the HSP70 family are shown to have 50-96% nucleotide identity 
in the genes and eight of the HSPs identified in more than 30 fractions are part of this 
family.
4
  Based on the peptides identified, there may have been an equal probability that 
multiple heat shock proteins were in a given sample.  PLGS2.4 outputs all of these proteins, 
resulting in the assignment of a single peptide to multiple proteins. 
 Analysis of differentially regulated proteins and significance of intensity 5.4.3
differences 
The individual protein lists from the processing of MS
E
 data from the analysis of the 
anion exchange fractions of a given sample were combined to give an overall list of proteins 
identified in the entire sample.  The intensities of proteins identified in multiple fractions 
were summed such that overall intensities could be compared between samples.  The lists of 
proteins identified in the glycerol-grown and dextrose-grown samples were compared to 
generate a list of proteins identified in both.  The overlap of proteins identified at 95% 
confidence in both samples is shown in Figure 5-3a with a log/log plot of the abundance in 
fmol of a protein in one sample versus the abundance in the other.  Figure 5-4 includes the 
same analysis performed for the comparison in growth phase using the dextrose-grown 
sample harvested at the log phase and the dextrose-grown sample harvested at the stationary 
phase.  The log/log plots in both of these figures indicate that it would be difficult to 
determine whether or not the intensity of a protein is significantly different in a given 
comparison based on these plots alone.   
In chapters 3 and 4, the absence of a clear cut-off in the log/log comparison was 
resolved by performing replicate analysis of the digested samples.  However, due to the 
number of fractions that were collected in this experiment, it was not feasible to run them in 
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triplicate eliminating the opportunity for a replicate analysis.  Instead, the replicate analysis 
performed in the experiment described in Chapter 4 was used to infer the relative error in the 
determination of protein abundance in the heavily fractionated experiment described in this 
chapter.  Figure 5-5 shows the analysis of the replicate data and how it was used to determine 
the error of abundance measurements for the fractionated BU analysis described here.  The 
replicate data from Chapter 4 was used as opposed to that obtained in the total BU analysis 
from Chapter 3 due to the greater similarity in the experimental methods.  The overall 
abundance of proteins in a given sample determined in Chapter 4 was the result of the 
summation of the quantitative analysis performed on multiple anion exchange fractions as 
opposed to the abundance determined from the analysis of the sample as a whole as was 
described in Chapter 3. 
To calculate the average relative error in protein abundance, proteins that replicated 
in the analysis from the previous chapter were grouped based on the greatest number of 
peptides that were used for its identification.  Relative errors of protein abundance from 
proteins identified with the same number of peptides were averaged.  This average was then 
plotted versus the number of peptides and is shown in Figure 5-5.  A clear trend is observed 
in that there is an increase in the relative error as the number of peptides used to identify a 
protein decreases. The application of this analysis to infer the relative error in the 
quantitation of proteins in the sample after summing 80 fractions is described in section 
5.3.3.  After arbitrarily segmenting the data into 10-peptide segments, the median average 
error observed across the segment was used as the relative error in the quantitation of 
proteins with an equivalent number of peptides used for identification.   
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Bar graphs of total protein abundance were plotted for individual proteins identified 
in both the glycerol-grown and dextrose-grown samples harvested at the log phase.  Using 
the rationale outline above for the determination of relative error, error bars were plotted.  
When there was no overlap of error bars for the intensity of a single protein, the difference 
was considered significant.  Overall, 231 proteins identified in both samples exhibited 
significantly different expression.  Considering that there were 298 proteins identified in both 
samples, 78% had significant changes in intensity.  A similar trend was observed for the 
comparison between the two samples that differed in growth phase with 190, or 82%, of the 
233 proteins identified in both samples having significant changes in abundance.  The 
percentage of proteins identified in both samples that had significant changes in intensity is 
quite high.  For comparison, the percentage of proteins with significant differential 
expression from the top down analysis in Chapter 2 was approximately 20%.  Looking at the 
scatter in the differential log/log plots in Figure 5-3B and Figure 5-4B, there are a large 
number of points that differ from the majority of the replicate data points.  The increase in 
fractionation and the resulting increase in sample handling performed in this analysis could 
have resulted in more variability in the abundance measurements than was predicted based 
on the replicate data from a less fractionated sample.  This would have the potential to cause 
an increase in the number of proteins considered to have significant differential expression.  
The complete lists of proteins having significant difference in expression in either 
comparison are included in the Appendix. 
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 Comparison of results of fractionated bottom-up workflow to un-fractionated 5.4.4
bottom-up analysis in Chapter 3 
The differential expressions of proteins determined after fractionation of the cell 
lysates as presented in this chapter were compared to those determined from the BU analysis 
of the same proteins through the analysis of the samples without any pre-fractionation that 
was described in Chapter 3.  Only proteins that were identified in both differential yeast 
samples in an analysis were included since relative changes in abundance from the two 
experimental methods were to be compared.  For the comparison between the two samples 
that differed in preparation by the carbon source on which they were grown, the differential 
proteins that were identified in the fractionated and un-fractionated analyses are included in 
Table 5-5 and 5-6.   
All of the proteins included in these tables were determined to have significant 
differences in abundance in the fractionated BU analysis.  Of the 231 proteins that were 
mentioned earlier, 76 were also identified in both samples of the un-fractionated BU analysis.  
Only 53, however, were determined to also have significant changes in the un-fractionated 
analysis.  Proteins with changes in abundance that were not significantly different in the un-
fractionated samples are included in the tables in red text.  The majority of the significantly 
different proteins were up-regulated in the same yeast sample in both experiments.  Forty-one 
of the 53 proteins, or 77%, were consistently up-regulated in the same sample.  
With regards to the degree to which proteins were differentially expressed, however, 
there were some differences.  The histogram in Figure 5-6 illustrates the occurrence of the 
ratios of protein fold changes determined by dividing the larger of the fold changes by the 
small to give a ratio greater than 1.  Only proteins that were determined to have significant 
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differences in both the fractionated and un-fractionated analyses are included in the plot.  The 
majority of the proteins, 63%, had fold changes that differed by a factor less than two, which 
shows consistent regulation in terms of both the sample in which the protein was up-
regulated and the extent by which it was up-regulated.  Proteins that were found to be most 
abundant in opposing samples between the two methods were more concerning.  Four of 
these proteins in listed Table 5-6 that had differences in abundance that were significant in 
both methods had fold changes of less than 1.5 in one of the methods.  With a fold change so 
close to 1, variability in abundance could easily alter the determination of the sample in 
which the protein was most abundant.  An increase in the number of replicates analyzed may 
resolve this by more accurately calculating the error in the quantitation.  It could also be the 
result of using the replicate data from a previous experiment to infer the relative error in of 
protein abundance in the fractionated BU approach, since replicates of the actual fractions 
collected were not analyzed. 
One change in the data that was expected was the increase in both the number of 
proteins identified and the number of differentially expressed proteins identified.  The anion 
exchange fractionation allowed for the simplification of the samples prior to digestion, 
reducing the occurrence of peptides from more abundant proteins drowning out signal of the 
less abundant proteins.  For example, if many of the peptides from a given protein co-eluted 
with peptides from a more abundant protein in the un-fractionated analysis, these proteins 
could be split into different anion exchange fractions allowing for the independent MS 
analysis of the two protein digests.  In the un-fractionated BU analysis, there were 302 and 
221 unique proteins identified in the glycerol-grown and dextrose-grown samples, 
respectively.  After comparing the two proteins lists, there were 121 proteins identified in 
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both samples with 80 having significantly different expression.  In comparison, there were 
481 and 390 identified in the same two samples in the fractionated BU experiment, with an 
overlap of 298 proteins.  A total of 231, or close to three times more proteins than the un-
fractionated analysis, were determined to have significant changes in protein abundance.   
Although the improvement in differential protein identifications is large, it did come 
at the expense of a much larger increase in the analysis time.  The un-fractionated BU 
experiment was performed over the course of 48 hours including digestion and triplicate 
analysis of all three differential yeast samples.  For the fractionated experiment, the anion 
exchange fractionation was conducted over the course of three days, one day for each 
sample, followed by roughly one month of analyzing the digested fractions by LC-MS
E
.  The 
end result was a single analysis of each fraction from all three differential samples.  While 
more differential proteins were identified, the increase did not scale in proportion to the 
increase in the amount of time required to perform the experiment. 
5.5 Summary and Conclusions 
The soluble fraction of yeast cell lysates that were grown on either dextrose or 
glycerol and harvested at either the logarithmic or stationary phase of growth were analyzed 
in a BU fashion after anion exchange fractionation.  Eighty fractions were collected across 
the entire anion exchange separation of each differential yeast sample.  After digestion with 
trypsin, a standard of a protein digest was spiked in and each fraction was analyzed by LC-
MS
E
 to both identify and quantify the proteins contained in each fraction.  Individual protein 
intensities were summed across all fractions of a given sample to give the total abundance of 
each protein in the sample.  The summed intensities were used for the comparison of protein 
expression between yeast samples grown on different carbon sources or harvested during 
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different phases of growth.  To determine the significance of the changes in abundance, 
replicate data from Chapter 4 was used to infer error in the measurement.  The determination 
of error was performed by using the average relative error in the quantitation of proteins that 
were identified with a similar number of peptides.   
The purpose of this experiment was to look at the increase in the number of proteins 
and differential proteins that could be identified by simplifying the cell lysate prior to 
digestion.  Fifty-one proteins were determined to have significant intensity differences in 
both the un-fractionated and fractionated BU analyses.  The majority of the proteins 
exhibited fold changes that were within a factor of 2 when compared between the two 
experiments which demonstrated good correlation between them.  Overall, three times as 
many proteins with significantly different levels of expression between the glycerol-grown 
and dextrose-grown samples were identified in the fractionated analysis than were identified 
in the un-fractionated analysis.  While this increase is substantial, it does not compare to the 
increase in time necessary to perform the experiments.  To get this 3x increase in the 
differentially expressed proteins that were identified, it required a greater than 15x increase 
in the amount of time required to acquire all of the data.  Because of this significant increase 
in time, it was not feasible to run triplicate or even duplicate analysis of all of the samples.   
In conclusion, while this analysis did prove that by further fractionating a cell lysate, 
greater detail can be learned about the composition of the samples, it also demonstrated that 
there is a point of diminishing returns of the time invested in the analysis.  If fewer fractions 
were collected, there would have still been an increase in the identification of differentially 
expressed proteins.  It is unclear how many additional differential proteins were identified 
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due to fractionating the sample 80 times that would not have been identified if the sample 
were only fractionated 40 times. 
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5.7 Tables 
Time (min) % Mobile phase B 
0 0 
12 7 
360 67 
405 67 
410 0 
 
Table 5-1: AXC gradient conditions for the fractionated bottom-up analysis of the differential 
yeast lysates.  Mobile phase A contained 10mM ammonium acetate, pH 9.0.  Mobile phase B 
contained 750mM ammonium acetate, pH 9.0.  The flow rate of the separation was 0.39 
mL/min. 
 
 
Time (min) % Mobile phase B 
0 5 
60 40 
65 85 
70 85 
73 5 
 
Table 5-2: RPLC gradient condition for the analysis of digested fraction from the anion 
exchange column. Mobile phase A was water with 0.1% formic acid and mobile phase B was 
acetonitrile with 0.1% formic acid. The flow rate was 300 nL/min. 
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Processing Parameters Value 
Chromatographic peak width Automatic 
MS TOF resolution Automatic 
Lock Mass for charge 1 - 
Lock Mass for charge 2 785.8426 Da/e 
Lock mass window 0.25 Da 
Low energy threshold 200 counts 
Elevated energy threshold 75 counts 
Retention time window Automatic 
Elution start time - 
Elution stop time - 
Intensity threshold 1500 counts 
Workflow Template Value 
Search engine type PLGS 
Databank Yeast proteins with trypsin, BSA, 
and 5 human keratin proteins with 
a 1x randomization 
Peptide tolerance Automatic 
Fragment tolerance Automatic 
Minimum ions per peptide 3 
Minimum ions per protein 7 
Minimum peptides per protein 1 
Maximum protein mass 250,000 Da 
Primary digest reagent Trypsin 
Secondary digest reagent None 
Missed cleavages 1 
Fixed modifications None 
Variable modifications Acetyl N-term, Carbamidomethyl 
C, Deamidation N, Oxidation M 
False positive rate 4 
Calibration protein P02769 (BSA) 
Protein concentration on column 40 fmol 
 
Table 5-3: PLGS 2.4 RC7 processing parameters used for raw data processing and database 
searching. 
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 Glycerol/Log Dextrose/Log Dextrose/Stat 
Total protein hits 4032 4487 3362 
ID confidence (2/1/0) 3300/576/156 3802/577/108 3034/303/25 
Unique proteins 702 605 504 
Unique proteins at 95% 481 391 385 
Avg. peptides/protein 10.1 10.8 9.6 
Median hits/protein 8 9 8 
Avg. fractions/protein 6.9 9.7 7.9 
Median fractions/prot. 3 3 2 
Total mass acct. for 203 µg 244 µg 302 µg 
 
Table 5-4: Evaluation of protein identifications by PLGS2.4.  Total protein hits signifies the 
total number of yeast proteins identified across all 80 fractions in each sample.  ID 
Confidence denotes the confidence level as output from PLGS (‘2’ indicates 95% 
confidence;’1’ indicates 50%; ‘0’ indicates ‘not probable).  Unique proteins are the proteins 
remaining after all duplicates are removed regardless of confidence level.  Unique proteins 
at 95% includes only proteins identified with a confidence level of 95%.  Avg. 
peptides/protein and Median hits/protein indicate the average or median number of 
peptides used to identify a protein.  Avg. fractions/protein and Median fractions/prot. 
specify the average or median number of fractions in which a protein was identified.  Total 
mass acct. for is the total amount of digested protein injected onto the column multiplied by 
20 to account for the analysis of 4 µL of the 80 µL of sample present at the conclusion of the 
digestions 
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Swiss 
Prot 
Name 
Description 
Fractionated Un-fractionated 
Pep 
Hits 
FC 
Pep 
Hits 
FC 
Up- 
reg 
in 
FHP Flavohemoprotein 5 16.5 18 3.4 Gly 
ADH2 Alcohol dehydrogenase 2 22 11.5 28 41.5 Gly 
ALDH4 Potassium activated aldehyde dehydrogenase 39 10.9 49 27.9 Gly 
H2B1 Histone H2B 1 3 8.9 6 4.0 Gly 
RIR4 60S ribosomal protein L4 A 24 7.7 10 2.5 Gly 
GBLP Guanine nucleotide binding protein beta 5 6.5 12 11.4 Gly 
SUCA Succinyl CoA ligase ADP forming sub alpha 27 4.3 10 7.5 Gly 
MDHM Malate dehydrogenase mitochondrial 29 3.2 20 6.5 Gly 
ARO8 Aromatic amino acid aminotransferase 1 18 3.1 10 2.2 Gly 
PABP Polyadenylate binding protein 10 3.0 15 1.7 Gly 
BCA2 Branched chain amino acid aminotransferase 7 2.7 10 3.7 Gly 
CISY1 Citrate synthase mitochondrial 16 2.7 19 4.8 Gly 
SYDC Aspartyl tRNA synthetase cytoplasmic 22 2.6 13 2.6 Gly 
G3P1 Glyceraldehyde 3 phosphate dehydrogenase 1 14 2.1 21 2.0 Dex 
SYV Valyl tRNA synthetase mitochondrial 40 1.9 25 1.7 Gly 
CH10 10 kDa heat shock protein mitochondrial 10 1.9 4 1.3 Gly 
HS104 Heat shock protein 104 12 1.8 16 1.4 Gly 
G3P3 Glyceraldehyde 3 phosphate dehydrogenase 3 30 1.7 31 1.8 Gly 
EF2 Elongation factor 2 33 1.6 40 2.4 Gly 
HSP12 12 kDa heat shock protein 17 1.5 9 1.3 Gly 
DHE4 NADP specific glutamate dehydrogenase 1 23 1.4 15 1.9 Gly 
FKBP FK-506 binding protein 1 14 1.3 11 1.4 Gly 
EF1A Elongation factor 1 alpha 18 1.3 24 2.6 Gly 
TAL1 Transaldolase 25 1.3 16 1.7 Gly 
MMF1 Protein MMF1 mitochondrial 11 16.1 5 2.0 Gly 
DCPS Scavenger mRNA decapping enzyme DcpS 17 2.5 9 1.8 Dex 
TRX1 Thioredoxin 1 11 2.4 7 1.4 Gly 
HSP77 Heat shock protein homolog SSE1 29 2.4 26 1.4 Dex 
SODM Superoxide dismutase Mn 4 2.4 6 1.1 Dex 
ZEO1 Protein ZEO1 14 2.2 12 1.1 Dex 
VATA V type proton ATPase catalytic subunit A 21 2.1 20 2.7 Gly 
UBIQ Ubiquitin 6 1.7 6 1.0 Gly 
Table 5-5: Proteins up-regulated in the glycerol-grown sample that were also identified in the 
dextrose-grown and glycerol-grown samples in the completely bottom-up experiment from 
Chapter 3.  The fractionated peptide hits and fold changes (FC) are from the experiment 
described in this chapter and the un-fractionated columns correspond to data presented in 
Chapter 3.  Proteins written in red text were identify in both BU samples, but were not 
determine to have significantly different abundance.  Shaded proteins were up-regulated in 
different samples in the two analyses. 
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Swiss 
Prot 
Name 
Description 
Fractionated Un-fractionated 
Pep 
Hits 
FC 
Pep 
Hits 
FC 
Up- 
reg 
in 
PDC1 Pyruvate decarboxylase isozyme 1 26 15.2 45 1.8 Dex 
IF5A2 Eukaryotic translation initiation factor 5A 2 2 14.8 9 1.8 Gly 
ADH1 Alcohol dehydrogenase 1 19 14.7 25 2.8 Dex 
ENO2 Enolase 2 35 7.0 50 3.0 Dex 
IMDH3 Probable inosine 5 monophosphate dehydrog. 19 6.2 18 2.0 Dex 
CPGL Glutamate carboxypeptidase like protein 6 5.9 17 2.2 Gly 
CYS3 Cystathionine gamma lyase 17 4.8 17 2.1 Dex 
TRX2 Thioredoxin 2 11 4.0 9 3.9 Dex 
RLA4 60S acidic ribosomal protein P2 beta 3 4.0 3 2.1 Gly 
HSP72 Heat shock protein SSA2 56 3.7 47 1.8 Dex 
ACT Actin 7 3.4 21 1.6 Gly 
ENO1 Enolase 1 58 3.1 34 3.4 Dex 
PMG1 Phosphoglycerate mutase 1 25 2.8 17 2.7 Dex 
PGK Phosphoglycerate kinase 37 2.5 40 1.7 Dex 
TPIS Triosephosphate isomerase 20 2.5 19 1.8 Dex 
TRXB1 Thioredoxin reductase 1 11 2.4 12 6.9 Dex 
HSP82 ATP dependent molecular chaperone HSP82 44 2.1 35 9.3 Dex 
CYPH Peptidyl prolyl cis trans isomerase 12 2.0 8 1.8 Dex 
METE 5 methyltetrahydropteroyltriglutamate homoC 47 1.9 24 1.5 Dex 
IPYR Inorganic pyrophosphatase 12 1.9 13 1.2 Gly 
HXKB Hexokinase 2 6 1.8 27 1.8 Gly 
PNC1 Nicotinamidase 4 1.7 19 1.8 Dex 
DHAS Aspartate semialdehyde dehydrogenase 13 1.7 5 1.4 Gly 
SODC Superoxide dismutase Cu Zn 14 1.7 14 2.0 Dex 
MET17 Protein MET17 22 1.7 18 3.3 Dex 
HSP60 Heat shock protein 60 mitochondrial 33 1.6 23 2.4 Gly 
COFI Cofilin 5 1.5 7 1.3 Gly 
HSC82 ATP dependent molecular chaperone HSC82 54 1.2 35 1.4 Gly 
IF4A ATP dependent RNA helicase eIF4A 29 1.2 19 1.6 Gly 
ADK Adenosine kinase 8 21.9 14 1.1 Gly 
HSP73 Heat shock protein SSA3 19 3.3 24 2.8 Dex 
KPYK1 Pyruvate kinase 1 25 2.6 29 1.1 Dex 
UBA1 Ubiquitin activating enzyme E1 1 11 2.3 16 1.2 Dex 
ALF Fructose bisphosphate aldolase 14 2.2 24 1.1 Dex 
CBS Cystathionine beta synthase 30 1.9 15 3.4 Gly 
NTF2 Nuclear transport factor 2 6 1.8 7 1.1 Gly 
DHOM Homoserine dehydrogenase 23 1.7 13 1.1 Dex 
STI1 Heat shock protein STI1 19 1.7 16 1.2 Dex 
HSP76 Heat shock protein SSB2 34 1.7 32 1.2 Gly 
G3P2 Glyceraldehyde 3 phosphate dehydrogenase 2 23 1.6 25 1.3 Dex 
G6PI Glucose 6 phosphate isomerase 25 1.3 28 1.0 Dex 
KAD1 Adenylate kinase 1 21 1.3 15 1.1 Dex 
BMH1 Protein BMH1 22 1.2 15 1.4 Gly 
Table 5-6: Equivalent to Table 5-5 except with proteins up-regulated in the dextrose-grown 
sample. 
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5.8 Figures 
 
Figure 5-1: Workflow diagram for fractionated bottom-up experiment including column and 
instrumentation information. 
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Figure 5-2: Anion fractionation of differential yeast cell lysates monitored by UV absorption 
at 280nm. 
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Figure 5-3:  Identification of yeast proteins and intensity scatter results for the comparison of 
cell lines grown on different carbons sources. A) Venn diagram illustrating the overlap 
between yeast proteins identified in each sample. B) Log/Log intensity plot of the absolute 
intensity in fmol of the proteins identified in both the glycerol-grown and glucose-grown 
samples. 
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Figure 5-4:  Comparison of the yeast proteins identified in the differential yeast samples 
based on differences in growth cycle at the time of cell harvest. A) Venn diagram indicating 
the degree of overlap between yeast proteins identified in the log phase sample and those 
identified in the stationary phase sample. B) Log/Log intensity plot of the absolute intensity 
in fmol of the proteins identified in both the log phase and stationary phase samples. 
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Figure 5-5: Reproducibility of absolute quantitation of replicating proteins from Chapter 4.  
The average relative difference in intensity measurement between replicates is plotted against 
the maximum number of peptides used to identify each protein.  Gray bars indicate the error 
in intensity that was used to infer the potential error in the quantitation of proteins 
determined in this chapter based on the number of peptide hits used to identify a particular 
protein.  This was used to decipher whether or not differences in intensity were significant. 
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Figure 5-6: Analysis of the difference between fold changes of proteins with significantly 
different expression in both the fractionated and un-fractionated BU analyses. 
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 Differential proteomic analysis of the soluble fraction of proteins CHAPTER 6:
produced by cell lysates of mouse embryonic fibroblast cells: both wild-type vs. β-
arrestin 1, 2 double-knockout 
 
6.1 Introduction 
Previous chapters have used Baker’s yeast samples as a model system for the 
characterization of the hybrid top-down/bottom-up proteomics methodology due to its well-
characterized biology.  These samples have proven the validity of this approach as a platform 
for differential expression proteomics.  This concluding chapter aims to apply this analysis to 
a less well-understood sample set to advance the knowledge of a more complex biological 
system. 
 Beta-arrestin signaling 6.1.1
Cellular signaling that involves the sensing of molecules outside of a cell that elicit a 
change at the cell wall or within the cell itself is of high biological and therapeutic 
importance.  The 7-transmembrane spanning G-protein coupled receptors (GPCR) are the 
largest family of cell surface receptors and roughly 40% of all drugs in clinical use target 
GPCRs in some way.
1
  The classical pathway of GPCR signaling, illustrated in Figure 6-1 A, 
involves an activation based on ligand binding which causes the conversion of guanosine-5’-
triphosphate (GTP) for guanosine-5’-diphosphate (GDP) on heterotrimeric G-proteins.  This 
activation results in the dissociation of the G-protein into two subunits, which in turn regulate 
the activity of enzymatic effectors to produce secondary messengers that regulate activity of 
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intermediary metabolic enzymes.  Desensitization of the GCPR occurs through 
phosphorylation by a G protein receptor kinase (GPK) and the subsequent binding to arrestin 
to uncouple the G protein from GPCR and sterically inhibit further activation via ligand 
binding.
2, 3
   
Recently, a second type of GPCR-related signaling has been discovered.
2, 4
  In this 
cell signaling pathway, GPCR operates in a G protein-independent manner.  β-arrestin 
signaling was initially found to regulate the endocytosis of activated GPCR, but has now 
been linked as a recruiter of many enzymes to agonist-occupied GPCRs including the Src 
family tyrosine kinases, the E3 ubiquitin kinase, diacylglycerol kinase, and a serine/threonine 
protein phosphatase.
5
  An increasing number of signaling pathways are being uncovered as 
the beta-arrestin signaling pathway after GPCR activation becomes better understood.  An 
example of β-arrestin-dependent signaling as it applies to heart failure is illustrated in Figure 
6-1 B. 
The samples studied here have the larger goal of understanding the signaling 
processes involved in heart failure. A heavily studied pathway involving a beta-arrestin 
dependent signaling in this model is the activation of the extracellular regulated kinase 
(ERK).  Classical activation of this pathway is via agonist stimulation of the epidermal 
growth factor receptor (EGFR).  The beta-arrestin dependent activation of this signaling 
cascade has been shown to have a cardioprotective effect in mice when chronically 
stimulated with catecholamine, whereas this effect is not seen with G protein-dependent 
signaling.
6, 7
  Studies have further demonstrated that the classical G protein-dependent 
signaling is detrimental in heart failure causing hypertrophy, the thickening of the ventricular 
walls that decrease the capacity of the heart, and bradycardia, a slowing of the heart rate.
8
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One of the pathways known to cause cardioprotective remodeling as a result of β-arrestin-
mediated signaling is shown in Figure 6-1 B.  Src is recruited by β-arrestin after agonist 
activation of the GPCR, specifically the β-2-adrenergic receptor.  Src-dependent matrix-
metalloproteinase (MMP) then mediates the shedding of Heparin-Binding epidermal growth 
factor (HB-EGF).  The resulting cascade promotes cardioprotective promoting mitogenic and 
anti-apoptotic effects.
7
 
In order to add to the information gained through the study of the β-arrestin 
interactome
9
 and the continuing work using genetic mutations
10, 11
, both wild-type and β-
arrestin 1,2 double knockout mouse embryonic fibroblast cells were studied.  An on-line 2D-
LC separation of the intact proteins with fraction collection was performed on each sample.  
2D chromatograms of the deconvoluted mass spectra were compared to identify protein 
masses with varying intensities between the two samples.  Subsequent digestion and LC-MS
E
 
analysis were performed to identify the differentially expressed proteins. 
6.2 Experimental 
 Outline for experimental method 6.2.1
The experimental workflow for this method is identical to that described in section 
2.2.1.  Briefly, differential samples were individually analyzed by online 2D-LC-MS.  
Protein masses were deconvoluted in an automated fashion and the resulting deconvoluted 
2D chromatograms were compared on a mass slice basis to select masses with differential 
expression.  Fractions containing those masses were tryptically digested and analyzed by LC-
MS
E
.  Theoretically processed masses of the identified proteins from the database searching 
of the peptide data were compared to the differentially expressed intact protein masses to 
identify a differential protein. 
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 Preparation of mouse embryonic fibroblast cell lysates 6.2.2
MEF cell lysates were provided by Kevin Xiao from the Lefkowitz lab at Duke 
University.  β-arrestin 1,2 double knockout mouse embryos were prepared as described 
previously.
12
  Mouse embryonic fibroblast cells (MEF) were prepared and cultured according 
to the 3T3 protocol of Todar and Green.
13
  Cell harvesting and lysis was performed by 
harvesting the cells in a phosphate buffered saline solution, centrifuging, and removing the 
supernatant to form a cell paste.  Re-suspension buffer was composed of 25 mM ammonium 
bicarbonate with the following phosphatase inhibitors: 1 mM potassium fluoride, 1 mM 
sodium pervanadate, 1 µM microcystin, and 10 nM calyculin A.  Protease inhibitors from 
Roche were added as well at a concentration of 1 tablet/10 mL.  Cells were re-suspended in 1 
mL of the buffer described above and subjected to three freeze/thaw cycles.  An additional 9 
mL of buffer was added and samples were dounced for 20 strokes.  Sonication was 
performed for a total of 1 minute by sonicating for 10 seconds followed by a cooling time of 
20 seconds.  Centrifugation at 15,000 x g for 30 minutes was performed in order to remove 
cell debris and insoluble protein.  Filtration was performed with a 0.2 µm filter to further 
clean up the sample.  Cell lysates were frozen at -80° C for storage prior to analysis.  Upon 
thawing the samples immediately before analysis, further centrifugation was performed to 
remove proteins that did not go back into solution after freezing and thawing. 
A Bradford protein assay was performed just as was done in Chapter 2 to determine 
the total protein concentration in both the wild-type and β-arrestin 1,2 double knockout 
samples.  Bovine serum albumin was used as the calibration protein.  Total protein 
concentrations for the wild-type lysate and double knockout lysate were 2.88 ± 0.22 mg/mL 
and 2.35 ± 0.08 mg/mL, respectively. 
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 Instrumentation and run conditions at the intact protein level 6.2.3
The instrumentation for the online 2D-LC of intact proteins was similar to that 
described in Chapter 2.  The anion exchange column was a quaternary amine strong anion 
exchange column with dimensions of 110 cm x 6.6 mm ID packed with 13 µm polymeric 
particles.  Anion exchange mobile phase consisted of ammonium acetate buffer adjusted to 
pH 9.0 with ammonium hydroxide.  The buffer concentration was 25 mM ammonium acetate 
in mobile phase A and 750 mM in mobile phase B.  The gradient conditions for the first 
dimension separation were the same as used in Chapter 2.  New reversed phase columns were 
used with the same dimensions (4.6 mm x 7.5 cm) and packing material (10 µm polymeric 
particles bonded with a phenyl stationary phase) as well.  The RP gradient was also identical 
to that used previously ranging from 5 – 40% mobile phase B over 20 minutes with a step up 
to 20% B at 2 minutes and was operated at a flow rate of 0.5 mL/min.  The effluent from the 
reversed-phase column was split at a 9:1 ratio such that only 55 µL/min was sent to the mass 
spectrometer for intact protein mass analyses with the remainder sent to a UV detector, a 
Waters 2487 dual wavelength detector set to 280 nm, followed fraction collection.  Fractions 
were collected every minute from four minutes to 20 minutes for a total of sixteen fractions 
per RP run.  With thirty RP runs performed throughout the anion exchange separation, this 
resulted in a total number of 480 fractions collected per sample.  The initial injection 
contained 1.3 mg of total protein for both samples. 
MS detection was performed on a Waters Q-TOF Premier (Q-TOF P) instrument 
(Milford, MA) set to acquire MS scans only (MS/MS analysis was not performed on the 
intact proteins).  A standard flow electrospray ionization lockspray source was used to 
interface the LC to the MS.  The reference channel was sampled once every thirty seconds to 
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perform dynamic calibration and contained a solution of glu-fibrinopeptide.  The capillary, 
extraction cone, and sample cone voltages were set at +3000 V, +4 V, and +35 V, 
respectively.  The desolvation gas flow rate was 350 L/hr at 300°C and the source 
temperature was set at 100°C to improve desolvation of ions.  Continuum data were acquired 
over the range 400 – 1600 m/z over a scan duration of 1 sec with a 0.1 sec interscan delay. 
Intact protein mass spectra were deconvoluted using automated maximum entropy 
processing (AutoME) as described previously.  Some parameters were adjusted to account 
for a more sensitive mass spectrometer.  Three separations were performed at the intact 
protein level; two replicate analyses of a β-arrestin 1, 2 double knockout MEF cell lysate and 
one analysis of a wild-type MEF cell lysate. 
 Digestion and LC-MSE analysis of individual fractions 6.2.4
The digestion was performed in a similar fashion to that described in section 3.2.3.  
Briefly, fractions were lyophilized to dryness and reconstituted in 50 mM ammonium 
bicarbonate with 0.1% RapiGest SF.  After reduction of disulfide linkages with dithiothreitol 
and alkylation with iodoacetamide, digestion was initiated by the addition of trypsin and 
allowed to continue overnight at 37°C.  Trypsin was added at a ratio of 25:1 assuming equal 
distribution of proteins over the 480 fractions collected in an online 2D analysis.  This ratio 
was chosen to reduce the likelihood of having undigested protein with the understanding that 
this would cause the presence of peptides resulting from the autolysis of trypsin. 
LC-MS
E
 analysis of the digested fractions was performed on a Waters nanoAcquity 
coupled to a Q-TOF P mass spectrometer, also from Waters.  LC run conditions and MS 
voltages were identical to those described in section 3.2.4.  Processing of the raw data and 
database searching were performed by ProteinLynx Global Server 2.4 RC7 (PLGS2.4).  The 
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processing parameters were similar to those described in Table 3-2 with the exception of the 
database.  The database was composed of the reviewed Mus musculus protein entries in the 
UniProt knowledgebase release 15.7.
14
  Porcine trypsin and bovine serum albumin were also 
added to the database.  A 1x randomization of the complete database was appended to the 
end to set the false discovery rate. 
6.3 Results 
 Differential analysis of intact protein 2D chromatograms 6.3.1
Both the wild-type (WT) and β-arrestin 1, 2 double knockout (βarr-KO) samples were 
analyzed by online 2D-LC-MS for intact protein molecular weight.  After processing by 
AutoME deconvolution, 2D chromatograms were constructed from the individual second 
dimension runs for comparison.  While the comparisons were actually made on a mass-slice 
basis, as reported earlier, the 2D chromatograms for both samples that include the entire mass 
range of deconvoluted molecular weights is shown in Figure 6-2 for reference.  In this plot, 
the intensity of the protein peaks are plotted in false color, with the maximum of the color 
scale set at 100,000 counts.  The small number of peaks that appear black in color are above 
this threshold.  For the purposes of showing all of the proteins in one plot, the threshold was 
set below the actual maximum to allow for some of the lower intensity proteins to be seen.   
When looking at the mass slice comparisons to identify differential proteins, three 
different intensity maxima were used to attempt to reduce potential bias that could be caused 
by intensity values at the limits of the color spectrum.  The mass slices of each 1 kDa 
molecular weight range were plotted at maximum intensity levels of 200,000, 50,000, and 
20,000 counts.  The number of proteins determined to have changes in intensity between 
samples based on the changes in color in the mass slice chromatograms is shown in Table 
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6-1.  A total of 65 fractions were selected for digestion in order to identify 68 masses that 
showed different intensities in the comparison of mass slice chromatograms. 
 Replicate analysis of βarr-KO cell lysates 6.3.2
The intact protein 2D chromatograms for replicate injections of the double knockout 
cell lysates are shown in Figure 6-3.  Overall, the pattern of peaks is very similar between the 
two analyses.  In order to more readily see the differences between intensity values for 
proteins between the two analyses, a log/log intensity plot was made.  This is shown in 
Figure 6-4a.  Also included in the figure is a log/log plot in which the replicate data from this 
analysis is overlaid atop the replicate data obtained from multiple injections of the glycerol-
grown yeast cell lysate as described in Chapter 2.  The intensity scatter of this replicate data 
appears to be slightly lower than what was found in Chapter 2.  To quantify this difference, a 
correlation coefficient was calculated for the replicate analysis of yeast samples acquired on 
the LCT mass spectrometer and for the replicate analysis of MEF samples acquired on the Q-
TOF P instrument.  The correlation for the yeast replicate analysis, plotted in gray, was 0.82, 
whereas for the MEF replicates plotted in red, the correlation coefficient was 0.88, indicating 
slightly less scatter. 
 Protein identifications based on MSE data 6.3.3
The identification of proteins within each fraction containing a differentially expressed 
protein mass was performed by PLGS2.4.  Overall, across all 65 fractions analyzed, a total of 
1,153 protein identifications were made.  This value includes all proteins found at an 
identification probability of 50% or greater as determined by PLGS2.4.  As this data was 
used merely as a qualitative analysis of which proteins were present, replication was not 
necessary for either the 50% or the 95% confidence levels.  From previous experiments, such 
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as those described in Chapter 3, proteins with an identification probability value of ‘0’, or 
‘not likely’, rarely replicated and were therefore removed from further processing.  The 
average and median number of peptides used to identify each protein was 7.2 and 5, 
respectively.  After removing proteins that were identified in multiple fractions, the number 
of unique protein identifications was 318.  These values are listed in Table 6-2.  Of the 
proteins identified in all 65 fractions, 39 had masses similar, meaning it differed by less than 
1 kDa, to the 68 differentially expressed masses from the top-down analysis.  A complete list 
of the identified differential proteins found to be up-regulated in each sample can be found in 
Table 6-3 and Table 6-4 and the overlap of proteins identified and those that were searched 
for as being differential is shown in Figure 6-5. 
6.4 Discussion 
 Selection of differential proteins 6.4.1
The selection of differentially expressed proteins was initially performed based on 
changes in color of the intact protein MS data after deconvolution by AutoME.  This was 
performed on a mass-slice basis in order to simplify the 2D chromatograms and facilitate the 
selection process.  As described in section 6.3.1, three different maxima were used for the 
false color scale.  The purpose of this was to allow for changes in the most intense peaks to 
be seen at that highest intensity maximum, 200,000 counts.  By lowering this maximum and 
allowing high intensity peaks to go off-scale, changes in intensity of proteins of lower 
abundance could be seen.  The total numbers of differentially expressed proteins selected at 
each intensity threshold level are listed in Table 6-1.  For example, in the WT MEF sample, 
19 proteins were seen to have changes in color (intensity) when the maximum of the color 
scale was set to 200,000 counts.  By lowering this threshold to 50,000 counts, an additional 
16 proteins were found to have changes in color and nine more were found at a maximum of 
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20,000 counts.  Varying the maximum of the color scale allowed for the selection of almost 
three times more differential proteins than if the plots were set to a maximum corresponding 
to the most intense protein. 
 Identification of differential proteins 6.4.2
Overall, the theoretically processed masses of the 39 proteins identified from the 
bottom-up analyses matched the protein masses that were found to be differentially expressed 
in the top-down analysis to within 1 kDa.  Of those 39 matches, ten included some ambiguity 
meaning that likely only 34 proteins were identified.  This ambiguity can arise from two 
sources.  The first, which accounts for four out the five occurrences, happens when two 
proteins identified from the bottom-up analysis have similar theoretically processed 
molecular weights both within 1 kDa of the mass determined experimentally in the top-down 
analysis.  One of the two proteins is likely to be the true protein, but without further analysis, 
it is not clear which one.  The other case that occurred just once was due to the fact that two 
differentially expressed protein masses from the top-down analysis had the greatest 
abundance in the same fraction and were within 100 Da of each other.  After digesting and 
analyzing the fraction by LC-MS
E
, only one protein was identified with a processed mass 
within 100 Da of either protein that was searched for.  Therefore, only one of the two 
differential masses was identified, but it remains unclear which one.  In Table 6-3, proteins 
from both cases are listed with superscripts identifying which pairs are ambiguous.  
Assuming that one of the protein identifications is correct in each ambiguous pair, 34 of the 
68 proteins were identified, which gives 50% success rate for the identification of 
differentially expressed protein masses. 
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As noted in the description of the AutoME processing parameters, the background ion 
counts for the intact protein analysis performed on the Q-TOF P instrument was higher than 
that seen before on the LCT.  To account for this, the threshold for the total number of ion 
counts in a summation of ten 1 sec scans was increased from 20,000 counts to 100,000.  This 
threshold was set by summing the appropriate number of scans during a time in the LC run in 
which no proteins were eluting.  For the purpose of AutoME processing, this worked fairly 
well, with a relatively small number of 10 sec scans converging on noise alone.  However, 
this did still occur.  After looking through the differential protein masses that were not 
identified from the bottom-up analysis, six of the unidentified masses were cases in which 
AutoME converged on noise and were not actual protein masses.  Removing these masses 
from the total number of proteins searched for increases the identification percentage from 
50% to 55%, which is slightly better than what was achieved in the experiment from Chapter 
2. 
  Determination of the significance of the intensity differences 6.4.3
A duplicate analysis was performed on the βarr-KO sample to identify the extent of 
differences in intensity resulting from the methodology rather than between the differential 
samples themselves.  AutoME-deconvoluted masses that were found in both replicates were 
plotted on a log scale in Figure 6-4a and overlaid with the replicate yeast lysate data from 
Chapter 2 Figure 6-4b.  As described earlier, the correlation coefficient of the βarr-KO 
analysis was slightly better than that obtained with the yeast data, 0.88 versus 0.82.  This 
could be the result of using the Q-TOF P instead of the LCT, which has two times the 
resolving power.  It could also be an artifact from the lower number of data points in the 
analysis performed on the Q-TOF P, 250 as opposed to 1,000 for the comparison between 
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two replicates.  Also, due to the increased background in the raw data as well as the 
deconvolution of the Q-TOF P data, the limit of detection was slightly greater and thus may 
have led to an apparent decrease in the intensity scatter near the limit of detection.  Lastly, 
since the difference was so small, it could have just been due variability in the 2D separation 
after more than two years of use.   
Nevertheless, due to the difference being so slight, confidence curves from the yeast 
replicate data were plotted with the βarr-KO replicate analysis and the differential proteins 
from the comparison with a WT cell lysate in Figure 6-6 to determine significance.  As 
described in Chapter 2, these confidence curves in the log scale represent straight lines when 
plotted in the linear scale.  The percentages noted in the legend signify the percentage of 
points from the yeast replicate analysis that fall between the confidence lines.  The 
corresponding percentages for the replicate βarr-KO analysis are included in parentheses for 
comparison.  Because the scatter in the data between the two replicate analyses is relatively 
close, the percentage value used for the confidence threshold is based on the yeast replicate 
data due to the greater number of data points.  Setting 96.5% as the threshold would make 14 
of the differentially expressed proteins significant, whereas lowering this to the 94% cut-off 
would make 19 of the 34 differentially expressed proteins significant.  The 94% threshold 
was arbitrarily set as the confidence limit for labeling proteins as significantly different due 
to the slightly greater correlation from the βarr-KO replicate data as opposed to the yeast 
replicate data in which a 96.5% threshold was used.  The percent confidence value for the 
significance of the intensity difference is noted in the last column in Table 6-3 and Table 6-4. 
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 General comparison of results with those obtained in the differential analysis of 6.4.4
the Baker’s yeast samples 
For the intact protein separation, there were fewer protein masses detected in this 
experiment than were found in the differential analysis of yeast cell lysates.  One explanation 
for this could be in the sample itself.  When analyzing the yeast samples, the lysates could be 
injected directly onto the column without the need for filtering after thawing.  However, with 
the MEF lysates, proteins appeared to be less well-behaved and did not react well to the 
freezing and thawing performed to preserve the sample during the time between cell harvest 
and intact protein analysis.  The result was a thick, murky, lysate that needed further 
centrifugation and filtration.  This may have resulted in the removal of some proteins that 
were soluble when the lysate was initially prepared.  This loss of protein is definitely a 
concern and will be remedied by improved coordination with the lab at Duke to analyze the 
lysates directly after harvest preventing the need for freezing.  There were also fewer 
differential proteins which may have been the result of fewer proteins detected overall or that 
the changes induced by the removal of the β-arrestins were less that those created by 
changing carbon source or growth phase as was done in the yeast sample preparation.  It is 
probably a combination of the two. 
In terms of protein identification statistics from the LC-MS
E
 analysis, the average and 
median numbers of peptides used to identify each protein were 7.2 and 5.  These values are 
slightly lower than those used to identify proteins in the bottom-up only analysis reported in 
Chapter 3 where, on average, 16.4 peptides were used to identify each protein.  However, 
when looking at the average and median number of proteins used to identify the proteins that 
were similar in molecular weight to those determined to be differential from the TD data, the 
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values increase to 14.5 and 12, respectively.  These values are more in line with what was 
seen in Chapter 3.  A possible explanation for the lower number of peptides used to identify 
the proteins overall could be that in Chapter 3, only the most abundant proteins were 
identified.  For example, in the glycerol-grown log phase sample, the 302 most abundant 
proteins were probably identified.  This is in contrast to the data presented in this chapter 
where 480 fractions were collected from a single analysis.  Because only fractions containing 
proteins that changed in intensity were digested and analyzed further, some of the most 
abundant proteins were never digested and identified.  Also, due to the fractionation and 
simplification of the protein mixtures, some proteins of lower abundance that would have 
been overshadowed by more abundant proteins without fractionation were able to be 
identified.   
As stated earlier, there was a substantial increase in the average and median number 
peptide hits per protein when only looking at those proteins identified as differential proteins.  
This increase is due in large part to the increase in scatter of the proteins at lower intensities.  
In order for a protein intensity difference to be significant it was a large change at a low 
intensity, with smaller and smaller changes being significant as the intensity increased.  
Looking back at the data, few, if any, of the lower abundance proteins that were identified 
actually had significant changes in intensity.  Because, in general, more peptides are used to 
identify a more abundant protein, the increase in peptides/protein when limiting only to those 
used to identify differential proteins is expected. 
In comparison to the data-directed acquisition performed for the tandem MS analysis 
of the peptides in Chapter 2, the peptide hits per protein almost doubled.  This demonstrates 
the clear advantage of the MS
E
 acquisition over a more traditional DDA MS analysis.  As 
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stated in Chapter 3, the more parallel nature of MS
E
 in contrast to the serial DDA analysis 
allows for more peptides to be analyzed by MS/MS while at the chromatographic apex 
resulting in greater coverage of each protein. 
 Comparison of differential regulations with literature 6.4.5
In 2007, the Yates and Lefkowitz labs published a paper reporting the β-arrestin 
interactome, which includes the proteins found to interact with β-arrestin.9  The experiment 
was performed using MS-based proteomics approaches including both the multidimensional 
protein identification technique (MudPIT) and a gel-based LC-MS/MS approach.  Over 300 
proteins were found to potentially interact with β-arrestin 1 and/or 2.  To isolate interacting 
proteins, β-arrestin complexes were immunoprecipitated from HEK293 cells overexpressing 
β-arrestin with a C-terminal FLAG epitope.  The list of proteins determined to be 
differentially regulated in this experiment was compared to the list of interacting proteins 
from that paper.  There was no overlap in protein identifications between the two 
experiments.  However, the authors did note the presence of metabolic enzymes in the 
interactome, which was not initially expected.  Most of the metabolic enzymes reported in 
the interactome were involved in the glycolysis pathway and it was hypothesized that the β-
arrestins may scaffold the glycolytic enzymes to facilitate energy production.  This may be 
an explanation for the up-regulation of phosphoglycerate mutase, PGAM1, in the WT 
sample. 
General signaling proteins were also found to interact with the β-arrestins including 
annexin II (ANXA2).  In the combined TD/BU differential proteomics experiment, annexin 
V (ANXA5) was found to be up-regulated in the WT sample.  While they serve different 
purposes, ANXA2 as a calcium-regulated membrane-binding protein and ANXA5 as an 
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anticoagulant protein, they are both annexins that interact with the phospholipids of the cell 
membrane and are in some way involved in extocytosis of which the β-arrestins are also 
known to be involved.
14
  The remaining proteins do not have immediately apparent 
relationships to β-arrestins and further analysis and experiments must be performed to both 
improve the understanding of and verify the differential regulation. 
6.5 Summary and conclusions 
An LC-based multidimensional separation was performed on intact proteins from 
lysates of both wild-type and β-arrestin 1, 2 double-knockout mouse embryonic fibroblast 
cells.  The methodology used in this experiment was similar to that used in Chapter 2 with 
the major exception being the separation and analysis of the digested fractions.  A data-
independent acquisition, MS
E
, was used instead of a data-directed tandem MS acquisition 
which allowed for greater coverage of the peptides present in the sample and a greater 
number of proteins identified in each fraction.  Using this technique and matching the masses 
of proteins identified from the LC-MS
E
 analysis of the peptides with the experimental masses 
of intact proteins obtained from the 2DLC-MS analysis, 34 of the 68 differentially expressed 
intact protein masses were able to be identified.  Using a confidence threshold of 94% to 
determine the significance of the difference, 19 of the 34 identified were significantly 
different. 
In order to gain a better understanding of the biological significance of the differential 
proteins, the list was compared to the recently reported β-arrestin interactome.  Although 337 
proteins were identified as interacting with either β-arrestin 1 or 2, there was no overlap with 
the differential proteins identified here.  There were some similarities in the types of proteins 
identified in that some enzymes involved in glycolysis were in the interactome and a 
glycolytic enzyme, PGAM1, was identified as more abundant in the WT sample.  However, 
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it is still unclear how β-arrestin is involved in metabolism.  Overall, with the information 
obtained solely from this experiment, little insight is gained into the β-arrestin-mediated 
signaling in the heart, which is the end goal.  The hope, however, is that this information may 
be used in the future to supplement and support other experimental data to improve the 
understanding of this cardioprotective signaling pathway. 
6.6 Future studies 
Of the methods that have been discussed in this dissertation, currently only the hybrid 
TD/BU approach with an on-line 2D separation of intact proteins has been performed.  From 
the other approaches that have been presented for the analysis of differential yeast cell 
lysates, it is clear that to complete analysis of these samples, it would be beneficial to 
perform a completely BU analysis.  One of the limitations posed by the MEF cell lysates was 
the insolubility of some proteins after even one freeze/thaw cycle.  An un-fractionated 
bottom-up analysis would not be limited by this and could therefore have the potential to 
analyze a larger set of proteins.  Some of the lower abundant proteins may be lost in this 
analysis, but it may offer a complementary subset of differential proteins that may be of 
interest.  This type of analysis would not be difficult to implement as it is the least time 
consuming of all that have been discussed here. 
Another type of analysis that was not performed on the yeast cell lysates and has not 
been discussed yet is a western blot.  In a western blot analysis, proteins are separated by gel 
electrophoresis in a native or denaturing environment.  In native conditions proteins are 
separated by their 3D structure, whereas in denaturing conditions, they are separated by the 
length of the polypeptide.  Proteins are transferred to a membrane and detected using 
antibodies, monoclonal or polyclonal, specific to a single protein.  This type of analysis 
would not be realistic without prior information on the samples.  For the MEF cells, this 
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could be used to confirm the differential expression determined by the hybrid TD/BU 
approach in this chapter.  Some of the proteins have antibodies readily available and would 
therefore be used first to see if the intensity changes seen in this experiment correlated with 
those of the antibody-based western blot analysis.  With a polyclonal antibody, this would 
have the same effect as an un-fractionated bottom-up analysis, where different isoforms of a 
protein would be created equal.  Though more expensive and therefore probably not feasible 
for this analysis, a monoclonal antibody offers the opportunity to probe the different isoforms 
provided that the modification occurred at the epitope of the protein.  If more site-specific 
information were known about post translational modifications on each protein this would be 
an expensive, though feasible experiment. 
With the depth of data that is acquired at both the intact protein and peptide level, there 
are innumerable ways to look at the data.  One way that was not probed was to look for 
repeating mass shifts in the intact molecular weight of the protein equal to those expected for 
various post-translational modifications.  For example, looking for occurrences of 
phosphorylation, offsets could be made every 80 Da.  This would be interesting when 
looking at the 2D chromatograms because a shift in the anion exchange retention time would 
also be expected due to the addition of a negative charge on each phosphorylation site.  The 
easiest way to view this type of shifting in mass would be to plot mass versus anion exchange 
or reversed phase retention time.  For phosphorylation, for example, a diagonal pattern of 
peaks should be seen corresponding to the shifts in both mass and anion exchange retention 
time. 
It also may prove to be beneficial to attempt to reduce the sample consumption of the 
analysis.  Currently, the lowest amount of total protein that has been injected onto the anion 
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exchange column is 1.3 mg, which is a prohibitive amount of protein for many analyses.  The 
driving factor for the need for that much protein initially was due to the limitations imposed 
by the sensitivity of a DDA acquisition and that the protein injected had the potential to be 
spread over 480 fractions.  It was not likely that a peptide would be fragmented at its 
chromatographic apex due to the cycle of a single precursor scan followed by multiple 
fragment ion scans.  Therefore, the analysis benefitted from overloading the capillary 
columns to broaden the peaks in an attempt to ensure that a sufficient amount of peptide 
would continue to elute from the column during the fragmentation scans.  With the advent of 
MS
E
 fragmentation, this is not as critical, thus the amount of digested protein needed for 
proper sequencing is less.  By reducing the inner diameter of both dimensions of the intact 
protein 2D separation and coupling the second dimension to a nanoflow electrospray as 
opposed to the standard spray the sensitivity of the intact protein MS signal may not be 
detrimentally affected. 
Lastly, with regard to these samples in particular, it would be interesting to look at the 
differential expression of knock-outs of β-arrestin 1 and 2 separately.  Recent literature has 
reported that these two arrestins may serve divergent or opposing roles.
15, 16
  β-arrestins 1 and 
2 are the two most abundant non-retinal β-arrestins and have been known to be involved in 
the activation of extracellular signal-regulated kinase ½ (ERK1/2).  These two studies 
investigated the role of these two β-arrestins on the desensitization and internalization of 
protease-activated-receptors 1 and 2.  Their findings suggest that the arrestins can promote 
their desensitizing effects differently and can mediate internalization and downstream 
signaling of a receptor in different ways.  Therefore, it may be interesting to look at 
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individual knockouts of the arrestins in addition to the wild-type and double knockout cell 
lysates. 
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6.8 Tables 
Plotted Max Up in WT Up in βarr-KO Total 
200,000 19 4 23 
50,000 16 17 35 
20,000 9 3 12 
All 44 24 68 
 
Table 6-1: Intensity distribution of differentially expressed protein masses based on intact 
protein MS signal. Plotted Max-maximum of the intensity plotted in false color.  Up in WT- 
number of proteins more abundant in WT sample.  Up in βarr-KO- number of proteins more 
intense in double knockout sample.  Total- combined differential proteins across both 
samples at given intensity maxima. 
 
 
 
 
Differentially expressed protein masses 68 
Protein hits from LC-MS
E
 analysis 1153 
Unique protein identifications 318 
Average peptides/protein 7.2 
Median peptides/protein 5 
Average peptides/differential protein 14.5 
Median peptides/differential protein 12 
 
Table 6-2: Protein identification statistics from the analysis of 65 fractions containing 
differentially expressed protein masses. 
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Swiss- 
Prot 
Name 
Description 
Pep. 
Hits 
Exp. 
Intact 
Mass 
Theo. 
Intact 
Mass 
Fold 
change 
% 
Prob. 
Diff. 
AATC Aspartate aminotransferase cytoplasmic 24 46102.1 46100.39 2.8 94.0 
AK1A1 Alcohol dehydrogenase 3 36450.5 36455.73 61.3 96.5 
ANXA5 Annexin A5 32 35664.3 35752.44 n/a 99.5 
CH10 10 kDa heat shock protein mitochondrial 10 10873.3 10831.51 1.4 98.0 
COF1 Cofilin 1 16 18466.7 18428.35 1.3 94.0 
FKB1A Peptidyl prolyl cis trans isomerase FKBP1A 13 11791.4 11791.44 1.4 96.5 
GSTM1
a 
Glutathione S transferase Mu 1 25 26022.7 25838.8 3.7 88.6 
GSTM2
a
 Glutathione S transferase Mu 2 18 26022.7 25585.51 3.7 88.6 
GSTP1 Glutathione S transferase P 1 22 23479.6 23477.99 2.2 - 
LEG3 Galectin 3 11 27326.2 27383.68 n/a 88.6 
NQO1 NAD(P)H dehydrogenase quinone 1 14 30871.1 30828.48 n/a 96.5 
PA1B3 
Platelet activating factor acetylhydrolase IB 
subunit gamma 
8 25764.7 25853.4 17.3 - 
PGAM1 Phosphoglycerate mutase 1 26 28742.9 28700.79 1.8 98.0 
PRDX1 Peroxiredoxin 1 9 22628.9 22176.5 4.2 - 
PROF1 Profilin 1 12 14868.1 14826.02 9.1 99.5 
RSU1
c 
Ras suppressor protein 1 12 31372.9 31419.08 3.7 88.6 
RSU1
c
 Ras suppressor protein 1 12 31555.4 31419.08 2.8 - 
S10A6 Protein S100 A6 8 9961.33 10050.62 2.2 99.5 
SERC Phosphoserine aminotransferase 9 40516.5 40472.58 n/a - 
SODM Superoxide dismutase Mn mitochondrial 12 22222.6 22222.14 14.9 98.0 
SUMO2 Small ubiquitin related modifier 2 4 10519.5 10608.91 3.0 88.6 
TAGL2 Transgelin 2 4 22628.9 22264.24 4.2 - 
TBCA Tubulin specific chaperone A 7 12668.6 12626.48 6.1 96.5 
TPM1
b 
Tropomyosin alpha 1 chain 30 32751.4 32680.56 6.0 96.5 
TPM2
b
 Tropomyosin beta chain 19 32751.4 32836.7 6.0 96.5 
 
Table 6-3: Differentially expressed proteins found to be up-regulated in the Wild-Type MEF 
cell lysate.  Swiss-Prot Name: Protein entry in SwissProt database followed by ‘_MOUSE’.  
Description:  Brief description of the protein.  Pep. Hits: Number of peptides hits used to 
identify the protein in PLGS2.3.  Exp. Intact Mass: AutoME-deconvoluted molecular 
weight of the intact protein.  Theo. Intact Mass: Intact mass of protein including all 
annotated PTMs.  Fold-change: The degree to which a protein was up-regulated expressed as 
multiples of the intensity of the protein in the sample in which it was least intense.  The 
absence of a fold change signifies the protein was only present in one sample.  %Prob. Diff.: 
Confidence of the significance of the difference as determined through the analysis of 
replicate data. 
a.b
 Indicate the pairs of proteins in which both were within 100 Da of the differentially 
expressed mass from the TD data. 
c
 Indicates that two differentially expressed masses were found in the TD down data and only 
one protein with a similar mass was identified in the BU data and was within 100 Da of both 
of the differentially expressed masses. 
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Swiss- 
Prot 
Name 
Description 
Pep. 
Hits 
Exp. 
Intact 
Mass 
Theo. 
Intact 
Mass 
Fold 
change 
% 
Prob 
Diff. 
ACBP Acyl CoA binding protein 11 9911.1 9869.24 1.8  
FABPH Fatty acid binding protein heart 3 14729.5 14687.66 n/a  
G6PI Glucose 6 phosphate isomerase 44 62679.3 62635.73 1.3  
GDIR1 Rho GDP dissociation inhibitor 1 22 23318.6 23276.22 1.5  
LDHA L lactate dehydrogenase A chain 27 36408.7 36367.34 n/a  
LEG1 Galectin 1 11 14771 14734.66 2.3  
MIF Macrophage migration inhibitory factor 5 12526.3 12373.07 1.6  
NDKB
a 
Nucleoside diphosphate kinase B 10 17457.4 17231.87 2.2  
NENF Neudesin 11 15628 15612.35 1.4  
PARK7 Protein DJ 1 OS Mus musculus 16 19928.5 20021.31 4.4  
PPIA
a
 Peptidyl prolyl cis trans isomerase A 17 17457.4 17840.15 2.2  
PRDX1
b 
Peroxiredoxin 1 12 22117.8 22176.5 2.4  
PRDX5 Peroxiredoxin 5 mitochondrial 18 16881.6 17014.79 6.6  
SODM
b 
Superoxide dismutase Mn mitochondrial 7 22117.8 22222.14 2.4  
 
Table 6-4: Proteins determined to be more abundant in the β-arrestin 1,2 double knockout 
sample.  Swiss-Prot Name: Protein entry in SwissProt database followed by ‘_MOUSE’.  
Description:  Brief description of the protein.  Pep. Hits: Number of peptides hits used to 
identify the protein in PLGS2.3.  Exp. Intact Mass: AutoME-deconvoluted molecular 
weight of the intact protein.  Theo. Intact Mass: Intact mass of protein including all 
annotated PTMs.  Fold-change: The degree to which a protein was up-regulated expressed as 
multiples of the intensity of the protein in the sample in which it was least intense.  The 
absence of a fold change signifies the protein was only present in one sample.  %Prob. Diff.: 
Confidence of the significance of the difference as determined through the analysis of 
replicate data. 
a.b
 Indicate the pairs of proteins in which both were within 100 Da of the differentially 
expressed mass from the TD data. 
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6.9 Figures 
 
Figure 6-1: Signal transduction by seven transmembrane G protein coupled receptors. A) 
Classical paradigm involving stimulates G protein signaling and is desensitized by 
phosphorylation and β-arrestin recruitment. B) New paradigm in which β-arrestins can act as 
signal transducers themselves.  A cardioprotective signaling cascade is shown. 
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Figure 6-2: 2D chromatograms of AutoME deconvoluted data from intact protein 2D-LC-MS 
including full molecular weight range of deconvolution. A) Wild-type MEF cells. B) β-
arrestin 1,2 double knockout MEF cells. 
 
A)
B)
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Figure 6-3: 2D chromatograms of deconvoluted intact protein mass spectra for the replicate 
analysis of βarr-KO MEF cell lysates. 
 
A)
B)
 200 
 
Figure 6-4: Log/Log intensity plots of the replicate analysis of βarr-KO MEF cell lysates. A) 
Replicate data from βarr-KO MEF samples only.  B) βarr-KO MEF replicates overlaid with 
the replicate analysis of Baker’s yeast cell lysates from Chapter 2. 
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Figure 6-5: Venn diagram illustrating the overlap of proteins selected as differentially 
expressed from the intact protein intensity comparison and those identified in selected 
fractions after digestion. 
29 39 282
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from PLGS searching
318 total
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Figure 6-6: Log/Log intensity plot of the replicate analysis with confidence lines from the 
yeast differential analysis.  The percentages noted in the graph legend designate the 
percentage of replicate points held within the corresponding confidence line for the yeast 
replicate analysis in Chapter 2. 
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APPENDIX 
The following tables include all of the identified proteins that were determined to 
have significantly different expression in the bottom-up analyses performed in Chapters 3 
and 5. 
Table A-1: List of proteins determined to be significantly different in the comparison 
between the glycerol-grown and dextrose-grown samples both harvested at the log phase.  
Data were taken from the analysis described in Chapter 3.  Swiss Prot Name: protein entry 
in the SwissProt database followed by ‘_YEAST’.  Ordered Locus Name: predicted gene 
that encodes the protein sequence.  Description: Brief description of the protein.  Pep. Hits: 
number of peptide hits used to identify the protein in PLGS2.3.  Intact Mass: AutoME-
deconvoluted molecular weight of the protein.  Up-reg in: sample in which the protein was 
most intense.  Fold Change BU: the degree to which a protein was up-regulated expressed as 
multiples of the intensity of the protein in the sample in which it was least intense for the BU 
analysis.  Fold Change TD: If a protein mass matched that of a protein that had a significant 
difference in Chapter 2, the corresponding fold change is included.  A value of N/A for the 
fold change indicates the protein was only present in one sample.  This table continues on the 
next page. 
 
Swiss- 
Prot 
Name 
Ordered 
Locus 
Name 
Description 
Pep. 
Hits 
Intact 
Mass 
Up- 
reg 
in 
Fold 
Change 
BU 
Fold 
Change 
TD 
6PGD1 YHR183W 6 phosphogluconate dehydrogenase 24/15 53509 GLY 2.4  
A9LFZ7 ALD6 Cytosolic Aldehyde dehydrogenase 34/35 54379 GLY 1.3  
ACT YFL039C Actin 32/23 41662 GLY 1.6  
ADH2 YMR303C Alcohol dehydrogenase 2 57/24 36708 GLY 42  
ALDH4 YOR374W 
Potassium activated aldehyde 
dehydrogenase 
100/24 56688 GLY 28 G – N/A 
ARF2 YDL137W ADP ribosylation factor 2 10/9 20644 GLY 4.1  
ARO8 YGL202W Aromatic amino acid aminotransferase 1 11/8 56142 GLY 2.1  
BCA2 YJR148W 
Branched chain amino acid 
aminotransferase 
10/9 41598 GLY 3.7  
CDC48 YDL126C Cell division control protein 48 18/14 91938 GLY 2.0  
CH10 YOR020C 10 kDa heat shock protein 5/8 11365 GLY 1.3  
CISY1 YNR001C Citrate synthase mit. 38/12 53327 GLY 4.8 G – 36 
COFI YLL050C Cofilin 10/16 15890 GLY 1.3 G – 1.3 
DUG1 YFR044C Cys-Gly metallodipeptidase 17/11 52837 GLY 2.2  
DHAS YDR158W Aspartate semialdehyde dehydrogenase 5/7 39518 GLY 1.4  
DHE4 YOR375C NADP specific glutamate dehydrogenase 19/13 49538 GLY 1.9  
EF1A YPR080W Elongation factor 1 alpha 63/47 50001 GLY 2.6 G – N/A 
EF1B YAL003W Elongation factor 1 beta 14/10 22613 GLY 1.7  
EF1G2 YKL081W Elongation factor 1 gamma 2 9/14 46490 GLY 1.6  
EF2 YOR133W Elongation factor 2 51/54 93230 GLY 2.4  
EF3A YLR249W Elongation factor 3A 29/15 115919 GLY 3.8  
FHP YGR234W Flavohemoprotein 28/13 44618 GLY 3.4  
FKBP YNL135C FK506 binding protein 11/9 12150 GLY 1.4 G – 2.9 
FPPS YJL167W Farnesyl pyrophosphate synthetase 16/8 40457 GLY 2.2  
G3P3 YGR192C 
Glyceraldehyde 3 phosphate 
dehydrogenase 3 
58/58 35724 GLY 1.8  
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GBLP YMR116C Guanine nucleotide binding protein 15/8 34783 GLY 1  
H2B1 YDR224C Histone H2B 1 9/3 14243 GLY 4.0  
HNT1 YDL125C Hit family protein 1 7/3 17668 GLY 1.6  
HS104 YLL026W Heat shock protein 104 18/16 101972 GLY 1.4  
HSC82 YMR186W ATP dependent chaperone 58/69 80849 GLY 1.4  
HSP12 YFL014W 12 kDa heat shock protein 11/21 11685 GLY 1.3  
HSP60 YLR259C Heat shock protein 60 34/25 60714 GLY 2.4  
HXKB YGL253W Hexokinase 1 32/30 53908 GLY 1.8  
HXKG YCL040W Hexokinase 2 47/28 55342 GLY 4.7  
IF4A YKR059W ATP dependent RNA helicase 25/23 44669 GLY 1.6  
IF5A2 YEL034W Eukaryotic translate initiation factor 5A 12/15 17103 GLY 1.8  
IPYR YBR011C Inorganic pyrophosphatase 17/20 32279 GLY 1.2  
K6PF1 YGR240C 6 phosphofructokinase alpha 15/17 107903 GLY 3.8  
K6PF2 YMR205C 6 phosphofructokinase beta 13/16 104552 GLY 2.1  
LSP1 YPL004C 
Sphingolipid long chain base responsive 
protein 
20/10 38047 GLY 3.8  
MDHM YKL085W Malate dehydrogenase mit. 29/9 35627 GLY 6.5 G – 6.3 
PABP YER165W Polyadenylate binding protein 18/12 64304 GLY 1.7  
RIR4 YGR180C Ribonucleoside diphosphate reductase 13/9 40028 GLY 2.5 G – 5.1 
RL4A YBR031W 60S ribosomal protein L4 10/4 39068 GLY 11  
RL7A YGL076C 60S ribosomal protein L7 13/4 27621 GLY 12  
RS5 YJR123W 40S ribosomal protein S5 12/4 25023 GLY 9.1  
RS7A YOR096W 40S ribosomal protein S7  12/3 21608 GLY 7.5  
SAHH YER043C Adenosylhomocysteinase 25/27 49094 GLY 1.9  
SNU13 YEL026W 
13 kDa ribonucleoprotein associated 
protein 
5/3 13560 GLY 2.4  
SUCA YOR142W Succinyl CoA ligase  13/8 35010 GLY 7.5 G – 15.4 
SYDC YLL018C Aspartyl tRNA synthetase 14/10 63476 GLY 2.5  
SYEC YGL245W Glutamyl tRNA synthetase 17/11 80791 GLY 3.2  
SYSC YDR023W Seryl tRNA synthetase 16/7 53276 GLY 3.3  
SYV YGR094W Valyl tRNA synthetase 27/21 125690 GLY 1.7  
TAL1 YLR354C Transaldolase 21/26 37013 GLY 1.7 G – 11 
TKT1 YPR074C Transketolase 26/19 73759 GLY 1.4 G – N/A 
TSA1 YML028W Peroxiredoxin TSA1 31/26 21576 GLY 1.5  
YMY9 YMR099C UPF0010 protein 10/11 33934 GLY 1.5  
ADH1 YOL086C Alcohol dehydrogenase 41/47 36799 DEX 2.8 G – N/A 
ARF1 YLD192W ADP ribosylation factor 1 9/8 20516 DEX 8.1  
CYPH YDR155C Peptidyl prolyl cis trans isomerase 10/23 17379 DEX 1.8  
CYS3 YAL012W Cystathionine gamma lyase 7/19 42516 DEX 2.1 D – N/A 
ENO1 YGR254W Enolase 1 42/92 46773 DEX 3.4 G – N/A 
ENO2 YHR174W Enolase 2 62/142 46885 DEX 3.0  
G3P1 YJL052W 
Glyceraldehyde 3 phosphate 
dehydrogenase 1 
18/27 35727 DEX 2.0  
HSP72 YLL024C Heat shock protein SSA2 65/89 69427 DEX 1.8  
HSP75 YDL229W Heat shock protein SSB1 36/47 66560 DEX 0  
HSP7F YPL106C Heat shock protein homolog SSE1 21/32 77318 DEX 3.0  
HSP82 YPL240C ATP dependent molecular chaperone 42/57 81356 DEX 9.3  
IMDH3 YLR432W Inosine 5 monophosphate dehydrogenase 12/21 56548 DEX 2.0  
KAR YDL124W 
NADPH dependent alpha keto amide 
reductase 
9/22 35538 DEX 2.8  
MET17 YLR303W Protein MET17 14/26 48641 DEX 3.3  
PDC1 YLR044C Pyruvate decarboxylase isozymes 1 58/106 61456 DEX 1.8  
PDC6 YGR087C Pyruvate decarboxylase isozymes 3 10/24 61542 DEX 1.7  
PGK YCR012W Phosphoglycerate kinase 69/114 44710 DEX 1.7 D – 2.0 
PMG1 YKL152C Phosphoglycerate mutase 1 24/39 27591 DEX 2.7  
PNC1 YGL037C Nicotinamidase 5/14 24977 DEX 1.8  
SODC YJR104V Superoxide dismutase Cu Zn 24/34 15844 DEX 2.0 D – 1.9 
TPIS YDR050C Triosephosphate isomerase 36/36 26778 DEX 1.8 D – 1.7 
TRX2 YGR209C Thioredoxin 2 9/15 11196 DEX 3.8 D – N/A 
TRXB1 YDR353W Thioredoxin reductase 7/15 34216 DEX 6.9 D – 3.2 
 
 
205
Table A-2: List of proteins determined to be significantly different in the comparison 
between the log phase and stationary phase harvests of yeast samples grown on dextrose.  
Data were taken from the analysis described in Chapter 3.  Swiss Prot Name: protein entry 
in the SwissProt database followed by ‘_YEAST’.  Ordered Locus Name: predicted gene 
that encodes the protein sequence.  Description: Brief description of the protein.  Pep. Hits: 
number of peptide hits used to identify the protein in PLGS2.3.  Intact Mass: AutoME-
deconvoluted molecular weight of the protein.  Up-reg in: sample in which the protein was 
most intense.  Fold Change BU: the degree to which a protein was up-regulated expressed as 
multiples of the intensity of the protein in the sample in which it was least intense for the BU 
analysis.  Fold Change TD: If a protein mass matched that of a protein that had a significant 
difference in Chapter 2, the corresponding fold change is include.  A value of N/A for the 
fold change indicates the protein was only present in one sample.  This table continues on the 
next page. 
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ACBP YGR037C Acyl-CoA-binding protein 5/3 10055 Log 1.4 L – 2.5 
ADH1 YOL086C Alcohol dehydrogenase 47/33 36799 Log 2.1  
ADH2 YMR303C Alcohol dehydrogenase 2 19/15 36708 Log 5.4  
ADK YJR105W Adensosine kinase 19/15 36349 Log 1.7  
AHP1 YLR109W Peroxiredoxin type-2 19/16 19102 Log 1.5  
ALF YKL060C Fructose-bisphosphate aldolase 60/27 39595 Log 4.7  
BCA2 YJR148W Branched chain amino acid aminotransferase 9/5 41598 Log 2.4  
BMH1 YER177W Protein BMH1 21/17 30072 Log 1.9 L – N/A 
CBS YGR155W Cystathionine beta-synthase 32/15 55987 Log 2.0  
EF1B YAL003W Elongation factor 1 beta 10/4 22613 Log 1.5  
EF2 YOR133W Elongation factor 2 54/31 93230 Log 1.3  
ENO2 YHR174W Enolase 2 142/125 46885 Log 1.2  
G3P3 YGR192C Glyceraldehyde 3 phosphate dehydrogenase 3 58/43 35724 Log 2.2 L – 123 
HSP60 YLR259C Heat shock protein 60 25/13 60714 Log 1.5  
HSP71 YAL005C Heat shock protein SSA1 92/83 69614 Log 1.1  
HSP72 YLL024C Heat shock protein SSA2 89/73 69427 Log 1.4  
HSP74 YER103W Heat shock protein SSA4 47/37 69608 Log 2.5  
HSP82 YPL240C ATP dependent molecular chaperone 57/14 81356 Log 2.4  
KAD1 YDR226W Adenylate kinase 1 23/5 24239 Log 4.7 L – 1.1 
KPYK1 YAL038W Pyruvate kinase 1 51/27 54510 Log 1.7  
MET17 YLR303W Protein MET17 26/21 48641 Log 1.6  
PDC1 YLR044C Pyruvate decarboxylase isozymes 1 106/83 61456 Log 1.3  
PGK YCR012W Phosphoglycerate kinase 114/51 44710 Log 3.3 L – N/A 
PNC1 YGL037C Nicotinamidase 14/10 24977 Log 1.4 L – 18 
SAHH YER043C Adenosylhomocysteinase 27/19 49094 Log 1.2  
SYDC YLL018C Aspartyl tRNA synthetase 10/7 63476 Log 1.2  
THRC YCR053W Threonine synthase 19/9 57438 Log 1.9 L – N/A 
TRX1 YLR043C Thioredoxin 1 13/7 11227 Log 5.4  
TRX2 YGR209C Thioredoxin 2 15/11 11196 Log 1.3  
TSA1 YML028W Peroxiredoxin TSA1 26/24 21576 Log 2.0  
ZEO1 YOL109W 
Protein ZEO1 
 
 
14/6 12581 Log 7.6  
ALDH4 YOR374W Potassium activated aldehyde dehydrogenase 24/31 56688 Stat 2.4  
AMPL YKL103C Vacuolar aminopeptidase 1 14/20 57057 Stat 3.2  
ARO8 YGL202W Aromatic amino acid aminotransferase 1 8/8 56142 Stat 2.1  
ASSY YOL058W Argininosuccinate synthase 23/23 46910 Stat 1.6  
CISY1 YNR001C Citrate synthase mit. 12/28 53327 Stat 2.4  
DAK1 YML070W Dihidroxyacetone kinase 10/15 62167 Stat 1.9  
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DHE4 YOR375C NADP specific glutamate dehydrogenase 13/14 49538 Stat 2.2  
ENO1 YGR254W Enolase 1 92/93 46773 Stat 2.1  
G3P1 YJL052W Glyceraldehyde 3 phosphate dehydrogenase 1 27/37 35727 Stat 3.0 S – N/A 
G6PD YNL241C Glucose-6-phosphate 1-dehydrogenase 20/15 27485 Stat 1.8  
G6PI YBR196C Glucose-6-phosphate isomerase 51/61 61261 Stat 1.4 S – 1.7 
GRE2 YOL151W NADPH-dependent methylglyoxal reductase 18/23 38145 Stat 1.9 S – N/A 
GSHR YPL091W Glutathione reductase 9/12 53407 Stat 2.0  
HBN1 YCL026-C-B Putative nitroreductase 12/24 20980 Stat 5.4 S – 7.1 
HS104 YLL026W Heat shock protein 104 16/19 101972 Stat 1.7  
HSP31 YDR533C Probable chaperone protein 16/17 25654 Stat 1.4 S – N/A 
HXKA YFR053C Hexokinase-1 23/33 53704 Stat 2.0  
HXKB YGL253W Hexokinase 1 30/27 53908 Stat 1.3  
IPYR YBR011C Inorganic pyrophosphatase 20/22 32279 Stat 1.5  
KAR YDL124W NADPH dependent alpha keto amide reductase 22/25 35539 Stat 2.0  
MDHM YKL085W Malate dehydrogenase mit. 9/21 35627 Stat 2.7  
METE YER091C 5-methyltetrahydropteroyltriglutamate – homocysteine methyltransferase 32/38 85806 Stat 1.8  
OYE2 YHR179W NADPH dehydrogenase 2 30/43 44982 Stat 2.6  
OYE3 YPL171C NADPH dehydrogenase 3 23/40 44892 Stat 3.6  
PMG1 YKL152C Phosphoglycerate mutase 1 39/49 27591 Stat 1.4 L – 2.0 
PROF YOR122C Profilin 9/6 13668 Stat 1.8  
PUR92 YMR120C Bifuntional purine biosynthesis protein ADE17 36/48 65222 Stat 1.7  
PURA YNL220W Adenylosuccinate synthetase 11/20 48249 Stat 3.4  
SODC YJR104V Superoxide dismutase Cu Zn 34/34 15844 Stat 1.1 L – 1.8 
SUCA YOR142W Succinyl CoA ligase  8/3 35010 Stat 1.3  
TKT1 YPR074C Transketolase 19/24 73759 Stat 1.3  
TRXB1 YDR353W Thioredoxin reductase 15/15 34216 Stat 1.4  
YMN1 YML131W Uncharacterized membrane protein 8/14 39951 Stat 5.8  
YMY0 YMR090W UPF0659 protein 9/11 24866 Stat 1.4  
YNN4 YNL134C Uncharacterized protein YNL134C 40/48 41138 Stat 1.5  
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Table A-3: List of proteins determined to be significantly different in the comparison 
between the glycerol-grown and dextrose-grown samples both harvested at the log phase.  
Data were taken from the analysis described in Chapter 5.  Swiss Prot Name: protein entry 
in the SwissProt database followed by ‘_YEAST’.  Ordered Locus Name: predicted gene 
that encodes the protein sequence.  Description: Brief description of the protein.  Pep. Hits: 
number of peptide hits used to identify the protein in PLGS2.3.  Intact Mass: Average 
molecular weight of the protein after loss of initiating Methionine if known.  Up-reg in: 
sample in which the protein was most intense.  Fold Change frac: the degree to which a 
protein was up-regulated expressed as multiples of the intensity of the protein in the sample 
in which it was least intense for the fractionated BU analysis.  Fold Change un-frac: If the 
protein was also found to be differential expressed in the un-fractionated BU analysis, the 
corresponding fold change is included here.  This table continues on the next page. 
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3HAO YJR025C 3 hydroxyanthranilate 3 4 dioxygenase 4 20222 GLY 3.7  
AATC YLR027C Aspartate aminotransferase cytoplasmic 19 46028 GLY 2.4  
ABP1 YCR088W Actin binding protein 7 65536 GLY 3.9  
ACON YLR304C Aconitate hydratase mitochondrial 32 85314 GLY 28.6  
ACPM YKL192C Acyl carrier protein mitochondrial 4 13934 GLY 8.6  
ADH2 YMR303C Alcohol dehydrogenase 2 22 36708 GLY 11.5  G - 42 
AGX1 YFL030W Alanine glyoxylate aminotransferase 1 18 41880 GLY 45.2  
AIP1 YMR092C Actin interacting protein 1 16 67283 GLY 4.0  
ALDH4 YOR374W Potassium activated aldehyde dehydrogenase  39 56688 GLY 10.9 G - 28 
AP2B YJR005W AP 2 complex subunit beta 5 80402 GLY 16.9  
ARA1 YBR149W D arabinose dehydrogenase NAD P  19 38859 GLY 2.0  
ARO8 YGL202W Aromatic amino acid aminotransferase 1 18 56142 GLY 3.1 G - 2.1 
AROC YGL148W Chorismate synthase 13 40812 GLY 3.3  
AROG YBR249C Phospho 2 dehydro 3 deoxyheptonate aldolase 7 39724 GLY 9.7  
ARP2 YDL029W Actin related protein 2 6 44045 GLY 6.1  
ARP3 YJR065C Actin related protein 3 6 49510 GLY 6.1  
ARPC2 YNR035C Actin related protein 2 3 complex subunit 2 7 39541 GLY 13.4  
ATIF YDL181W ATPase inhibitor mitochondrial 7 9864 GLY 3.2  
ATPA YBL099W ATP synthase subunit alpha mitochondrial 14 58572 GLY 11.1  
ATPB YJR121W ATP synthase subunit beta mitochondrial 36 54760 GLY 6.7  
ATPO YDR298C ATP synthase subunit 5 mitochondrial 7 22800 GLY 5.6  
ATX1 YNL259C Metal homeostasis factor ATX1 2 8215 GLY 15.4  
BCA2 YJR148W Branched chain amino acid aminotransferase  9 41598 GLY 2.7 G - 3.7 
CAPZB YIL034C F-acting-capping protein subunit beta 3 32629 GLY 1.7  
CCPR YKR066C Cytochrome c peroxidase mitochondrial 13 40327 GLY 1.1  
CH10 YOR020C 10 kDa heat shock protein mitochondrial 10 11365 GLY 1.9 G - 1.3 
CISY1 YNR001C Citrate synthase mitochondrial 16 53327 GLY 2.7 G - 4.8 
CKS1 YBR135W Cyclin dependent kinases regulatory subunit 3 17783 GLY 4.5  
COX12 YLR038C Cytochrome c oxidase subunit 6B 4 9781 GLY 4.3  
COX4 YGL187C Cytochrome c oxidase subunit 4 mit. 3 17131 GLY 17.5  
COX6 YHR051W Cytochrome c oxidase subunit 6 mit. 10 17330 GLY 2.5  
CUE5 YOR042W Ubiquitin binding protein CUE5 6 46841 GLY 3.0  
CYPC YML078W Peptidyl prolyl cis trans isomerase C mit. 19 19906 GLY 4.6  
DCPS YLR270W Scavenger mRNA decapping enzyme DcpS 17 40743 GLY 2.5  
DCS2 YOR173W Protein DCS2 10 40914 GLY 2.3  
DHE4 YOR375C NADP specific glutamate dehydrogenase 1 23 49538 GLY 1.4 G - 1.9 
DLDH YFL018C Dihydrolipoyl dehydrogenase mitochondrial 40 53976 GLY 8.4  
DLHH YDL086W Putative carboxymethylenebutenolidase 3 30817 GLY 2.1  
ECM33 YBR078W Cell wall protein ECM33 4 43741 GLY 6.1  
EF1A YPR080W Elongation factor 1 alfpha 18 50033 GLY 1.3 G – 2.6 
EF1G2 YPL048W Elongation factor 1 gamma 2 6 46490 GLY 1.4 G - 1.6 
EF2 YOR133W Elongation factor 2 33 93230 GLY 1.6 G - 2.4 
ELP2 YGR200C Elongator complex protein 2 8 89354 GLY 1.4  
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ERG19 YOL110W Diphosphomevalonate decarboxylase 13 44088 GLY 1.7  
ESS1 YJR017C Peptidyl prolyl cis trans isomerase ESS1 12 19392 GLY 1.9  
ETR1 YBR026C Enoyl acyl carrier protein reductase NADPH 15 42040 GLY 37.6  
FAT2 YBR222C Peroxisomal coenzyme A synthetase 11 60450 GLY 1.8  
FHP YGR234W Flavohemoprotein 3 44618 GLY 16.5 G - 3.4 
FIMB YDR129C Fimbrin 19 71728 GLY 1.5  
FKBP YNL135C FK-506 binding protein 1 14 12158 GLY 1.3 G – 1.4 
FMP21 YBR269C Protein FMP21 mitochondrial 3 15494 GLY 2.7  
FUMH YPL262W Fumarate hydratase mitochondrial 21 53118 GLY 96.8  
G3P1 YJL052W Glyceraldehyde 3 phosphate dehydrogenase 1 14 35727 GLY 2.1 D - 2.0 
G3P3 YGR192C Glyceraldehyde 3 phosphate dehydrogenase 3 30 35724 GLY 1.7 G - 1.8 
GBLP YMR116C Guanine nucleotide binding protein subunit  5 34783 GLY 6.5 G - 1.0 
GCY YOR120W Protein GCY 30 35057 GLY 1.5  
GDIR YDL135C Rho GDP dissociation inhibitor 8 23124 GLY 3.1  
H2B1 YDR224C Histone H2B 1 1 14243 GLY 8.9 G - 4.0 
HS104 YLL026W Heat shock protein 104 12 101972 GLY 1.8 G - 1.4 
HSP12 YFL014W 12 kDa heat shock protein 17 11685 GLY 1.5 G - 1.3 
HSP77 YJR045C Heat shock protein SSC1 mitochondrial 29 70584 GLY 2.4  
IDH1 YNL037C Isocitrate dehydrogenase NAD subunit 1 mito 18 39299 GLY 28.2  
IDH2 YOR136W Isocitrate dehydrogenase NAD subunit 2 mito 12 39714 GLY 38.7  
IF4B YPR163C Eukaryotic translation initiation factor 4B 10 48493 GLY 4.2  
IF6 YPR016C Eukaryotic translation initiation factor 6 10 26441 GLY 5.1  
IPB2 YNL015W Protease B inhibitors 2 and 1 13 8584 GLY 7.0  
LEU1 YNL104C 2 isopropylmalate synthase 6 68366 GLY 9.2  
MBF1 YOR298C Multiprotein bridging factor 1 5 16393 GLY 1.9  
MDHM YKL085W Malate dehydrogenase mitochondrial 29 35627 GLY 3.2 G - 6.5 
MDHP YDL078C Malate dehydrogenase peroxisomal 18 37162 GLY 26.8  
MLC1 YGL106W Myosin light chain 1 14 16434 GLY 1.6  
MMF1 YIL051C Protein MMF1 mitochondrial 11 15898 GLY 16.1  
MNP1 YBL068W 54S ribosomal protein L12 mitochondrial 7 20637 GLY 5.1  
MPG1 YDL055C Mannose 1 phosphate guanyltransferase 5 39541 GLY 1.7  
MPI YER003C Mannose 6 phosphate isomerase 15 48158 GLY 3.9  
MRP8 YKL142W Uncharacterized protein MRP8 27 25081 GLY 1.2  
NACA YHR193C Nascent polypeptide associated complex sub. 6 18697 GLY 1.9  
NACB1 YPL037C Nascent polypeptide associated complex sub. 5 17009 GLY 12.2  
NDK YKL067W Nucleoside diphosphate kinase 12 17155 GLY 1.4  
NHP6A YPR052C Non histone chromosomal protein 6A 6 10795 GLY 20.9  
ODPB YBR221C Pyruvate dehydrogenase E1 component sub. 9 40028 GLY 2.9  
PABP YER165W Polyadenylate binding protein cytoplasmic  3 64304 GLY 3.0 G - 1.7 
PFD6 YLR200W Prefoldin subunit 6 6 13275 GLY 3.1  
PHO85 YPL031C Cyclin dependent protein kinase PHO85 6 34883 GLY 7.6  
PRX1 YBL064C Mitochondrial peroxiredoxin PRX1 11 29477 GLY 3.0  
PSA4 YGR135W Proteasome component Y13 6 28696 GLY 6.0  
PUR91 YLR028C Bifunctional purine biosynthesis ADE16 21 65241 GLY 1.1  
PYRD YKL216W Dihydroorotate dehydrogenase 8 34778 GLY 4.4  
QCR2 YPR191W Cytochrome b c1 complex subunit 2 mit. 21 40453 GLY 14.1  
RIB4 YOL143C 6 7 dimethyl 8 ribityllumazine synthase 5 18543 GLY 4.3  
RIR4 YGR180C Ribonucleoside diphosphate reductase 24 40028 GLY 7.7 G - 2.5 
RL12 YEL054C 60S ribosomal protein L12 3 17811 GLY 2.5  
RL30 YGL030W 60S ribosomal protein L30 3 11408 GLY 2.3  
RLA0 YLR340W 60S acidic ribosomal protein P0 4 33745 GLY 22.5  
RPAB4 YHR143W DNA directed RNA polymerases I II and III  1 7711 GLY 2.4  
RS12 YOR369C 40S ribosomal protein S12 7 15462 GLY 3.0  
RS20 YHL015W 40S ribosomal protein S20 2 13898 GLY 28.7  
RS21A YKR057W 40S ribosomal protein S21 A 9 9739 GLY 8.7  
RS21B YJL136C 40S ribosomal protein S21 B 7 9753 GLY 2.8  
RS27A YKL156W 40S ribosomal protein S27 A 4 8873 GLY 2.0  
SCW4 YGR279C Probable family 17 glucosidase SCW4 8 40148 GLY 7.5  
SEC23 YPR181C Protein transport protein SEC23 15 85330 GLY 4.4  
SGS1 YMR190C ATP dependent helicase SGS1 12 163734 GLY 4.5  
SODM YHR008C Superoxide dismutase Mn mitochondrial 4 25758 GLY 2.4  
SUCA YOR142W Succinyl CoA ligase ADP forming sub. 27 35010 GLY 4.3 G - 7.5 
SYDC YLL018C Aspartyl tRNA synthetase cytoplasmic 22 63476 GLY 2.5 G - 2.5 
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SYV YGR094W Valyl tRNA synthetase mitochondrial 40 125690 GLY 1.9 G - 1.7 
TAL1 YLR354C Transaldolase 25 37013 GLY 1.3 G - 1.7 
TBCA YOR265W Tubulin specific chaperone A 7 12371 GLY 2.1  
THIL YPL028W Acetyl CoA acetyltransferase 15 41702 GLY 1.4  
TIM10 YHR005C Mit. import inner membrane translocase 6 10297 GLY 2.5  
TIM13 YGR181W Mit. import inner membrane translocase 8 11278 GLY 34.2  
TIM9 YEL020W Mit. import inner membrane translocase 5 10194 GLY 2.4  
TRX1 YLR043C Thioredoxin 1 11 11227 GLY 2.4  
UBIQ YIL148W Ubiquitin 6 8551 GLY 1.7  
UGPA1 YKL035W UTP glucose 1 phosphate uridylyltransferase 22 55953 GLY 1.7  
ULS1 YOR191W ATP dependent helicase ULS1 19 184290 GLY 14.3  
VATA YKL080W V type proton ATPase catalytic subunit A 21 118562 GLY 2.1  
VATC YKL080W V type proton ATPase subunit C 24 44161 GLY 2.0  
VATE YOR332W V type proton ATPase subunit E 10 26455 GLY 2.5  
WTM1 YOR230W Transcriptional modulator WTM1 27 48353 GLY 1.5  
YBM6 YBR016W Uncharacterized protein YBR016W 3 14607 GLY 5.5  
YCP4 YCR004C Flavoprotein like protein YCP4 12 26333 GLY 5.6  
YMH9 YML079W Uncharacterized protein YML079W 6 22447 GLY 1.8  
YN14 YNL274C Putative 2 hydroxyacid dehydrogenase  4 38807 GLY 14.4  
YO285 YOR285W Putative thiosulfate sulfurtransferase 2 15403 GLY 4.0  
YP067 YPL067C Uncharacterized protein YPL067C 7 22761 GLY 3.5  
YP225 YPL225W UPF0368 protein YPL225W 13 17433 GLY 2.0  
ZEO1 YOL109W Protein ZEO1 14 12581 GLY 2.2  
ACE2 YLR131C Metallothionein expression activator 9 86580 DEX 1.7  
ACT YFL039C Actin 7 41662 DEX 3.4  
ADH1 YOL086C Alcohol dehydrogenase 1 19 36799 DEX 14.7 D - 2.8 
ADH6 YMR318C NADP dependent alcohol dehydrogenase 6 8 39591 DEX 3.3  
ADK YJR105W Adenosine kinase 8 36349 DEX 21.9  
AHP1 YLR109W Peroxiredoxin type 2 12 19102 DEX 20.8  
ALF YKL060C Fructose bisphosphate aldolase 14 39595 DEX 2.2  
AMPL YKL103C Vacuolar aminopeptidase 1 10 57057 DEX 2.9  
BMH1 YER177W Protein BMH1 22 29960 DEX 1.2 G – 1.4 
CALM YBR109C Calmodulin 10 16124 DEX 4.5  
CBS YGR155W Cystathionine beta synthase 30 55987 DEX 1.9  
CCS1 YMR038C Superoxide dismutase 1 copper chaperone 6 27312 DEX 9.7  
COFI YLL050C Cofilin 5 15900 DEX 1.5 G – 1.3 
CPYI YLR178C Carboxypeptidase Y inhibitor 3 24357 DEX 2.0  
CYPD YDR304C Peptidyl prolyl cis trans isomerase D 12 25310 DEX 1.5  
CYPH YDR155C Peptidyl prolyl cis trans isomerase 12 17379 DEX 2.0  
CYS3 YAL012W Cystathionine gamma lyase 17 42516 DEX 4.8 D - 2.1 
DHAS YDR158W Aspartate semialdehyde dehydrogenase 13 39518 DEX 1.7 G - 1.4 
DHOM YJR139C Homoserine dehydrogenase 23 38478 DEX 1.7  
DOHH YJR070C Deoxyhypusine hydroxylase 5 36142 DEX 1.7  
DUG1 YFR044C Glutamate carboxypeptidase like protein  6 52837 DEX 5.9 G - 2.2 
ENO1 YGR254W Enolase 1 28 46773 DEX 3.1 D - 3.4 
ENO2 YHR174W Enolase 2 35 46885 DEX 7.0 D - 3.0 
FADH YDL168W S hydroxymethyl glutathione dehydrogenase 19 41015 DEX 2.3  
FAS2 YPL231W Fatty acid synthase subunit alpha 26 206816 DEX 5.7  
FES1 YBR101C Hsp70 nucleotide exchange factor FES1 6 32604 DEX 1.8  
FMP31 YOR286W Putative thiosulfate sulfurtransferase FMP31 5 16686 DEX 2.1  
FRDS YEL047C Fumarate reductase 8 50812 DEX 6.2  
FSH1 YHR049W Family of serine hydrolases 1 12 27322 DEX 6.6  
G3P2 YJR009C Glyceraldehyde 3 phosphate dehydrogenase 2 23 35824 DEX 1.6  
G6PD YNL241C Glucose 6 phosphate 1 dehydrogenase 24 57485 DEX 3.4  
G6PI YBR196C Glucose 6 phosphate isomerase 25 61261 DEX 1.3  
GLRX1 YCL035C Glutaredoxin 1 12 12372 DEX 7.4  
GLRX2 YDR513W Glutaredoxin 2 12 12380 DEX 1.3  
GSHR YPL091W Glutathione reductase 22 53407 DEX 2.9  
GTO2 YGR154C Glutathione S transferase omega like 2 16 43246 DEX 4.1  
HBN1 YCL026C Putative nitroreductase HBN1 8 20980 DEX 5.1  
HCH1 YNL281W Hsp90 co chaperone HCH1 7 17235 DEX 2.3  
HIS7 YOR202W Imidazoleglycerol phosphate dehydratase 5 23818 DEX 4.8  
HOSC YDL182W Homocitrate synthase cytosolic isozyme 9 47069 DEX 3.6  
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HPRT YDR138W Hypoxanthine guanine phosphoribosyltransfe. 8 25174 DEX 15.9  
HSC82 YMR186W ATP dependent molecular chaperone HSC82 54 80849 DEX 1.2 G - 1.4 
HSP31 YDR533C Probable chaperone protein HSP31 13 25654 DEX 463.9  
HSP60 YLR259C Heat shock protein 60 mitochondrial 33 60714 DEX 1.6 G - 2.4 
HSP72 YLL024C Heat shock protein SSA2 26 69427 DEX 3.7 D - 1.8 
HSP73 YBL075C Heat shock protein SSA3 19 70503 DEX 3.3  
HSP74 YER103W Heat shock protein SSA4 15 69608 DEX 4.4  
HSP75 YDL229W Heat shock protein SSB1 31 66560 DEX 1.6 D - 1.0 
HSP76 YNL209W Heat shock protein SSB2 34 66553 DEX 1.7  
HSP79 YBR169C Heat shock protein homolog SSE2 29 77572 DEX 3.2  
HSP7Q YLR369W Heat shock protein SSQ1 mitochondrial 5 72320 DEX 1.7  
HSP82 YPL240C ATP dependent molecular chaperone HSP82 44 81356 DEX 2.1 D - 9.3 
HXKB YGL253W Hexokinase 2 6 53908 DEX 1.8  
IDI1 YPL117C Isopentenyl diphosphate Delta isomerase 1 33330 DEX 2.9  
IF4A YKR059W ATP dependent RNA helicase eIF4A 29 44669 DEX 1.2 G - 1.6 
IF5A2 YEL034W Eukaryotic translation initiation factor 5A 2 2 17103 DEX 14.8 G - 1.8 
IMDH2 YHR216W Inosine 5 monophosphate dehydrogenase  15 56493 DEX 4.1  
IMDH3 YLR432W Probable inosine 5 monophosphate dehydrog. 19 56548 DEX 6.2 D - 2.0 
IMDH4 YML056C Probable inosine 5 monophosphate dehydrog. 9 56357 DEX 5.1  
IPYR YBR011C Inorganic pyrophosphatase 12 32279 DEX 1.9  
KAD1 YDR226W Adenylate kinase 1 21 24239 DEX 1.3  
KES1 YPL145C Protein KES1 10 49461 DEX 1.5  
KPYK1 YAL038W Pyruvate kinase 1 25 54510 DEX 2.6  
MAS5 YNL064W Mitochondrial protein import protein MAS5 7 44642 DEX 3.2  
MET17 YLR303W Protein MET17 22 48641 DEX 1.7 D - 3.3 
METE YER091C 5 methyltetrahydropteroyltriglutamate homoC 47 85806 DEX 1.9  
METK1 YLR180W S adenosylmethionine synthetase 1 10 41792 DEX 24.9  
METK2 YDR502C S adenosylmethionine synthetase 2 10 42229 DEX 10.3  
NIF3 YGL221C NGG1 interacting factor 3 4 31868 DEX 6.6  
NPT1 YOR209C Nicotinate phosphoribosyltransferase 10 48987 DEX 2.3  
NTF2 YER009W Nuclear transport factor 2 6 14444 DEX 1.8  
OYE2 YHR179W NADPH dehydrogenase 2 25 44982 DEX 9.8  
OYE3 YPL171C NADPH dehydrogenase 3 21 44892 DEX 94.8  
PCNA YBR088C Proliferating cell nuclear antigen 7 28897 DEX 1.5  
PDC1 YLR044C Pyruvate decarboxylase isozyme 1 26 61456 DEX 15.2 D - 1.8 
PGK YCR012W Phosphoglycerate kinase 37 44710 DEX 2.5 D - 1.7 
PMG1 YKL152C Phosphoglycerate mutase 1 25 27591 DEX 2.8 D - 2.7 
PNC1 YGL037C Nicotinamidase 4 24977 DEX 1.7 D - 1.8 
PROF YOR122C Profilin 7 13677 DEX 1.4  
PRP5 YBR237W Pre mRNA processing ATP dep. RNA helic. 9 96299 DEX 4.4  
PSB2 YER012W Proteasome component C11 5 22502 DEX 2.0  
PUR6 YOR128C Phosphoribosylaminoimidazole carboxylase 11 62299 DEX 3.7  
PUR92 YMR120C Bifunctional purine biosynthesisADE17 40 65222 DEX 22.0  
RIR2 YJL026W Ribonucleoside diphosphate reductase 4 46118 DEX 1.7  
RLA4 YDR382W 60S acidic ribosomal protein P2 beta 3 11043 DEX 4.0  
SDO1L YHR087W SDO1 like protein YHR087W 9 12002 DEX 3.3  
SEC31 YDL195W Protein transport protein SEC31 9 138617 DEX 1.5  
SGT2 YOR007C Small glutamine rich tetratricopeptide repeat 12 37195 DEX 1.7  
SODC YJR104C Superoxide dismutase Cu Zn 14 15844 DEX 1.7  
SRO9 YCL037C RNA binding protein SRO9 4 48030 DEX 6.2  
STI1 YOR027W Heat shock protein STI1 19 66224 DEX 1.7  
SYC YNL247W Cysteinyl tRNA synthetase 9 87475 DEX 1.4  
TPIS YDR050C Triosephosphate isomerase 20 26778 DEX 2.5 D - 1.8 
TRX2 YGR209C Thioredoxin 2 11 11196 DEX 4.0 D - 3.8 
TRXB1 YDR353W Thioredoxin reductase 1 11 34216 DEX 2.4 D - 6.9 
UBA1 YKL210W Ubiquitin activating enzyme E1 1 11 114194 DEX 2.3  
YB085 YBR085C Uncharacterized protein YBR085C A 4 9398 DEX 5.8  
YGP1 YNL160W Protein YGP1 6 37305 DEX 9.6  
YHU6 YGR149C Uncharacterized protein YHR146W 5 51084 DEX 3.5  
YL301 YLR301W Uncharacterized protein YLR301W 6 27483 DEX 1.6  
YN034 YNR034W Uncharacterized protein YNR034W A 6 10774 DEX 5.1  
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YNN4 YNL134C Uncharacterized protein YNL134C 17 41138 DEX 62.4  
YPD1 YDL235C Phosphorelay intermediate protein YPD1 5 19156 DEX 2.3  
YPR1 YDR368W Putative reductase 1 14 34733 DEX 1.8  
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Table A-4: List of proteins determined to be significantly different in the comparison 
between the log phase and stationary phase harvests of yeast samples grown on dextrose.  
Data were taken from the analysis described in Chapter 5.  Swiss Prot Name: protein entry 
in the SwissProt database followed by ‘_YEAST’.  Ordered Locus Name: predicted gene 
that encodes the protein sequence.  Description: Brief description of the protein.  Pep. Hits: 
number of peptide hits used to identify the protein in PLGS2.3.  Intact Mass: Average 
molecular weight of the protein after loss of initiating Methionine if known.  Up-reg in: 
sample in which the protein was most intense.  Fold Change frac: the degree to which a 
protein was up-regulated expressed as multiples of the intensity of the protein in the sample 
in which it was least intense for the fractionated BU analysis.  Fold Change un-frac: If the 
protein was also found to be differential expressed in the un-fractionated BU analysis, the 
corresponding fold change is included here.  This table continues on the next page. 
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AATC YLR027C Aspartate aminotransferase cytoplasmic 12 46028 LOG 1.9  
ADH1 YOL086C Alcohol dehydrogenase 1 19 36692 LOG 1.3 L – 2.1 
ADH3 YMR083W Alcohol dehydrogenase 3 mitochondrial 4 40344 LOG 4.5  
ADH6 YMR318C NADP dependent alcohol dehydrogenase 6 8 39591 LOG 15.3  
AHP1 YLR109W Peroxiredoxin type 2 12 19102 LOG 1.6 L - 1.5 
ARF2 YDL137W ADP ribosylation factor 2 5 20644 LOG 2.4  
CALM YBR109C Calmodulin 10 16124 LOG 7.6  
CCPR YKR066C Cytochrome c peroxidase mitochondrial 7 40327 LOG 4.7  
CH10 YOR020C 10 kDa heat shock protein mitochondrial 11 11365 LOG 19.4  
CPGL YFR044C Cys-Gly metallodipeptidase DUG1 6 52871 LOG 1.5 S – 1.1 
CYPC YML078W Peptidyl prolyl cis trans isomerase C mitocho 11 19906 LOG 2.5  
CYPD YDR304C Peptidyl prolyl cis trans isomerase D 12 25310 LOG 15.1  
CYPH YDR155C Peptidyl prolyl cis trans isomerase 12 17379 LOG 3.6  
CYS3 YAL012W Cystathionine gamma lyase 17 42516 LOG 2.0  
DCPS YLR270W Scavenger mRNA decapping enzyme DcpS 9 40743 LOG 2.9  
DHAS YDR158W Aspartate semialdehyde dehydrogenase 13 39518 LOG 7.5  
DHOM YJR139C Homoserine dehydrogenase 23 38478 LOG 1.8  
DUT YBR252W Deoxyuridine 5 triphosphate nucleotidohydro. 7 15297 LOG 1.5  
EF1A YPR080W Elongation factor 1 alpha 19 50001 LOG 1.3  
ESS1 YJR017C Peptidyl prolyl cis trans isomerase ESS1 5 19392 LOG 8.0  
EST1 YLR233C Telomere elongation protein EST1 5 81747 LOG 8.3  
FADH YDL168W S hydroxymethyl glutathione dehydrogenase 19 41015 LOG 1.4  
FAT2 YBR222C Peroxisomal coenzyme A synthetase 6 60450 LOG 4.5  
FIMB YDR129C Fimbrin 19 71773 LOG 1.3  
FKBP YNL135C FK506 binding protein 1 15 12150 LOG 5.3  
FKBP2 YDR519W FK506 binding protein 2 8 14477 LOG 8.0  
FRDS YEL047C Fumarate reductase 8 50812 LOG 6.0  
FSH1 YHR049W Family of serine hydrolases 1 12 27322 LOG 5.0  
G4P1 YGL105W GU4 nucleic binding protein 1 12 42057 LOG 5.7  
GCY YOR120W Protein GCY 30 35057 LOG 2.5  
GDIR YDL135C Rho GDP dissociation inhibitor 2 23124 LOG 2.6  
GLRX1 YCL035C Glutaredoxin 1 12 12372 LOG 1.4  
GPX3 YIR037W Peroxiredoxin HYR1 7 18629 LOG 20.8  
GRP78 YJL034W 78 kDa glucose regulated protein homolog 11 74422 LOG 1.6  
HOSC YDL182W Homocitrate synthase cytosolic isozyme 9 47069 LOG 2.0  
HPRT YDR399W Hypoxanthine guanine phosphoribosyltransf. 8 25174 LOG 2.0  
HSC82 YMR186W ATP dependent molecular chaperone HSC82 54 80849 LOG 1.3  
HSP12 YFL014W 12 kDa heat shock protein 18 11685 LOG 19.6  
HSP31 YDR533C Probable chaperone protein HSP31 13 25654 LOG 1.1 S - 1.4 
HSP60 YLR259C Heat shock protein 60 mitochondrial 33 60714 LOG 1.1 L - 1.5 
HSP74 YER103W Heat shock protein SSA4 15 69608 LOG 1.7 L - 2.5 
HSP76 YNL209W Heat shock protein SSB2 34 66553 LOG 1.9  
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HSP77 YJR045C Heat shock protein SSC1 mitochondrial 27 70584 LOG 1.3  
HSP7E YEL030W Heat shock protein SSC3 mitochondrial 11 70041 LOG 10.6  
IF4A YKR059W ATP dependent RNA helicase eIF4A 29 44669 LOG 5.7  
IF5A2 YEL034W Eukaryotic translation initiation factor 5A 2 2 17103 LOG 1.9  
IMDH3 YLR432W Probable inosine 5 monophosphate dehydrog. 19 56548 LOG 2.8  
KES1 YPL145C Protein KES1 10 49461 LOG 4.2  
KGUA YDR454C Guanylate kinase 15 20624 LOG 6.8  
KPYK2 YOR347C Pyruvate kinase 2 6 55160 LOG 18.1  
MET4 YNL103W Transcriptional activator of sulfur metabolism 3 74328 LOG 5.3  
METE YER091C 5 methyltetrahydropteroyltriglutamate homoC 47 85806 LOG 1.2 S - 1.8 
MLC1 YGL106W Myosin light chain 1 6 16434 LOG 4.0  
MMF1 YIL051C Protein MMF1 mitochondrial 8 15898 LOG 1.6  
MRP8 YKL142W Uncharacterized protein MRP8 23 25081 LOG 3.7  
NACA YHR193C Nascent polypeptide associated complex sub. 6 18697 LOG 6.4  
NDK YKL067W Nucleoside diphosphate kinase 10 17155 LOG 1.7  
NET1 YJL076W Nucleolar protein NET1 15 128453 LOG 22.5  
PCNA YBR088C Proliferating cell nuclear antigen 7 28897 LOG 1.6  
PDX3 YBR035C Pyridoxamine 5 phosphate oxidase 7 26891 LOG 1.6  
PGK YCR012W Phosphoglycerate kinase 37 44710 LOG 2.3 L - 3.3 
PNC1 YGL037C Nicotinamidase 4 24977 LOG 3.9 L - 1.4 
PROF YOR122C Profilin 7 13668 LOG 2.1 S - 1.8 
PRX1 YBL064C Mitochondrial peroxiredoxin PRX1 7 29477 LOG 2.5  
PUR7 YAR015W Phosphoribosylaminoimidazole succinocarb. 6 34510 LOG 39.3  
PUR91 YLR028C Bifunctional purine biosynthesis ADE16 24 65241 LOG 15.4  
PYRE YML106W Orotate phosphoribosyltransferase 1 9 24649 LOG 6.4  
RIB4 YOL143C 6 7 dimethyl 8 ribityllumazine synthase 2 18543 LOG 1.9  
RS27A YKL156W 40S ribosomal protein S27 A 5 8873 LOG 2.3  
SDO1L YHR087W SDO1 like protein YHR087W 9 12002 LOG 15.0  
SEC14 YMR079W SEC14 cytosolic factor 15 34878 LOG 2.2  
SGT2 YOR007C Small glutamine rich tetratricopeptide repeat 12 37195 LOG 9.5  
SMT3 YDR510W Ubiquitin like protein SMT3 5 11589 LOG 2.3  
SNU13 YEL026W 13 kDa ribonucleoprotein associated protein 4 13560 LOG 42.1  
STI1 YOR027W Heat shock protein STI1 19 66224 LOG 2.0  
SUCA YOR142W Succinyl CoA ligase ADP forming sub. 19 35010 LOG 4.3 S - 1.3 
SYEC YGL245W Glutamyl tRNA synthetase cytoplasmic 5 80791 LOG 1.9  
SYV YGR094W Valyl tRNA synthetase mitochondrial 31 125690 LOG 1.6  
THIL YPL028W Acetyl CoA acetyltransferase 15 41702 LOG 1.8  
TKT1 YPR074C Transketolase 1 19 73759 LOG 5.1 S - 1.3 
TRX1 YLR043C Thioredoxin 1 10 11227 LOG 1.6 L - 5.4 
TSA2 YDR453C Peroxiredoxin TSA2 2 21601 LOG 3.5  
UBC1 YDR177W Ubiquitin conjugating enzyme E2 24 kDa 7 24163 LOG 2.6  
UBIQ YIL148W Ubiquitin 13 8551 LOG 3.1  
UMPK YKL024C Uridylate kinase 13 22918 LOG 17.4  
VATA YKL080W V type proton ATPase catalytic subunit A 23 118562 LOG 3.3  
YB085 YBR085C Uncharacterized protein YBR085C A 4 9398 LOG 9.0  
YGP1 YNL160W Protein YGP1 6 37305 LOG 2.8  
YK23 YKR043C Uncharacterized protein YKR043C 8 31002 LOG 2.0  
YM71 YMR226C Uncharacterized oxidoreductase YMR226C 17 29140 LOG 2.1  
YO021 YOR021C Uncharacterized protein YOR021C 10 24744 LOG 2.4  
YPR1 YDR368W Putative reductase 1 14 34733 LOG 2.2  
ZEO1 YOL109W Protein ZEO1 11 12581 LOG 1.8 L - 4.6 
6PGD1 YHR183W 6 phosphogluconate dehydrogenase decarbox. 5 53509 STAT 40.7  
ABP1 YCR088W Actin binding protein 1 65536 STAT 54.6  
ACON YLR304C Aconitate hydratase mitochondrial 16 85314 STAT 2.7  
ACT YFL039C Actin 6 41662 STAT 17.4  
ADH2 YMR303C Alcohol dehydrogenase 2 12 36708 STAT 1.9 L - 5.4 
ADK YJR105W Adenosine kinase 7 36349 STAT 2.7 L - 1.7 
AGX1 YFL030W Alanine glyoxylate aminotransferase 1 5 41880 STAT 1.9  
ALF YKL060C Fructose bisphosphate aldolase 13 39595 STAT 2.0 L - 4.7 
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AMPL YKL103C Vacuolar aminopeptidase 1 14 57057 STAT 4.4 S - 3.2 
ATPA YBL099W ATP synthase subunit alpha mitochondrial 14 58572 STAT 11.4  
ATPB YJR121W ATP synthase subunit beta mitochondrial 10 54760 STAT 2.7  
BMH2 YDR099W Protein BMH2 20 31042 STAT 1.4  
CAJ1 YER048C Protein CAJ1 2 44826 STAT 3.8  
CCS1 YMR038C Superoxide dismutase 1 copper chaperone 7 27312 STAT 2.8  
CISY1 YNR001C Citrate synthase mitochondrial 11 53327 STAT 2.9 S - 2.4 
DAK1 YML070W Dihydroxyacetone kinase 1 17 62167 STAT 5.1 S - 1.9 
DHE4 YOR375C NADP specific glutamate dehydrogenase 1 16 49538 STAT 1.8 S - 2.2 
DLDH YFL018C Dihydrolipoyl dehydrogenase mitochondrial 5 53976 STAT 3.1  
DLHH YDL086W Putative carboxymethylenebutenolidase 7 30817 STAT 2.3  
ECM33 YBR078W Cell wall protein ECM33 2 43741 STAT 4.2  
EF1G1 YPL048W Elongation factor 1 gamma 1 14 47058 STAT 2.4  
EF1G2 YKL081W Elongation factor 1 gamma 2 5 46490 STAT 8.5  
EF2 YOR133W Elongation factor 2 16 93230 STAT 1.5 L - 1.3 
ENO1 YGR254W Enolase 1 18 46773 STAT 1.5 S - 2.1 
ESA1 YOR244W Histone acetyltransferase ESA1 3 52579 STAT 9.6  
FHP YGR234W Flavohemoprotein 5 44618 STAT 52.4  
G3P1 YJL052W Glyceraldehyde 3 phosphate dehydrogenase 1 15 35727 STAT 13.4 S - 3.0 
G3P2 YJR009C Glyceraldehyde 3 phosphate dehydrogenase 2 16 35824 STAT 3.5  
G3P3 YGR192C Glyceraldehyde 3 phosphate dehydrogenase 3 15 35724 STAT 1.4 L - 2.2 
G6PD YNL241C Glucose 6 phosphate 1 dehydrogenase 15 57485 STAT 1.3 S - 1.8 
G6PI YBR196C Glucose 6 phosphate isomerase 24 61261 STAT 1.4 S - 1.4 
GGA2 YHR108W ADP ribosylation factor binding GGA2 10 64307 STAT 3.0  
GLRX2 YDR2153W Glutaredoxin 2 mitochondrial 10 15851 STAT 1.6  
GLYC YLR058C Serine hydroxymethyltransferase cytosolic 8 52185 STAT 2.1  
GRE3 YHR104W NADPH dependent aldose reductase GRE3 6 37095 STAT 6.0  
GSHR YPL091W Glutathione reductase 22 53407 STAT 1.4 S - 2.0 
GTO2 YGR154C Glutathione S transferase omega like 2 17 43246 STAT 4.0  
HBN1 YCL026C Putative nitroreductase HBN1 9 20980 STAT 4.7 S - 5.4 
HS104 YLL026W Heat shock protein 104 15 101972 STAT 23.3 S - 1.7 
HSP26 YBR072W Heat shock protein 26 11 23865 STAT 1.9  
HSP71 YAL005C Heat shock protein SSA1 30 69614 STAT 2.1 L - 1.1 
HSP72 YLL024C Heat shock protein SSA2 26 69427 STAT 2.1 L - 1.4 
HSP73 YBL075C Heat shock protein SSA3 15 70503 STAT 2.8  
HSP7F YPL106C Heat shock protein homolog SSE1 8 77318 STAT 2.3  
HSP82 YPL240C ATP dependent molecular chaperone HSP82 30 81356 STAT 1.5 L - 2.4 
HXKB YGL253W Hexokinase 2 9 53908 STAT 2.2 S - 1.3 
HXKG YCL040W Glucokinase 1 6 55342 STAT 16.4  
IDH1 YNL037C Isocitrate dehydrogenase NAD subunit 1 mito 11 39299 STAT 15.8  
IDH2 YOR136W Isocitrate dehydrogenase NAD subunit 2 mito 4 39714 STAT 11.0  
IF4B YPR163C Eukaryotic translation initiation factor 4B 6 48493 STAT 11.0  
IMDH2 YHR216W Inosine 5 monophosphate dehydrogenase 10 56493 STAT 2.0  
IMDH4 YML056C Probable inosine 5 monophosphate dehydrog. 8 56357 STAT 1.5  
KAR YNL188W NADPH dependent alpha keto amide reduct. 8 35538 STAT 9.2 S - 2.0 
KPYK1 YAL038W Pyruvate kinase 1 11 54510 STAT 1.5 L - 1.7 
LEU1 YNL104C 2 isopropylmalate synthase 9 68366 STAT 7.3  
MAS5 YNL064W Mitochondrial protein import protein MAS5 4 44642 STAT 2.8  
MBF1 YOR298C Multiprotein bridging factor 1 5 16393 STAT 6.6  
MDHM YKL085W Malate dehydrogenase mitochondrial 23 35627 STAT 2.3 S - 2.7 
MDHP YDL078C Malate dehydrogenase peroxisomal 13 37162 STAT 17.1  
MET17 YLR303W Protein MET17 13 48641 STAT 1.6 L - 1.6 
METK1 YLR180W S adenosylmethionine synthetase 1 8 41792 STAT 1.7  
MPG1 YDL055C Mannose 1 phosphate guanyltransferase 2 39541 STAT 2.8  
NACB1 YPL037C Nascent polypeptide associated complex 5 17009 STAT 2.6  
ODPB YBR221C Pyruvate dehydrogenase E1 component sub. 7 40028 STAT 2.0  
OMS1 YDR316W Methyltransferase OMS1 mitochondrial 2 55554 STAT 32.7  
OYE2 YHR179W NADPH dehydrogenase 2 13 44982 STAT 2.3 S - 2.6 
OYE3 YPL171C NADPH dehydrogenase 3 21 44892 STAT 3.1 S - 3.6 
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OYE3 YPL171C NADPH dehydrogenase 3 21 44892 STAT 3.1 S - 3.6 
PABP YER165W Polyadenylate binding protein cytoplasmic  9 64304 STAT 2.6  
PDC1 YLR044C Pyruvate decarboxylase isozyme 1 24 61456 STAT 2.2 L - 1.3 
PDI YCL043C Protein disulfide isomerase 20 58190 STAT 13.4  
PMM YFL045C Phosphomannomutase 6 29044 STAT 9.5  
PPID YLR216C Peptidyl prolyl cis trans isomerase CPR6 12 42045 STAT 8.1  
PUR2 YGL234W Bifunctional purine biosynthetic ADE5 13 86014 STAT 3.1  
PUR92 YMR120C Bifunctional purine biosynthesis ADE17 26 65222 STAT 1.8 S - 1.7 
PURA YNL220W Adenylosuccinate synthetase 6 48249 STAT 103.9 S - 3.4 
QCR2 YPR191W Cytochrome b c1 complex subunit 2 mit. 11 40453 STAT 2.9  
RAD7 YJR052W DNA repair protein RAD7 4 63737 STAT 4.1  
RIB3 YOL143C 3 4 dihydroxy 2 butanone 4 phosphate synth. 1 22553 STAT 3.4  
RIR4 YGR180C Ribonucleoside diphosphate reductase 6 40028 STAT 2.2  
RLA0 YLR340W 60S acidic ribosomal protein P0 4 33745 STAT 4.0  
RS3 YNL178W 40S ribosomal protein S3 1 26486 STAT 3.6  
RTN1 YDR233C Reticulon like protein 1 2 32895 STAT 2.2  
SAHH YER043C Adenosylhomocysteinase 4 49094 STAT 14.2 L - 1.2 
SIS1 YNL007C Protein SIS1 12 37566 STAT 1.5  
SODM YHR008C Superoxide dismutase Mn mitochondrial 5 25758 STAT 2.4  
SUB2 YDL084W ATP dependent RNA helicase SUB2 4 50277 STAT 2.4  
SYLC YPL160W Leucyl tRNA synthetase cytoplasmic 12 124062 STAT 1.5  
TMA7 YLR262C Translation machinery associated protein 7 2 6936 STAT 2.5  
TRXB1 YDR353W Thioredoxin reductase 1 14 34216 STAT 2.4 S - 1.4 
VTI1 YMR197C t SNARE VTI1 3 24652 STAT 3.1  
YCP4 YCR004C Flavoprotein like protein YCP4 4 26333 STAT 1.8  
YCZ2 YCR102C Uncharacterized protein YCR102C    2 40096 STAT 1.8  
YMN1 YML131W Uncharacterized membrane YML131W 13 39951 STAT 6.6 S - 5.8 
YMY0 YMR090W UPF0659 protein YMR090W 3 24866 STAT 4.4 S - 1.4 
YMY9 YMR099C UPF0010 protein YMR099C 3 33934 STAT 3.9  
YN14 YNL274C Putative 2 hydroxyacid dehydrogenase 2 38807 STAT 32.9  
YNN4 YNL134C Uncharacterized protein YNL134C 19 41164 STAT 1.3 S – 1.5 
 
 
 
